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Summary
This project addressed a variety of aspects of the bacterial transposon Tn7. 
Firstly, the known sequence of the element was completed and the entire 
sequence compiled and presented. This was analysed with particular 
emphasis on the evolutionary implications of a series of directly repeated 
DNA motifs in the interior of Tn7 were discussed. These repeats were tested 
by gel retardation analysis for potential function as binding sites for Tn7 
encoded proteins. These data are presented in Chapter 3.
Chapter 4 deals with the construction of plasmids designed to co-ordinately 
over-express the TnsA, B, C and D proteins. These plasmids were tested for 
their ability to support transposition in vivo. One plasmid gave rise to a 
peculiar phenomenon in these assays,, a model is proposed for its action. A 
number of attempts to establish a Tn7 in vitro reaction are also described.
Chapter 5 addresses the level of TnsD activity present in various cell extracts. 
An interaction between TnsD and one or more of TnsABC is detected and 
investigated and found be regulated by the hydrolysis of ATP. In the absence 
of ATP and magnesium ions a TnsABCD extract has no TnsD activity 
detectable by gel retardation assays, however in the presence of ATP and 
magnesium the same extract displays a detectable activity. Extracts 
containing TnsC and TnsD or TnsD on its own are not affected in this way.
Chapter 6 presents data, initially identifying an IHF binding site in the attTn7 
locus and localising the sequence determinants required for binding. IHF is 
demonstrated to induce a bend at the locus is demonstrated. The role of IHF 
in vivo in Tn7 transposition is investigated and it is demonstrated that 
transposition is reduced 6 fold in the absence of IHF. The potential role of IHF 
in the expression of the phoS gene, adjacent to attTn7 is also addressed.
vi
Chapter 1 
Introduction
1
1.1 General Introduction
The study of genetic recombination has been a vital corner stone in the 
development of molecular biology. Recombination has been used both as 
a powerful tool for dissection of genetic function and equally importantly 
also as a topic of research in its own right Studies of recombination 
processes have shed much light on processes ranging from genome 
evolution to the molecular intricacies of protein-DNA interactions and 
DNA structure. Recombination can be essentially viewed as the process 
whereby DNA molecules can be broken and rejoined. However, within 
this broad definition, it is possible to discriminate between two distinct 
classes of recombination reactions.
1)Homologous Recombination
This process is dependent on the presence of regions of homology in the 
exchanging molecules. One of the principle roles of homologous 
recombination is probably in the repair of DNA damage. However, 
homologous recombination is also important in the generation of genetic 
diversity in the processes of meiotic recombination in eukaryotes and Hfr 
generation and mating in prokaryotes (Smith, G. R., 1991).
2)Non-homologous Recombination
This class of events contains a wide and varied spectrum of rearrangement 
processes. The best studied non-homologous recombination reactions are 
those of conservative site specific recombination (CSSR) and 
transposition.
The simplest CSSR system comprises two DNA sites and a recombinase 
enzyme. The recombinase functions by bringing the two DNA sites 
together (synapsis) and catalyses a strand exchange reaction between the 
two sites. No external energy source is required, the energy of cleaved 
phosphodiester bonds is conserved by formation of a covalently linked 
recombinase-DNA intermediate (Stark et al., 1992).
Transposition is a process whereby a defined segment of DNA, the 
transposable element, can translocate to a novel site in the host cell’s
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genome. Transposable elements are a very diverse family of molecules 
varying in size, structure, number of encoded genes and transposition 
mechanism. A simplistic view of transposition involves the recognition 
of the ends of the transposable element by an element encoded protein, 
the transposase. The transposase brings about synapsis of the ends of the 
transposon. Thus far the process seems very similar to that of CSSR, 
however in transposition a third DNA site, the target site, must be 
recruited into the synapse prior to the strand exchange reaction. As will be 
discussed below the precise order of DNA cleavage and strand exchange 
reactions varies depending on the transposable element being studied. 
However, one emerging rule of transposition is that the 3-OH groups at 
the ends of the element are exposed and used in a nucleophilic attack on 
the phosphodiester bonds in the target DNA. As with CSSR no external 
energy is required in the strand exchange process. In contrast with CSSR, 
however, in the systems where this question has been addressed the 
reaction appears to proceed via a one step transesterification rather than 
via a covalent protein-DNA intermediate (Engelman, 1991 Mizuuchi,
1991).
1.2 Classes of Transposable Elements
As stated above transposable elements are highly diverged in structure. It 
is possible, however, to divide bacterial elements into several broadly 
defined classes.
1) Insertion Sequences
Insertion sequences (IS) are structurally the most simple transposable 
elements. They encode only the required cis acting sequences and trans 
acting functions to catalyse the transposition reaction. These elements are 
typically 700bp to 1.6kbp in length (Galas and Chandler 1989 ).
2) Compound Transposons
Compound transposons are created by two IS elements mobilising the 
region between them. Thus, in a compound transposon, the IS encoded 
transposase acts at the outer ends of the flanking IS elements.
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3) Complex Transposons
This is a highly diverse family of elements. They are characterised by their 
large size and complex architecture. The cis acting terminal sequences are 
frequently large and contain complex arrays of protein binding sites. There 
may also be several transposon encoded genes whose functions are 
required for transposition.
4) a) Conjugative transposons
These transposons differ from the elements described above in that they 
do not cause target site duplications on insertion. When present in a Gram 
positive host these elements confer the ability to act as a conjugational 
donor to the host. Thus the element excises from the genome of one 
bacterium and inserts into the genome of another. The element appears to 
excise by making nicks flush with either the 5' or 3* end and nicks on the 
opposite strand 5 bases into the flanking host sequences. These staggered 
ends are ligated creating a covalently closed supercoiled transposon circle, 
in which the ends of the element are separated by a 5 bp heteroduplex 
region (Caparon and Scott 1989). This region corresponds to the host 
extensions made in the initial excision and is termed the coupling 
sequence. The excision also generates a covalently closed donor backbone 
molecule lacking the transposon. Incision into the recipient is essentially 
the reverse of excision. Nicks are made at either end of the coupling 
sequence and a 5 base staggered cut made in the target sequence. The 
exposed ends are then ligated. This generates an insertion product flanked 
by 5 bp heteroduplexes. These heteroduplexes are apparently resolved by 
DNA replication. Thus the final product is the inserted transposon 
flanked by the initial 5 bp target sequence on one side and one of the 5 bp 
coupling sequences derived from the initial host (Scott 1992 ).
4) b) Integrons
A variety of mobile genetic elements have been shown to possess various 
antibiotic resistance genes in a common sequence element. This element 
comprises a gene with homology to lambda integrase ( Mercier, Lachapelle 
et al. 1990 ), one or more antibiotic resistance genes, and a conserved
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region downstream of the resistance genes (Nucken, Henschke et al. 1991, 
Stokes and Hall 1989 ). This work was recently reviewed (Amabile-Cuevas, 
1992). Although the commonest genes found in integrons are for 
antibiotic resistance determinants other genes are also found. The 
resistance genes are positioned in the opposite orientation to the integrase 
gene and appear to be transcribed by a promoter located between the 
integrase and first resistance gene. Each resistance gene is associated with a 
conserved 59 bp element found at the 3' end of the gene (Hall, Brookes et 
al. 1991 ). The 59 bp element possesses dyad symmetry. The discovery of a 
family of integrons, differing only in resistance genes, led to the proposal 
that these elements were able to recruit resistance genes via a site specific 
recombination process. It has subsequently been shown that the integron 
encoded integrase can direct a site specific recombination reaction between 
59 bp repeats. This has been demonstrated by studies of integrase mediated 
formation of co-integrates between two replicons containing integrons, 
(Martinez and De la Cruz 1988, Martinez and De la Cruz 1990 ), and also by 
the observation that over-expression of the integrase permits detection of 
excised, covalently closed dcular resistance gene cassettes (Collis and Hall 
1992 ). Although the recombination site has been mapped a number of 
fundamental questions as to the nature of the reaction itself remain. The 
recombination event occurs within the sequence GTT at the 3' end of the 
59 bp element. Because of the dyad symmetry of the 59bp there is a related 
GTT site at the 5' end of the element. However, the discoveries that 
inserted genes in the integrons always lie in the same orientation and that 
the same resistance genes in different integrons have identical 59bp 
repeats has demonstrated that recombination occurs exclusively at the 3' 
GTT. How this discrimination is mediated is unknown.
A further level of complexity to integrons is that the integron may be a 
transposable element itself (Bissonnette and Roy 1992 ). This matter as 
well as the integration of gene cassettes is dealt with in more detail in 
Chapter 3.
1.3 Regulation Of Transposition
Because of the potentially mutagenic effects of transposition it is 
important that transposable elements possess mechanisms to restrict the 
level of transposition. In principle transposition can be controlled at 
several levels.
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1) By restricting the amount of transposase present in the cell.
In the case of TnlO this is achieved by regulation of both transcription of 
the gene and translation of the mRNA. Both phage Mu and Tn3 also 
demonstrate control of expression of the transposase by repression of its 
transcription by other element encoded proteins (Pato 1989 ; Sherratt 1989).
2) By producing a protein which inhibits transposase activity or competes 
with transposase for binding to its cognate DNA site.
Perhaps the most sophisticated example of this form of control is that 
shown by certain IS elements. Analysis of the sequence of IS1 shows the 
presence of three potential open reading frames, Ins A, InsB and InsB'. 
InsB and B' are in phase and overlap, InsB' is extended by 42 codons at the 
5' end relative to InsB. The InsA protein has been detected and shown to 
bind the ends of IS1 (Zerbib, Jakowec et al. 1987 ). This protein appears to 
auto-regulate its expression, presumably by occlusion of its promoter in 
the left end of IS1. In addition to this role, InsA also exerts a negative 
control on transposition. InsB has never been directly detected. However 
both genetic and direct physical evidence have demonstrated that a fusion 
protein corresponding to InsAB' is produced by a -1 frameshifting event 
(Sekine and Ohtsubo 1989; Escoubas, Prere et al. 1991).
This frameshift is directed by a sequence in the IS1 mRNA which is 
similar to the -1 frameshifting signal used by some retroviruses in 
expression of gag-pro. Constitutive expression of an artificially engineered 
InsAB' fusion led to greatly elevated levels of transposition of both 
defective and wild type IS1 in vivo. Thus it appears that the InsAB' 
protein is the IS1 transposase.
These obsevations have led to the proposal that IS1 transposition is 
controlled by the relative ratios of the abundance of the InsA repressor and 
the InsAB’ transposase. Similar frameshifting is observed with several 
other IS elements.
3) By coordinating transposition events with aspects of the cell cycle.
As discussed below, TnlO perferentially undergoes transposition following 
DNA replication through the element.
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Diagramatic Representation of Replicative and Conservative Transposition Mechanisms. 
As discussed in the text the precise timings and requirements for the reaction steps vary 
between elements.
1.4 Transposition Mechanisms
Two broad classifications of transposition mechanism were inferred from 
in vivo genetic studies of transposition. Elements can transpose by either a 
conservative or a replicative mechanism (see Fig. 1). Models for these 
transposition processes have been proposed by Shapiro, 1979, and Arthur 
and Sherratt, 1979. In replicative transposition DNA replication is an 
obligatory step in the transposition reaction. In contrast, in conservative 
transposition DNA replication is not an intrinsic requirement of the 
reaction. It may, however, be required for repair of gaps and nicks left by 
the conservative reaction, see Fig. 1.1.
1.5 Replicative Transposition
The best characterised elements which transpose replicatively are the 
members of the Tn3 family and Phage Mu (Pato 1989 ; Sherratt 1989 ). Tn3 
encodes two functions which are required for the complete transposition 
reaction, transposase (tnpA gene) and resolvase (tnpR gene). Mu encodes 
two functions MuA and MuB which are involved in the transposition 
reaction. MuA is the transposase, the function of MuB is more complex 
but is involved in target molecule selection and also as an activator of 
MuA. Mu will be discussed in more detail below.
In replicative transposition the transposase catalyses the nicking of the 3' 
ends of the transposable element and cutting at the target site. The 3'-OH 
groups of the element are then joined to the exposed 5' phosphate of the 
cleaved target sequences. The exposed 3'-OH's of the target then prime 
DNA replication into the transposable element sequences. The net result 
of these processes is to link the donor and recipient molecule by two 
directly repeated copies of the transposable element. This structure is 
called a co-integrate. In the Tn3 family the resolvase then catalyses a CSSR 
reaction between sites on the two copies of the element. This resolution 
reaction restores the two starting molecules with the important difference 
that the recipient molecule now also contains a copy of the transposable 
element.
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1.6 Conservative Transposition
In contrast with replicative transposition, conservative transposition 
results from double strand cleavage at the ends of the transposable 
element. The excised linear transposon is then inserted into the target site. 
In the systems thus far studied the exposed 3'-OH ends of the element are 
joined to the 5' phosphates of the cleaved recipient. Thus the net result of 
this is the generation of a linear donor backbone and a novel insertion 
product in the recipient. The insertion product will have short gaps at the 
5' ends of the newly inserted transposon. These will be repaired by the 
DNA replication machinery of the host. The broken donor molecule will 
either be degraded by cellular exonucleases or repaired by the host double 
strand break repair mechanism. If the template used for repair is a sister 
chromosome which lacks a copy of the element at the analogous locus 
then there will be an apparent loss of the element at that locus. However, 
if the template has a copy of the element then the original donor will 
effectively be regenerated.
The compound transposon TnlO has been demonstrated both in vivo and 
in vitro to transpose via a conservative mechanism(Morisato and 
Kleckner 1984 ; Bender and Kleckner 1986 ; Roberts and Kleckner 1988 ; 
Benjamin and Kleckner 1992 ). It has a mechanism whereby it increases 
the likelihood that the double strand gap repair will restore the donor site 
with a copy of TnlO. In wild type E. coli adenine residues within the 
sequence GATC are methylated at the N-6 position by the Dam methylase. 
However, following replication, the dam sites are transiently hemi- 
methylated. Elegant in vivo studies with IS10 revealed that IS10 
transposition is activated by hemi-methylation (Roberts, Hoopes et al. 
1985). This ensures that transposition is induced following replication. 
Further, one of the hemi-methylated forms is induced more strongly than 
the other. Combined, these effects serve to induce transposition from one 
of the sister molecules. As this event occurs shortly after replication the 
intact sister is available to act as a repair template, thus ensuring survival 
of the element at this locus.
Thus, although the actual transposition mechanism of TnlO is 
conservative, the end result of the process is effectively replicative. This 
problem has dogged the study of in vivo transposition mechanism. 
Whilst it is possible by mutational analysis to determine if an element
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transposes replicatively; mutation of the resolvase gene, or its site, will 
stabilise co-integrates and allow their detection, it is, however, harder to 
rigorously prove, in vivo, that an element transposes conservatively.
It is necessary, therefore, to develop an in vitro transposition reaction in 
order to be able to address questions of reaction mechanism. It has also 
become clear from in vitro studies that manipulation of reaction 
conditions enables the stabilisation of normally transient intermediates in 
the reaction. Thus the development of in vitro reactions both addresses 
the overall reaction mechanism, and also enables molecular dissection of 
individual steps in the reaction.
1.7 Consequences of Transposition for the host cell
The most obvious effect a transposon can have is to act as an insertional 
mutagen, indeed it was by virtue of this property that transposable 
elements were first identified. However transposons can also act to cause 
large scale alterations to the chrormosome structure of the host. If several 
copies of an element exist within an organism's genome then there is the 
potential for homologous recombination events to occur between 
different copies of the element. This can, therefore, lead to either 
inversions, deletions or translocations of large regions of DNA. In 
addition to these rearrangements brought about by the host cells 
homologous recombination machinery, the actual transposition process 
itself can lead to similar large scale inversions and deletions of the host 
geneome. In particlular intramolecular transposition can be potentially 
highly damaging to the host replicon. as detailed in Kleckner, 1989 
composite transposons have the largest potential to generate 
rearrangements. Potential transposon mediated rearrangements are 
shown in Fig. 1.2.
1.8 In vitro Transposition Systems
1.8.1 Phage Mu
Mu is a 37kb bacteriophage which replicates its genome by a replicative 
transposition mechanism.
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Mu encodes two proteins which are required in the transposition reaction; 
MuA, the transposase and MuB, involved in activating strand transfer by 
MuA and also in target molecule selection (Mizuuchi, 1992 ).
MuA has been demonstrated to bind to multiple repeat motifs at the Mu 
termini (Craigie, 1984). The sites are based on a 22 bp consensus and are 
present in three copies at both ends of the element. The sites are 
designated LI, L2 and L3 at the left end and Rl, R2 and R3 at the right end. 
A separate domain of MuA also binds a transpositional enhancer, the IAS 
(Mizuuchi, 1989 ). The structure and function of the IAS is discussed in 
Chapter 3.
Reconstruction of a Mu in vitro transposition reaction has allowed 
identification of the individual steps in the reaction. In the presence of 
MuA, the cellular proteins Hu and IHF, and Ca++ a mini-Mu substrate 
comprising Mu ends and the IAS forms a stable complex in which MuA 
has brought about synapsis of the Mu ends, this complex is termed the SSC 
(Surette, 1992). Addition of Mg++ to the reaction causes MuA to nick at 
the 3'-OH ends of Mu to form a Cleaved Donor Complex (CDC) (Craigie, 
1987). Addition of target DNA, MuB and ATP to the CDC catalyses the 
strand transfer reaction. Transposition can occur in the absence of MuB, 
however the presence of MuB greatly enhances the rate of the strand 
exchange reaction (Baker, 1991).
1.8.2 TnlO
In TnlO transposition there is only one element encoded protein required 
in the in vitro system, the transposase encoded by the ISlO(right). The 
transposase encoded by ISlO(left) is non-functional. Once again the host 
encoded proteins Hu and IHF play a stimulatory role in in vitro 
transposition reactions. The roles of these and other host proteins in 
transposition of a variety of elements is discussed in Chapter 6.
The TnlO in vitro reaction produces products analogous to the Mu CDC 
and STC, the terminology used, however is different. To date no complex 
corresponding to synapsed but non-cleaved ends has been detected. 
Because TnlO transposes non-replicatively the CDC analogue is an excised 
transposon form (ETF) of TnlO created by double strand cleavage at the 
ends of the element (Haniford, 1991). The ends are synapsed by bound
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transposase. Synapsis of the ends presumably occurs prior to cleavage as 
the excised transposon retains its supercoiling. The production of the 
strand transfer complex occurs primarily as an intramolecular event, 
producing a relaxed transposon circle as the principle product (Morisato, 
1987 ). Advances in the Kleckner laboratory, primarily in purification of 
the transposase, reported at a recent meeting, have permitted the 
development of an efficient intermolecular in vitro reaction.
1.8.3 Retro-elements
Retrotransposons and retroviruses share the ability to reverse transcribe 
an RNA copy of their genome to double stranded DNA and integrate this 
DNA into the host genome. The integration event is catalysed by the retro- 
element encoded protein, IN (Craigie, 1990).
In the majority of retro-elements thus far studied the IN protein initially 
serves to trim two nucleotides from the 3f end of the element to expose 
the true ends of the element. This single strand cleavage can be seen as 
analogous to the nicking reaction carried out by MuA (Haniford, 1992). 
This event is not an obligatory step in the integration process, artificially 
generated "pre-trimmed" substrates are efficiently used in vitro. 
Furthermore, most of the yeast Ty retrotransposons have reverse- 
transcripts exactly the same length as the integrated element (Sandmeyer,
1992). Trimming therefore appears to function purely to expose the ends 
of the element.
The integration event apparently proceeds by a one step trans- 
esterification reaction as is found for Mu transposition (Engelman, 1991; 
Mizuuchi, 1991).
1.9 Transposition Insertion Sites
A feature common to most transposable elements is that they create a 
duplication of host sequences at the site of integration. This is ascribed to a 
staggered break with 5’ extensions being generated in the target DNA. The 
3-OH of the transposable element are then ligated to these 5' ends. The 
result of this is to generate an insertion flanked by a short direct repeat of 
the host sequence. The length of the direct repeat varies between elements 
but is constant for a given element; e.g. TnlO duplicates 9 bp, Tn7 5 bp, IS1 
9 bp, Tn5 4 bp and Tn3 5bp. Whilst for some elements the choice of target
1 1
site is apparently random a growing body of evidence suggests that both 
sequence and structural determinants of the target DNA play important 
roles in determining insertion site specificity. As discussed below this is at 
its most extreme in the hot site transposition of Tn7, the predominant 
recipient site of Tn7 transposition on introduction to naive cells is a single 
locus in the genome, attTn7 (Lichtenstein, 1981; Lichtenstein, 1982). This is 
discussed in greater detail below.
Studies of the major IS1 insertion site in the plasmid pBR322 have 
revealed that this locus contains several binding sites for the host encoded 
protein IHF (Prentki, 1987). IHF induces strong bends in this region, it is 
possible, therefore, that local perturbation of the DNA structure may 
favour insertion of IS1 at this locus.
TnlO has a favoured target sequence, NGCTNAGCN. Sequences 
surrounding this consensus also influence the use of target sites (Lee, 1987; 
Bender, 1992 ). Intriguingly IHF also appears to influence target choice in 
TnlO intramolecular reactions. This effect may be mediated by IHF binding 
to the end of the element and inducing a bend which brings internal 
sequences close to the synapsed ends of the ETF (unpublished data cited in 
Mizuuchi, 1992 ).
An initial analysis of favoured retroviral integration sites suggested that 
retroviruses prefer to insert in transcriptionally active regions and regions 
which demonstrate DNAsel hypersensitivity in the host genome. Recent 
work in vitro studied the integration sites of MoMLV on nucleosome 
associated DNA. This gave the suprising result that the presence of 
nucleosomes on a given stretch of DNA actually stimulated insertion in 
that DNA. It is probable that some structural feature of the DNA, induced 
by nucleosome binding, causes this selection(Prydak, 1992; Craigie, 1992).
1.10 Discrimination between intra- and inter molecular transposition
A number of transposable elements appear to able to discriminate between 
target sites near to the transposon donor site and those located at a distance 
and to preferentially insert at the distant sites. This is the phenomenon of 
transpositional immunity. Another manifestation of the same process is 
that the presence of the transposable element in a DNA molecule blocks a 
second insertion event in that molecule. In the systems thus far studied
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the immunity is conferred by the ends of the transposable element, 
specifically those sequences involved in transposase binding. In the case of 
Mu the presence of a single Mu end will prevent insertion of Mu within 
approximately 20 kb of the single end. Immunity is also observed with Tn7 
and the Tn3 family. The mechanism of immunity in the Tn3 family is still 
mysterious, however, with the development of in vitro systems for Mu 
and Tn7 transposition some aspects of this phenomenon in these systems 
are becoming clear. Both Mu and Tn7 differ from Tn3 in that they encode 
several transposition proteins, including functions whose roles are 
specifically in target site selection. Thus, separate proteins are involved in 
transposon end binding and target site binding. The case of Mu is currently 
the best understood.
As described above MuA is responsible for end binding, synapsis and 
strand cleavage while MuB acts as a target site selector and activator of 
MuA catalysed strand transfer reaction. MuB is an ATP dependent DNA 
binding protein with little or no sequence specificity, its affinity for DNA is 
much greater in the presence of ATP (Adzuma, 1988). MuA protein 
induces the hydrolysis of ATP by MuB and thus its dissociation from 
DNA. Therefore, if MuA is bound to a Mu end on a DNA substrate it will 
effectively keep that molecule free of stably bound MuB. The net effect of 
these processes is to cause MuB to accumulate on DNA which does not 
possess Mu ends (Adzuma, 1988 ). A potential paradox exists as at some 
point MuA bound to transposon ends must come in contact with MuB 
bound to target DNA and perform a strand exchange reaction rather than 
simply cause MuB dissociation. A partial resolution of this paradox comes 
from the observation that MuA within the Cleaved Donor Complex is 
unable to cause MuB dissociation. However, once the Strand Transfer 
Complex is formed MuA must recover its ability to remove MuB in order 
to prevent the subsequent insertion of further donors into the target. 
Clearly several questions remain to be answered about this process.
1.11 Tn7
Tn7 is a large and complex transposon with a number of peculiar and 
unique properties(Craig, 1991). It encodes an unusually high number of 
genes whose functions are required for transposition, it transposes to a 
specific site, attTn7, at a high frequency and it can undergo two distinct 
transposition pathways, the site specific reaction and also a lower
13
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frequency random event. Five Tn7 encoded genes, tnsABCDE, are required 
for transposition, overlapping subsets of these genes are required for the 
two pathways. The pathway directed to the "hot site", attTn7, requires 
tnsABC  and D while the random site reaction requires tnsABC and E. 
(Rogers, 1986 ; Waddell, 1988; Smith, 1986 )
The tns genes were identified by complementation assays in vivo and 
have subsequently been sequenced (Flores, 1990). They are encoded in the 
right end of the element and are very closely linked to each other. In a 
number of cases the putative coding regions overlap by a few nucleotides. 
This has led to the suggestion that the genes may be translationally 
coupled.
Tn7 also encodes three drug resistance determ inants, for 
streptomycin/spectinomycin resistance, trimethoprim resistance and 
s trep to th ric in  resistence and an lam bda like in tegrase 
pseudogene(Sundstrom, 1991). These genes are in a structure that 
resembles the integron gene recruitment system found in the Tn21 family 
and several broad host range plasmids(Amabile-Cuevas, 1992). The 
significance of this structure will be discussed in Chapter 3.
When this project was started the majority of the sequence of Tn7 had 
been determined. Chapter 3 describes work to complete the sequence and 
subsequent analysis of the data obtained.
1 .1 2  cis Acting Sequences at Tn7 Ends
The ends of Tn7 possess a complex arrangement of sequence motifs. The 
extreme termini of Tn7 are perfect inverted repeats of an eight base pair 
element. The eight bp motif is adjacent to a 22bp element, thus the ends of 
Tn7 are effectively imperfect 30bp inverted repeats. The right end of Tn7 
contains 3 more copies of the 22bp repeat, these copies are directly repeated 
and abut onto one another. Contrastingly, the left end of Tn7 contains a 
further two copies of the 2 2 bp element, the left end motifs are also directly 
repeated but are more widely spaced than the right end repeats. See Fig. 
1.3. These 22bp motifs are bound by TnsB (McKown, 1987; Arciszewska, 
1989 ; Morrell, 1990; Arciszewska, 1991; Arciszewska, 1991; Tang, 1991). 
Work presented in Chapter 3 examines the sequence requirements for 
TnsB binding.
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In addition to being structurally diverged the two ends are also 
functionally distinct. A mini-Tn7 element with two right ends in inverted 
repeat transposes at a near to wild type level, however an element with 
two left ends in inverted repeat fails to transpose. Intriguingly a single Tn7 
right end confers transposition immunity to a 50kb plasmid, however, a 
left end does not have this effect(Arciszewska, 1989 ).
1.13 cis Acting Sequences at attTn7
The specific target site directed by the TnsABCD pathway is located at 
minute 84 of the E. coli chromosome (Lichtenstein, 1981 ; Lichtenstein, 
1982 ). The insertion site lies within the transcriptional terminator of the 
GlmS gene (Gay, 1986). This gene is highly conserved amongst Gram 
negative bacteria and appears to function as a site for Tn7 insertion in 
these bacteria. The discrimination between site specific and random site 
pathways is made by the use of TnsD or TnsE respectively. It has been 
shown that TnsD binds specifically to DNA sequences to the right of the 
actual insertion site. The central nucleotide of the 5 bp sequence duplicated 
on Tn7 insertion is designated position 0, positions to the right, GlmS side, 
are given a positive sign, those to the left, PstS, side are given a negative 
sign. The sequence determinants required for TnsD binding lie between 
+28 to +53. These are the only sequences required to direct wild type levels 
of Tn7 insertion in vivo; the sequence at the actual site of insertion can be 
altered with no effect on its function as a target site (Qadri, 1986 ; Gringauz, 
1988 ; Kubo, 1990 ; Waddell, 1989 ). A further feature of Tn7 insertion into 
attTn7  is that it occurs in a defined orientation, the Tn7 right end is 
proximal to GlmS.
When the attTn7 site is occupied by Tn7, although the sequences which 
define site activity are not altered, the site is not used as a recipient for a 
further insertion event. This is one manifestation of transposition 
immunity mediated by Tn7. When the site is occupied TnsABCD 
mediated transposition events still occur to related sequences in the 
genome, these sites are called pseudo attTn7 sites and have sequences 
homologous to the +23 to +53 TnsD binding site (Kubo, 1990 ).
These rare pseudo att site events occur at approximately the same 
frequency as the random site transposition supported by TnsABCE, 
roughly 100 fold lower than the rate of attTn7 transposition. It has been
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proposed that by using the two transposition pathways Tn7 is able to exist 
in a safe "harbour" in the hotsite yet be able to transpose into conjugative 
plasmids passing through the host This will ensure both vertical and 
horizontal transfer of the element.
1.14 Functions of the tns genes
1.14.1 tnsA
tnsA encodes a 31 kD protein. As with all the Tns proteins, this species has 
been observed both by immunoblotting, (Orle, 1991 ), and directly in whole 
cell lysates prepared from cells containing an over expression construction 
which have been electrophoresed on Laemmli gel followed by Coomassie 
staining (See Chapter 4). Although TnsA is absolutely required in both in 
vivo and in vitro transposition, its biochemical role is still a mystery.
1.14.2 tnsB
tnsB encodes an 85 kd protein. This protein has been purified and shown 
to bind to the 22bp repeats at the ends of Tn7. It contains a putative helix 
turn helix motif and has been demonstrated, by methylation protection 
studies, to interact with DNA primarily in the major groove. Hydroxy 
radical footprinting of TnsB interacting with the multiple repeats at the 
end of Tn7 has shown the TnsB to be present primarily on one side of the 
DNA double helix.
Experiments with purified TnsB have been unable to detect TnsB 
mediated synapsis of Tn7 ends or any cleavage or strand exchange 
reactions. It is possible that another tns protein carries out these reactions, 
however, by analogy with the transposases of other transposable elements 
it seems likely that these functions are specified by TnsB; perhaps TnsB 
requires an interaction with other components of the Tn7 transposition 
machinery to stimulate this activity (Arciszewska, 1991 ; Arciszewska, 
1991; Morrell, 1990; Tang, 1991).
In addition to the direct role TnsB plays in transposition it also is involved 
in regulation of expression of the tns genes. The innermost 22 bp repeat
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bound by Tn7 overlaps the major right end promoter of Tn7. 
Transcription from this promoter is reduced on TnsB binding.
1.14.3 tnsC
The 62kd protein encoded by tnsC has recently been purified and shown to 
be an ATP dependent non-specific DNA binding protein (Gamas and Craig 
1992 ). Although the purified protein has not been shown to demonstrate 
an ATP hydrolysis activity, it is thought that the requirement for ATP 
hydrolysis in the Tn7 in vitro reaction described below is mediated by 
TnsC. Recent work by the Craig group has shown that in the presence of 
AMP-PNP, a non-hydrolysable analogue of ATP the Tn7 in vitro reaction 
can proceed with just TnsA, B and C. The transposon insertion sites are 
apparently chosen at random and are presumed to reflect the non-specific 
DNA binding activity of TnsC. Because of this observation it has been 
proposed that TnsC is involved in target recognition, and has been 
demonstrated to interact with TnsD at the attTn7 site (R. Bainton pers 
comm).
1.14.4frfsD
The tnsD gene product has a predicted molecular weight of 58 kd and has 
been shown to bind to the attTn7 sequences +23 to +53 (Waddell, 1989). 
This region of DNA contains an inverted repeat, however this inverted 
repeat alone does not bind TnsD. It is intriguing to note that the vast 
majority, >90%, of TnsABCD mediated Tn7 insertions occur 
assymetrically, to the left side of the TnsD recognition site. If, by analogy 
with other proteins which bind to inverted repeats, TnsD binds as a 
symmetric dimer how is this directional bias exerted? The TnsD gene has 
been shown to interact with TnsC at the attsite; in the presence of TnsD, 
TnsC binds between the TnsD binding site and the actual site of Tn7 
insertion.
1.15 Tn7 Transposition in vitro
While the work for this thesis was being carried out details of a Tn7 in 
vitro transposition reaction were published (Bainton, 1991). This work 
used fully or partially purified extracts from cells overexpressing the
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Fig 1.4 A comparison of the structures of intermediates formed in the 
transposition reactions of Mu, TnlO, Tn7 and retroviruses.
tnsA ,B ,C  and D genes. These extracts were combined and were 
demonstrated to faithfully reproduce att site specific transposition using 
defined substrates in vitro. This showed that Tn7 transposes via a 
conservative pathway, in which an excised linear transposon (ELT) is an 
intermediate. Double strand breaks are produced at the ends of the 
element and the exposed 3' OH are joined to 5' phosphates in the cleaved 
recipient molecule. Several novelties are observed in the Tn7 reaction. 
Cleavage at the Tn7 ends is staggered, the cuts exactly expose the 3' ends of 
the element but create 5' extensions of donor backbone sequences, this 
extension is at least 3 nucleotides long. This, therefore generates an ELT 
that has some similarity to a trimmed retrovirus, however, with 
retroviruses the 5’ extension is 2 nt long, see Fig. 1.4.
Unlike the case of the Mu reaction no intermediates in the Tn7 reaction 
are detected unless all the components of the reaction are present. Thus 
the Tn7 in vitro reaction is highly concerted, presumably requiring 
assembly of a large nucleoprotein complex containing all 4 proteins and 
both donor and target DNAs prior to any strand cleavage and exchange 
reactions.
The reaction requires the presence of ATP and Mg+ + . However a 
preincubation prior to addition is essential. One effect of Mg++ is to 
inhibit binding to attTn7 by TnsD (Chapter 5, this thesis).
If a non-hydrolysable analogue of ATP, AMP-PNP, is used in the in vitro 
reaction TnsD is no longer required for transposition. Thus TnsA,B and C 
are sufficient to promote transposition under these conditions. The target 
site is apparently completely random, probably reflecting the non-specific 
association of TnsC-AMP-PNP with DNA. Presumably TnsD interacts with 
TnsC and stabilises binding to attTn7 containing DNA. Unpublished 
results from the Craig laboratory confirm this hypothesis, (R. Bainton pers. 
comm. ). The phenomenon of transposition immunity is abolished in the 
presence of AMP-PNP. It is tempting to suggest that TnsC may play a role 
in target selection similar to that of MuB. An obvious difference between 
MuB and TnsC is that in the Mu system donor strand cleavage occurs 
prior to recruitment of target DNA+MuB to the synapse. As stated above, 
with Tn7 the reaction is highly concerted, no donor cleavage is seen in the 
absence of target. This may reflect the crucial difference between the 
replicative transposition of Mu and the conservative reaction used by Tn7. 
The analogous complex to the Mu CDC in Tn7 is a fully excised copy of the
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element, the ELT. Generation of the ELT by definition causes the breakage 
and potential loss of the donor molecule. It, therefore, would make sense 
only to perform this highly committing reaction step when there is a 
suitable target site available.
It is important to note that, because of the intra-molecular nature of the 
published TnlO in vitro reaction, it is not possible to determine if this 
conservative transposon also displays such a requirement for a concerted 
reaction.
1.16 Aims of This Project
The initial aim of this project was to compile the complete DNA sequence 
of Tn7. When this work was started over 12 kb of the DNA sequence of 
Tn7 had already been determined. Work presented in Chapter 3 describes 
the sequencing of the remaining segments of Tn7. This chapter also 
presents an analysis of the sequence and in particular examines the 
potential role of a series of repeated DNA motifs in the middle of the 
element.
A long term aim of the Tn7 project in Glasgow has been to characterise 
the biochemical steps in the Tn7 transposition reaction. In order to address 
this matter it is necessary to develop an in vitro Tn7 transposition assay. 
For a number of reasons it was felt that the best approach to take would be 
to use crude cell extracts containing high levels of the tns gene products to 
develop such a system. Once a functional system had been developed it 
could then be used as an assay for the subsequent purification of the 
individual Tns proteins. Chapter 4 describes the construction of plasmids 
designed to exploit the operon like structure of tnsABCD to coordinately 
overexpress the gene products. This chapter also describes assays of the 
ability of these constructs to support transposition of a mini-Tn7 element 
in vivo and finally discusses attempts to establish an in vitro transposition 
reaction.
Chapter 5 presents data on the interaction of various Tns proteins in the 
extracts prepared from cells containing the above constructs. This chapter 
also presents data on the binding of TnsD to the attsite, and in particular 
addresses the effect of Mg ions on binding.
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Work on other bacterial transposition systems have revealed that host 
encoded proteins can play an accessory role in the transposition process.. 
The Craig group have shown that the minimal protein requirements for 
the reconstituted Tn7z« vitro reaction are the purified tns gene products. It 
has been noted that addition of a boiled and spun host extract to the in 
vitro reaction does, however, stimulate the reaction(Bainton, 1991 ). 
Furthermore in the characterisation of TnsD binding to attTn7 it was 
observed that a host factor also bound to this site(Waddell, 1989 ). Work 
presented in Chapter 6  attempts to identify this host factor and 
demonstrates a role for this factor in in vivo transposition of Tn7.
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Chapter 2 
Materials and Methods
21
2.1 Bacterial strains.
The derivatives of Escherichia coli K-12 used are listed in Table 2.1.
2.2 Plasmids and Phagemids.
The plasmids used and constructed in this study are listed in Table 2.2.
2.3 Bacteriophage.
Phage PI was a kind gift of Dr. M. Masters.
2.4 Oligonucleotides
The oligonucleotides listed in Table 2.3 were synthesised on an Applied 
Biosystems PCR Mate.
2.5 Chemicals.
CHEMICALS SOURCE
General chemicals, biochemicals
and organic solvents
Media
Agarose
X-gal, IPTG
Radiochemicals
10X Restriction enzyme buffer
Nucleotides
Antibiotics
BDH, May and Baker,
Sigma
Difco, Oxoid
BRL
BRL
NEN, ICN 
BRL, Boehringer 
M annheim
Boehringer Mannheim 
Sigma
2.6 Proteins.
Restriction and DNA 
modification enzymes 
IHF
BRL, Boehringer Mannheim, 
Promega, Pharmacia.
A generous gift of G. Szatmari.
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Table 2.3
Oligonucleotides used in this work 
Oligonucleotides used as sequencing primers
Primer LINT2R) GCGCTTTTTATGTTAGGCAT
Primer LINT2L) TAATTATTTGTGGGTGGAGG
Primer LE2 R) CCTGCCGCTCAGCTTAGTAC
Oligonucleotide used in mutagenesis of pT7-ANT 
CCGGACTTTCATATGGCTAAAGCA 
Oligonucleotides for cloning of attTn7 +9 to +55
CT AGGGC ATCCATTT ATTACTC AACCGTAACCG ATTTTGCC AGGTT ACG 
TCGACGTAACCTGGCAAAATCGGTTACGGTTGAGTAATAAATGGATGCC
2.7 Culture media.
L Broth: 10 g tryptone, 5 g yeast extract, 5 g NaCl, made up to 1 litre in 
distilled water and adjusted to pH7.5 with NaOH.
L Agar: as L Broth with the addition of 15 g/1 agar.
Iso-Sensitest Broth: 23.4g Iso-Sensitest Broth Oxoid CM473 made up to 1 1 
with distilled water.
Isosensitest Agar: As Iso-Sensitest broth with 15g/l agar.
4 x Davis and Mingioli minimal salts (D&M salts): 28 g K2 H PO 4 , 8  g 
KH 2 P0 4 , 1 g sodium citrate, 0.4 g MgS04 H 2 0 , made up to 1 litre in 
distilled water.
D&M Minimal agar: 25 ml D&M salts, 75 ml 2% agar in distilled water; 
supplemented with 0.2% glucose, 20 |j,g/ml thiamine (vitamin Bl) and 
amino acids as necessary.
Medium 121: A lOx stock was prepared by dissolving 4.68g NaCl, 1.5g KC1,
1.08g NH4 CI, 0.35g Na2 S04, 0 .2 g MgCl2, 0*029g CaCl2, 5xl0-4g FeCl3/ 
2.7x10'^g ZnCl2, 2.7x 1 0 ’^g Tris in 100ml of distilled H2 0 . The pH was 
adjusted to 7.5 with HC1. Plates were prepared by adding 10 ml lOx 
Medium 121 to 75 ml 2% agarose in distilled water and adding glucose, 
amino-acids and thiamine as described above.
K2HPC>4 was added to 8.3x10-4  M( excess Pi) or 8.3 xlO'5M (limiting Pi) and 
the volume made up to 100ml. XP was added to 20|ig/ml and plates 
poured.
Phage buffer: 7 g Na2 H P04, 3 g KH2 P 0 4, 5 g NaCl, 0.25 g MgS04, 15 mg 
CaCl2 .2H20  and 1 ml 1% gelatin made up to llitre in distilled water.
2.8 Sterilisation.
All growth media were sterilised at 120°C for 15 minutes; supplements 
and buffer solutions at 108°C for 10 minutes and CaCl2 at 114°C for 10 
minutes.
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2.9 Buffer solutions.
DNA Electrophoresis
50 xE buffer: 1210g Tris, 410g sodium acetate, 93g Na2 EDTA.2 H2 0 , made up 
to 5 litres in distilled water, adjusted to pH 8.2 with glacial acetic acid.
10 x TBE buffer: 109g Tris, 55g boric acid, 9.3g Na2 EDTA.2 H2 0 , made up to
1 litre in distilled water; pH is 8.3. (For sequencing gels, an alternative was 
used: 121.lg  Tris, 55g boric acid, 9.3g Na2 EDTA*2 H2 0 , made up to 1 litre in
distilled water)
Single colony gel loading buffer: 2% ficoll, 1% SDS, 0.01% bromophenol 
blue, 0.01% orange G in buffer E.
Polyacrylamide gel loading buffer: 1 % ficoll, 0.1% SDS, 0.02% orange G,
0 .0 1 % bromophenol blue in distilled water.
4 x Horizontal agarose gel loading buffer: 25% sucrose, and 0.01% 
bromophenol blue in distilled water.
Protein gel running buffer: lOx stock prepared as 288.2 g Glycine, 60.6 g Tris 
base and 20g SDS base made up to 2 litre.
Protein sample buffer: 5% SDS, 50% Glycerol, 0.01% bromophenol blue 
and 50mM Tris-HCl (pH6 .8 ), (3-mercaptoethanol added to 5% immediately 
prior to use.
Buffers for DNA work
1 0  x restriction buffers: as supplied with restriction enzymes.
5 x ligation buffer: supplied by BRL.
1 x TE buffer: lOmM Tris/HCl, ImM EDTA; pH 8.0.
20 x SSC: 3M NaCl, 300mM trisodium citrate.
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EDTA: 500mM solutions of EDTA were made up and titrated to pH8.0 
with 10M NaOH.
50x Denhardts solution: 5 g Ficoll, 5 g polyvinyl- pyrrolidone, 5 g BSA 
made up to 500 ml with H2 O.
Phenol: All phenol used in the purification of DNA contained 0.1% 8 - 
hydroxyquinoline and was buffered against 0.5M Tris-HCl pH8.0. The 
phenol was either distilled in the department or purchased pre­
equilibrated from Fisons.
2.10 Antibiotics.
The antibiotic concentrations used throughout for both liquid and plate 
selection were as follows:
Antibiotic Stock solution Selective concentration
Ampicillin (Ap) 5 mg/ml (water) 50 pg/ml
Tetracycline (Tc) 1.2 mg/ml (lOmM HC1) 1 2  pg/ml
Chloramphenicol (Cm) 2.5 mg/ml (ethanol) 25 pg/ml
Kanamycin (Km) 5 mg/ml (water) 50 pg/ml
Streptomycin (Str) 1 0  mg/ml(water) 1 0 0  pg/ml
Trimethoprim(Tp) 5mg/ml 50%EtOH 50|ig/ml
Rifampicin(Rif) 5mg/ml MeOH 50pg/ml
All stock solutions were stored at 4°C.
Antibiotics were added to molten agar which was precooled to 55°C.
2.11 Growth conditions.
Liquid cultures for transformation, conjugation or DNA preparations 
were routinely grown in L broth, or Iso-sensitest when trimethoprim 
selection was required, at 37°C with vigorous shaking. Both L agar, 
isosensitest agar and minimal solid media were used. Antibiotics and 
supplements were used as required. Plates were generally incubated
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overnight at 37°C. Any strains containing pGPl-2 were grown at 30°C to 
avoid induction of T7 RNA polymerase.
Bacterial strains were stored in 50% L broth, 20% glycerol and 1% peptone 
at -70°C or on L agar slopes at room temperature.
2 . 1 2  Indicators.
X-gal (5-bromo-4-chloro-3-indolyl-B-D-galactoside) was used in 
conjunction with the host strains DS941 and JM109 and the pUC and 
pSelect-1 vectors. Use of this indicator acts as a screen for plasmids with 
inserts in the polylinker region. Clones containing inserts were generally 
white; clones lacking inserts were blue. X-gal (40mg/ml in DMF) was 
stored at -20°C and added to L agar to a final concentration of 20|ig/ml. 
IPTG (isopropyly-B-D-thiogalactoside) was added to a final concentration 
of 25 pg/m l to medium containing X-gal.
XP (5-bromo-4-chloro-3-indolyl phosphate) was used as described in 
Chapter 6  as a indicator of the level of Alkaline Phosphatase expression in 
cells.
2.13 Plasmid DNA isolation.
Large scale DNA preparation ((Birnboim, 1979); as modified in this 
laboratory).
Solutions:
I. 50mM glucose, 25mM Tris/HCl pH 8.0, lOmM EDTA.
II. 0.2M NaOH, 1% SDS; made fresh.
III. 5M potassium acetate pH 4.8; mix equal volumes of 3M CH3 COOK 
and 2M CH3 COOH, pH will be 4.8.
1 0 0 ml cultures of stationary phase plasmid-containing cells were 
harvested by centrifugation (12,400g, 10 min at 4°C). The pellet was 
resuspended in 4 ml of solution I. 8  ml of solution II was added and the 
mixture was left on ice for a further 5 min. 6  ml of solution III was then 
added, gently mixed and the cell debris and chromosomal DNA removed 
by centrifugation (39,200g, 30 min at 4°C). The plasmid DNA was 
precipitated from the supernatant with 12 ml isopropanol for 15 minutes
26
at room temperature. The DNA was pelleted at 27,200g for 15 min at 20°C, 
rinsed with 70% ethanol and then further purified by banding on a 
CsCl/EtBr gradient. The DNA was resuspended in 2.1 ml of TE buffer and 
added to 270 pi of a 15 mg/ml ethidium bromide solution. 5 g of CsCl were 
dissolved in 3 ml of water and added to the DNA/EtBr solution. The 
gradients were centrifuged in a Beckman Ti70.1 fixed angle rotor at 
200/000g for 16 hours at 20°C. Where two bands were visible, a lower 
supercoiled plasmid band and an upper nicked DNA band, the lower band 
was removed using a 1ml syringe. The ethidium bromide was removed by 
repeated butanol extractions and the DNA recovered by ethanol 
precipitation, the pellet washed in 70% ethanol and resuspended in 500pl 
TE.
Mini preparation of DNA
Small scale preparations of plasmid DNA were performed using the 
Birnboim, Doly mini-prep method
1.5 ml of a stationary culture was harvested by centrifugation in an 
Eppendorf tube (12,100g, 30sec) and resuspended in 100 pi of solution I (as 
described above for large scale prep.). 200pl of solution II was added and 
mixed by gentle inversion of the Eppendorf tube. Following a 5 minute 
incubation on ice 150pl of solution III was added and mixed by vortexing at 
the lowest setting of a Vortex Genie-2 (Scientific Instruments) for 10 
seconds. Following a further 3 minutes on ice, the tube was centifuged 
(12,100g, 5 min). The supernatant was collected and extracted against 400pl 
of 1:1 phenolxhloroform. Following centrifugation (12,1 OOg, 5 min) the 
supernatant was added to 2 volumes of ethanol. After a 5 minute 
incubation at room temperture and centrifugation (12,100g, 5 min) the 
supernatant was carefully removed and the pellet was washed with 1 ml 
70% ethanol, dried and resuspended in 50 pi TE buffer. 5-10 pi of this DNA 
was suitable for restriction enzyme digests. 1 pi of a 1 mg/m l RNase A 
solution was added to the DNA with the gel loading buffer.
27
2.14 Chromosomal DNA isolation.
Buffer A: lOmM Tris.Cl pH8.0
ImM EDTA pH8.0 
0.1% Lauroyl Sarcosine 
250ml NaCl 
50pg/ml Proteinase K
100 ml of culture was harvested by centrifugation (12,400g, 10 min, 4°C) 
and resuspended in 10ml Buffer A. The suspension was frozen by 
immersion in liquid nitrogen and then thawed at 37°C for 45 minutes. 
7ml of phenol were added and mixed well but gently, 3mls of chloroform 
were added, mixed and centrifuged (29,000g, 20 min). The extraction was 
repeated on the supernatant.
0 . 6  volumes isopropanol was added; after 1 hour at room temperature 
DNA was either spooled or recovered by centrifugation (29,000g 30 min). 
The pellet was washed with 70% ethanol, and resuspended in 1ml 2xTE. 
This DNA was suitable for restriction digestion.
2.15 Transformation with plasmid DNA.
Genetic transformation introduced plasmid DNA into different host 
strains. An overnight culture of the recipient strain was diluted 1 in 100 
into 20 ml L broth and grown to a density of 2x10® cells/ml (about 90 min). 
The cells were harvested (12,1 OOg, 1 min, 4°C) and resuspended in 10 ml of 
50mM CaCl2 - The cells were pelleted again, resuspended in 0.5 ml cold 
(4°C) 50mM CaCl2  and kept on ice until use. 100 pi aliquots of competent 
cells were added to DNA in TE buffer and, after gentle mixing, were left on 
ice for 15 min. The cells were then heat shocked ( 2  min, 42°C or 5 min, 
37°C) and returned to ice for 15 min. 100 pi of L broth was added to the cell 
suspension and incubated at 37°C for 90 min to allow expression of 
plasmid genes. Transformation to ampicillin resistance did not require 
this expression time. lOOul aliquots of the transformation mixture were 
spread onto selective plates.
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2.16 Preparation of PI lysates.
The donor strain was grown up in L broth to late log phase. The cells from 
1 0 0  pi of culture were harvested by centrifugation and resuspended in 1 0 0  
pi fresh L broth, 100 pi CaCl2  (50mM) and 100 pi MgCl2  (lOOmM).
Sufficient PI was added to give a m.o.i. of approximately 0.001. The 
mixture was then incubated at 37°C for 25 min, mixed with precooled 
(45°C) molten soft agar and plated onto a fresh undried L agar plate. After 
overnight incubation, 2.5 ml of phage buffer was added and left at room 
temperature for 15 min. The buffer and soft agar were placed in a 
centrifuge tube with a few drops of chloroform and vortexed for 30 sec. 
The tube was left for 30 min at room temperature, re-vortexed and then 
centrifuged at 12,000g for 10 min. The supernatant, containing 
approximately 10  ^pfu/ml, was stored at 4°C.
2.17 PI transduction.
The recipient strain was grown up to mid-log phase in L broth, harvested 
and resuspended in an equal volume of L broth. To 100 pi of cells was 
added 100 pi of CaCl2  (50mM), 100 pi MgCl2  (lOOmM) and 0.1-10 pi of PI 
lysate. After 20 min incubation at 37°C, phage infection was stopped by the 
addition of 200 pi of 1M sodium citrate (filter sterilised). 500 pi of L broth 
was added followed by incubation for one hour at 37°C. The cells were 
then plated onto a suitable selective medium. All transductants were 
streaked out to single colony at least two times, to remove any 
contaminating PI bacteriophage.
2.18 Single colony gel analysis.
By using this technique, the plasmid content of an isolate can be observed 
without the need to purify the DNA. A single transformant was patched 
out (1cm square) on a selective plate and grown overnight. Using a 
toothpick, a large scrape of cells was collected and resuspended in 1 0 0  pi of 
single colony gel buffer. The cells were left to lyse at room temperature for 
15 minutes. Cell debris and chromosomal DNA was spun down in an 
Eppendorf microfuge for 15 min at 4°C). 30 pi of the supernatant was 
loaded onto an agarose gel.
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2.19 Bacterial Conjugation and Mate-out Assay
Conjugation mediated by the R388 derivative, pEN300 was used in the in 
vivo transposition assay. Cells containing a chromosomal Tn7-1 and 
appropriate tns encoding plasmid had pEN300 introduced to them by 
conjugation. Plate matings were carried out with 250 pi of both donor and 
recipient overnight culture being plated on a well dried L-agar plate. The 
plate was incubated at 37°C for 3-4 hours. 1 0  ml phage buffer were then 
added and the cells resuspended using a sterile glass spreader. The cell 
suspension was then transferred to a 40ml centrifuge tube and then 
centrifuged, (1200g, 5 min). The pellet was resupended in 1ml phage buffer 
and 1 0  fold serial dilutions plated on appropriate selectve plates. 
Following overnight selection for exconjugants, the new donor, 
containing Tn7-1, tns plasmid and pEN300 was used to innoculate a 2.5 ml 
culture. An analogous culture of recipient, usually DS916, was also set up. 
The following day another plate mating was carried out, as described 
above. Serial dilutions of the cell suspension, from 10° to 10'7, were made. 
1 0 0  pi of the 1 0 ° to 1 0 ' 3 dilutions were plated on medium selecting for 
exconjugants containing Tn7-1, the 10° to 10-4  were plated on medium 
selecting for exconjugants containing pEN300. The apparent transposition 
frquency is expressed as the ratio of tranfer of the Tn7-1 marker relative to 
the pEN300 marker (see Fig. 2.1).
2.20 Restriction of DNA.
Restriction enzyme digests were usually performed in a total volume of 20 
pi, containing 0.3-1.0 pg DNA and 2 pi of 10 x restriction buffer. 2-3 units 
of restriction enzyme was added per pg of DNA. The reactions were 
incubated at 37°C (or at the appropriate temperature) for 1-2 hours. For 
restrictions of larger quantities of DNA, the volume was scaled up 
accordingly. The enzymes were inactivated by the addition of loading 
buffer, heating to 70°C or by phenol extraction and ethanol precipitation if 
subsequent manipulations were necessary.
2 .2 1  Calf intestinal phosphatase (CIP) treatment.
Phosphatase was used to remove 5' phosphate groups from linearised 
vector to prevent recircularisation of the vector (thus increasing cloning
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efficiency). 1 unit of CIP was added directly to the digest and incubated at 
37°C for 15 min (or 45 min for blunt ends).
2.20 Ethanol precipitation of DNA.
One tenth volume of 3M NaOAc and 2 volumes of absolute ethanol was 
added to the DNA solution. After mixing, the DNA was precipitated at 
-20°C for at least 30 mins and pelleted for 15 min at 4°C. The pellet was 
washed with 70% ethanol and dried.
2.23 Ligation of DNA fragments.
Restriction fragments were ligated in volumes of 10-20 pi, containing 1 x 
ligation buffer and 0.5 units of DNA T4 DNA ligase. Generally a 3:1 insert 
to vector ratio of fragments was used (10:1 for blunt end ligations). The 
reactions were incubated at 16°C overnight or for 1 hour at room 
temperature. Aliquots of the ligation mix were used to transform 
competent cells.
2.24 Gel electrophoresis of DNA.
a) Agarose gels
0.7-1.2% agarose gels were used.
Agarose powder was dissolved at 100°C in E buffer E and precooled to 
55°C prior to use. Three types of gel apparatus were used:-
1) IBI Model QSH mini-gel kits: These kits required 25ml of molten agar. 
These gels were used for analysis of restriction digests.
2) IBI Model MPH midi-gel kits: Gels were 100ml of agar. These kits were 
used for most analysis of restriction digests, single colony gels and analyses 
of products of potential in vitro transposition reactions.
3) Large kits manufactured in the University which contained long 300ml 
gels. These gels were used to seperate restriction digests of genomic DNA
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prior to Southern Blotting and for analysis of some attempted in vitro 
transposition reactions.
Following electrophoresis gels were stained in 0.6 p g /m l ethidium 
bromide. The DNA was visualised on a 254 nm wavelength UV 
transilluminator. If the DNA was to be isolated from the gel then it was 
visualised on a 365nm wavelength UV transilluminator.
b) Polyacrylamide gels
Three types were used.
1) Polyacrylamide gels for analysis of restriction products..
Vertical gel kits were used with 1.5 mm spacers. The gel apparatus was 
sealed with 0 .6 % agarose in H2 O or with a continuous length of rubber
tubing compressed between the plates at the sides and bottom. An 
appropriate acrylamide gel mix was poured between the plates (with the 
insertion of a well former) and allowed to polymerise for up to 60 min.
50ml acrylamide gel consists of:- 
30% acrylamide: 0.8% bisacrylamide (w/v)(Protogel)
10 x TBE 
10% APS (w/v)
TEMED
The volume was made up to 50 ml with distilled water
The gels were run at room temperature in 1 xTBE at a constant current (25- 
30 mA), for 2-3 hours. DNA bands were visualised under 254nm UV 
illumination after staining in 0 .6  pg/m l ethidium bromide for 1 0  min.
2) Non-denaturing polyacrylamide gels.
These gels were used to separate protein:DNA complexes. Two separate 
buffer systems were used
X ml 
5 ml 
2 0 0  pi 
2 0  pi
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a) TBE based gels.
These gels were made as described above for analysis of restriction 
products. They were pre-run at 4°C at 200 volts for at least 45 minutes 
prior to loading of binding reactions. Following loading, electrophoresis 
was continued for 3 hours. The gel was then transferred to Whatman 
3MM filter paper and dried under vacuum at 80°C. Bands were visualised 
by autoradiography on Kodak SI or Fuji RX100 X-ray film for 1-3 days.
b) As detailed in the text some of the gels described in Chapter 3 were based 
on a Tris/Glycine buffer. This buffer, 50mM Tris/Glycine pH 9.4, O.lmM 
EDTA, was found to enhance the resolution of complexes produced by 
TnsB binding to the ends of Tn7 (E. Morrell 1990).
These gels were pre-run and run as described above.
3) Polyacrylamide sequencing gels.
The gel kit used was an 'IBI Base Runner’ kit. Gels were poured by 
'sliding', as described by the manufacturers. Both straight and wedge 
spacers were used. Sequencing reactions were run on 8 % high resolution 
polyacrylamide/urea gels in lxTBE as described in the "IBI Base Runner 
Operator's Manual" published by IBI. Gels were pre-run for at least 45 min 
and run for 1-4 hours at 45W. Samples were denatured prior to loading 
(80°C, 2 min). After the gel run was complete, the gel was fixed in 10% 
acetic acid, 10% methanol for 15 min, dried under vacuum at 80°C and 
autoradiographed on Fuji RX100 X-ray film.
2.25 Purification of DNA fragments from Agarose Gels
Following electrophoresis, the gel was stained in distilled water with 
0 .6 pg/m l ethidium bromide and viewed on a long wave transilluminator. 
The appropriate band was excised using a scalpel blade The agarose chip 
was then placed in a small (500 pi) Eppendorf tube over a small amount of 
siliconised glass wool covering a hole in the bottom of the tube. The small 
Eppendorf tube was then placed in a large (1.5 ml), lidless Eppendorf tube 
and centrifuged at 6000 rpm for 10 min. The liquid from the bottom tube 
was collected and the DNA was then predpated by the addition of NaOAc 
and ethanol. Following resuspension in distilled water the isolated DNA
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could be used for ligation, further digestion or random priming as 
described below.
2.26 Synthesis and Purification of Oligonucleotides
Oligonucleotides were synthesised on an Applied Biosystems PCR mate. 
Oligonucleotides were removed fromthe column matrix and de-protected 
following the protocol below.
The column was opened and the glass bead packing material poured into 
an Eppendorf tube, lml of 30% aqueous ammonia was added and the tube 
incubated at room temperature for 1 hour. The tube was then vortexed, 
briefly centrifuged and the supernatant removed to a Nunc tube. A further 
lml of ammonia was added and the tube incubated at 50°C overnight. 
Subsequent purification was as described in Sambrook et al (1990)
2.27 Photography of gels.
After staining in ethidium bromide, gels visualised by 254nm UV 
illumination were photographed using Polaroid type 667 land film or 
using a Pentax 35mm SRL loaded with Ilford HP5 film. Both cameras were 
fitted with a Kodak Wratten filter No.23A.
2.28 Electrophoresis of proteins in SDS-polyacrylamide gels.
The electrophoresis of proteins followed the procedure of (Laemmli, 1970 ) 
using 15% running gels and 4% stacking gels. Gels were poured in vertical 
gel kits sealed with 0.6% agarose in H2O. The kits were either made in the 
University or BioRad "Mini-Protean" kits. Gel mixes for the home-made 
kits were made up according to the table below, mini protean kits used the 
same proportions of reagents but lower final quantities:
Running Gel Stacking Gel 
10% 15%
30 /  0.8% acrylamide/bis 10 15 ml
(Protogel)
2 . 0  ml
1.5M Tris-HCl pH8 .8 , 0.4%SDS 7.5 ml 
0.5M Tris-HCl pH6 .8 , 0.4%SDS 3.75 ml 
0.15 ml10% SDS 0.3 ml
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H20
TEMED
Ammonium persulphate
to 30 ml 
20 pi 
150 pi
to 15 ml 
1 0  pi 
150 pi
(1 0 % w/v)
The running gel was poured and left to set with a layer of isopropanol 
over it. The isopropanol was washed off and the stacking gel was poured. 
After the gel had set, running buffer was poured into the gel tank, and the 
comb was removed. Prior to loading, the protein samples were mixed 
with protein sample buffer and boiled for 5 minutes. The gel was run 
overnight at a constant current of 8  mA, leaving the dye front just above 
the bottom of the gel.
2.29 35S Labelling of Proteins
This procedure enabled radiolabelling of proteins encoded by genes cloned 
downstream of T7 promoters. Cells containing pGPl-2 and a recombinant 
pT7 plasmid were grown in L-broth containing ampicillin and kanamycin 
at 30°C. At OD5 9 o=0 .5 , 0.2 ml of cells were centrifuged in a 1.5 ml 
Eppendorf tube (12,000g, 1 min). The cells were then washed in M9 
medium re-centrifuged and resuspended in lm l of M9 +MgSC>4 
supplemented with 2 0 m g/m l thiamine (vitamin Bl) and 0 .0 1 % of 18 
amino adds (lacking methionine and cysteine). The cells were then grown 
with shaking at 30°C for one hour. Incubation temperature was then 
raised to 42°C for 15 min. Rifampicin was then added to 200pg/ml and 
incubation continued for a further 10 min. Temperature was then shifted 
back to 30°C for 20 min. Samples were then pulsed with 10|iCi of 3 5 S- 
methionine for 5 min. Cells were then spun and the pellet resuspended in 
50|il of protein gel loading buffer. Samples were then boiled for 3 min and 
loaded onto a protein gel. Following electrophoresis the gel was fixed in 
30% methanol/10% acetic acid for 30 min then soaked in EN3HANCE for 1 
hour, transferred to soaking in water for a further 30 min, transferred onto 
Whatman 3MM paper and dried under vacuum at 60°C for 1.5 hours. 
The dried gel was then placed against an autoradiograph film and exposed 
at -70°C for 2  weeks.
35
Pulse/Chase experiment
The pulse chase experiment essentially follows the above protocol with 
the exception that 20pCi of 3 5 S-methionine were used, the pulse shortened 
to 1 minute, and immediately following the pulse unlabelled methionine 
added to 0.1%. Samples were then taken at various times into the chase 
and added to protein gel loading buffer as above.
2.30 Southern blotting and hybridisation.
Agarose gels were soaked in 0.25M HC1 for 30 min, transferred to a 
solution of 1.5M NaCl, 0.5M NaOH for 30 min and finally neutralised in 
1M Tris.Cl pH7.6, 1.5M NaCl for 30 minutes. The DNA was then 
transferred to a nylon membrane (Hybond N, Amersham) by pressure 
using a Posi-blotter ( Stratagene) at 80mm Hg for 30-45 minutes using 20x 
SSC as transfer buffer. The blot was then UV crosslinked at 254nm for 90 
seconds. Prehybridisation of the membrane was then performed for 3 hrs 
at 65°C in 10% dextran sulphate, 5 x Denhardt’s solution, 1 x SSC, 0.5% 
SDS and 0.1 mg/m l denatured salmon sperm DNA. The blot was then 
hybridised overnight at 65°C in 10 ml of the same solution to which the 
denatured 3^P labelled probe had been added. Following hybridisation the 
probe was removed and the membrane washed in 2 xSSC, 0.1% SDS at 
room temperature for 20 minutes, then twice with lxSSC, 0.1% SDS at 
65°C for 15 minutes each and finally twice with O.lxSSC, 0.1% SDS for 15 
minutes. The membrane was then dried and autoradiographed.
2.31 Random Priming of DNA.
The appropriate restriction fragment of DNA was gel isolated as described 
above. Following ethanol precipitation, 70% ethanol wash and drying, the 
pellet was resuspended in 9pl of distilled water. Random priming was 
carried out using a "Random Priming DNA Labeling Kit" (Boehringer 
Mannheim) following the manufacturers instructions. Unincorporated 
nucleotides were removed using a Nuctrap column ( Stratagene).
2.32 DNA sequencing.
All DNA sequencing reactions were performed on double stranded 
plasmid DNA prepared by the large scale preparation method described
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above. All sequencing reactions were carried out using the Sequenase 
enzyme and the reagents supplied in the Sequenase kit (United States 
Biochemicals). The method used was that described in the manual 
supplied with the kit with the exception that the initial labelling reaction 
was performed with the Eppendorf tubes lying on the surface of an ice 
bucket. This was found to reduce the incidence of sequence specific 
termination in all four tracks. The samples were denatured at 80°C and 
run on 8 % polyacrylamide /  urea gels as described above.
2.33 End-labelling of DNA fragments.
Purified DNA fragment were end-labelled by filling in recessed 3’ ends 
generated by restriction digestion with the Klenow fragment of DNA 
polymerase I. The reaction contained 3-5|ig DNA, 50nM unlabelled 
nucleotides (dCTP, dGTP and dTTP), lOuCi alpha 32P dATP, restriction 
buffer (50mM Tris/HCl pH 8.2, lOmM MgCl2 , 50mM NaCl) and 1 unit/pg
DNA Klenow enzyme in a total volume of 25pl. After incubation at room 
temperature for 1 hour, the reaction was stopped by heating to 70°C for 20 
minutes. Unincorporated nucleotides were separated using a "NucTrap" 
column (Stratagene) as described in the manufacturers instructions.
2.33 Preparation of Crude Cell Extracts
Crude cell extracts of the various strains worked with were prepared as 
follows. 200mls of L-broth containing appropriate antibiotics were 
innoculated and grown overnight at 30°C, if containing pGPl-2, or 
otherwise at 37°C, with shaking. In the morning 200ml fresh L-broth plus 
antibiotics were added and cells were induced. For those cells with plac or 
ptac expression vectors induction was by addition of IPTG to ImM, for 
those with pGPl-2 and T7 expression vectors induction was by heating to 
42°C  for 25 minutes then adding rifampicin to lOOpg/ml prior to 
continuing growth at 37°C. Cultures were incubated for a further 3 hours 
and then harvested by centrifugation (4,420g, 15 min). The pellet was 
resuspended in 10 mis lxD&M salts, transferred to a 40ml centrifuge tube 
and centrifuged at 12,000g, 5 min. The resultant pellet was then 
resuspended in 5ml of the appropriate buffer (see below) and lysozyme 
added to lOOng/ml. Cells were then disrupted by 6 , 10 second passes of a 
sonicator. The lysate was then centrifuged at 49,000g for 25 minutes. The
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supernatant was collected, protein concentration quantitated, and either 
directly used in gel binding or in vitro transposition reactions or was 
stored at -20°C following addition of glycerol to 50%.
2.34 Protein Quantiation
This was performed according to the method of Bradford, 1976
2.35 Gel binding assays.
TnsB
Binding assays with extracts containing TnsB were performed in 50mM 
Tris/glycine (pH 9.4), 55mM KC1, l.lmM EDTA l.lmM  DTT. The substrate 
DNA was either end-labelled pSBlOO (digested with EcoRI, Hindlll and 
Rsal), pSBllO (Digested with EcoRI and Hindlll) or pNE200 (digested with 
EcoRI and Hindlll).
Binding reactions comprised:-
2  pi extract 
20ng Labelled DNA 
lpg Salmon Sperm DNA 
18|il Binding buffer
Reactions were incubated for 10 minutes at room temperature, put on ice 
and loaded onto running non denaturing polyacrylamide gel.
TnsD Binding Assays
The standard TnsD binding Buffer was
50 mM Tris.Cl pH8.0 
ImM EDTA pH 8.0 
lOOmM KC1 
1 mM DTT
The DNA substrate used in these experiments was end-labelled,EcoRI, 
Hindlll digested pMR80. Other substrates were used as described in 
Chapter 6 .
The binding reactions were as described above for TnsB.
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2  pi extract 
20ng Labelled DNA 
1 pg Salmon Sperm DNA 
18pl Binding buffer
2.35 Site Directed Mutagenesis
This was performed as described in Lewis (1990) using the Altered Sites in 
vitro Mutagenesis System (Promega). See Chapter 4 for further details.
2.36 Attempts at Tn7 in vitro transposition reactions
These attempts essentially followed the protocol described by Bainton et ah 
(1991).
Briefly, a varying quantity, up to 500 pg, of cell extract was incubated with 
0.5pg of transposon donor DNA, pMRll and lpg of recipient DNA, pEALl 
in lOOpl reaction mixtures containing 2 mM ATP, 26 mM Hepes (pH8.0), 
1.3mM Tris.Cl (pH8.0), 2.5mM KPO4  (pH8.0), lOOmM KC1, 15mM NaCl, 
O.lmM EDTA, 2.2mM DTT, lOOpg/ml tRNA, 50pg/ml BSA and 5% w /v  
PEG 8000.. The reaction was incubated for 7 minutes at 30°C then Mg 
acetate added to 15mM. Incubations were then continued for a further 30 
minutes and DNA recovered as detailed in Bainton et ah (1991).
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Chapter 3 
The DNA Sequence of Tn7
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3.1 Introduction
When this project was started the majority of the sequence of Tn7 had 
been determined (Lichtenstein and Brenner 1982 ; Fling and Richards 1983 
; Fling, Kopf et al. 1985 ; Flores, Qadri et al. 1990 ; Sundstrom, Roy et al. 
1991). Two un-sequenced portions remained, approximately 800 nt 
between the unique EcoRI site and the Hindlll site at the 3' end of tnsE 
gene, and approximately 800nt at the left end, the sequence of the absolute 
left end had already been determined.The work presented in this chapter 
establishes the DNA sequence of these regions. This has enabled the 
reconstruction of the entire Tn7 sequence. This chapter presents an 
analysis of the sequence. This analysis revealed the presence of several 
directly repeated motifs in the centre of Tn7. The potential role of these 
repeats is also addressed.
3.2 Sequencing Strategy
3.2.1 EcoRI-Hindlll Fragment
The sequence of this fragment was determined using a series of 
overlapping restriction fragments, see Fig. 3.1.
This fragment was subcloned from pUC18::Tn7-l into EcoRI/Hindlll 
digested pUC18. This plasmid, pSB200, was sequenced as described in 
Chapter 2 using both forward and reverse primers. This allowed 
identification of internal PvuII and Aval restriction sites. The PvuII site 
was 216 nt from the EcoRI site, the Aval site 158 nt from the Hindlll site. 
The EcoRI/Aval and PvuII/H indlll fragments were subcloned into 
EcoRI/Aval and Smal/Hindlll digested pUC 18, to create pSB250 and 
pSB230 respectively. The PvuII/Hindlll fragment in pSB230 was sequenced 
using reverse primer. pSB250 was sequenced using forward primer. This 
sequence revealed the presence of a further internal site, Xbal, this was 101 
bp from the Aval, 259 nt from the Hindlll site. The EcoRI/Xbal and 
Hindlll/Xbal fragments were then sub-cloned into appropriately digested 
pUC18 to generate pSB240 and pSB260 respectively. pSB240 was then 
sequenced using the forward primer, pSB260 was sequenced using the 
reverse primer. When compiled these various sequences were shown to 
overlap and thereby give continuous sequence from the EcoRI site to the 
Hindlll site. This region was found to be 790 nt in length, in good
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agreement with the observed mobility of the EcoRI/Hindlll fragment in a 
2 % agarose gel (data not shown).
From the previously published sequence of the Tn7 aadAl gene it was 
known that there was a further PvuII site 22 nt towards the left end of Tn7 
from the EcoRI site (Fling, Kopf et al. 1985 ). The 238nt PvuII/PvuII 
fragment encompassing the EcoRI site was subcloned into Smal digested 
pUC18. This was sequenced to confirm that the EcoRI site in Tn7 was, 
indeed, unique and not two sites very close together. The site was found to 
be unique.
3.2.2 Left end
From an examination of the restriction map of Tn7 it was apparent that 
fewer restriction sites had been mapped at the left end of Tn7. It was 
possible to subclone a 1.7kb HincII fragment, seeFig. 3.1. This fragment 
encompassed the right half of the unknown region and the integrase 
pseudogene and part of the dhfr open reading frame. This fragment was 
subcloned into Sma I digested pUC18, this made pSB210. The orientation 
of the fragment, confirmed by Aval/EcoRI digestion and DNA sequence 
determined from the reverse primer. This sequence revealed the location 
of the internal Aval site to be 79 nt to the right of the HincII site. The 1.6 kb 
Aval-Hindlll fragment of pSB210 was sub-cloned into Aval-Hindlll 
digested pUC18. The sequence of this plasmid was determined using 
reverse primer. No further useful restriction sites were uncovered from 
an analysis of this sequence, therefore the following strategy to determine 
the remaining sequence was adopted. Synthetic oligonucleotides were 
synthesised complementary to known DNA sequences at the left end of 
Tn7, and the left and right ends end of the sequence determined above. 
These oligonucleotides were designated primer LE2R, LINT2L and 
LINT2R respectively. Fig. 3.2 shows the sequence of these primers and the 
strands to which they are complementary. Primers LE2R and LINT2L were 
designed to hybridise to opposite strands of the denatured plasmid DNA 
and hopefully produce overlapping sequence. As shown in Fig. 3.1 the 
sequence derived from primer LINT2L completely overlapped that 
derived from LE2R.
A fourth primer LE2L was designed to hybridise to DNA towards the left 
end of Tn7 from the integrase pseudo gene. This region of un-published 
sequence was kindly given to me by Hilary-Kay Young of Dundee
42
P rim er LE2R->
180
240
300
360
420
480
540
600
660
720
780
840
900
960
AACCTGCCGCTCAGCTTAGTACGATCCATATCCAACTGATATAATCCTTTCATCAGTATC
TTGGACGGCGAGTCGAATCATGCTAGGTATAGGTTGACTATATTAGGAAAGTAGTCATAG
CCAAATTAAATGCCCTCCTAGGACTGCCTCACCAACACTTTACAGTGATCCCGTATTTGT
GGTTTAATTTACGGGAGGATCCTGACGGAGTGGTTGTGAAATGTCACTAGGGCATAAACA
ATTTCCGGACAGGTGATTGATTTTTTTCGCTTGTACAGGTGTTAAGCCACAGTTATCTTG
TAAAGGCCTGTCCACTAACTAAAAAAAGCGAACATGTCCACAATTCGGTGTCAATAGAAC
ATGTGGACATTATGCATTGTAATAGCCCATTAACATGCGCTAAGAGCATAAATTAATATA
TACACCTGTAATACGTAACATTATCGGGTAATTGTACGCGATTCTCGTATTTAATTATAT
CAGTAACAAGCATTACGAGGTGCTAATGTTTGGAAAGCAGCCTCTTCCAACTACAATAAT
GTCATTGTTCGTAATGCTCCACGATTACAAACCTTTCGTCGGAGAAGGTTGATGTTATTA
H
i
n
c
I
I
AAGTTAACTATCCTCCACCCACAAATAATTACAAATGACCCCTTTCCGCTATAACTCCGA
+ + + + + +-------------
TTG A A TTG A TAGGAGQTGGOTGTTTATTAATGTTTACTGGGGAAAGGCGATATTGAGGCT
<- Primer LINT2L
A
v
a
I
TCTCACCAGTGGCTCGCTACAAACCCGAGAGTGTCGCATTATTACTGGCTTGTTACTCCA
AGAGTGGTCACCGAGCGATGTTTGGGCTCTCACAGCGTAATAATGACCGAACAATGAGGT
AGAGCTTGATGAAGCTGCCTGGGATAAAGCCATGTATAAGGAAAATGTGCTTCAGAAACG
TCTCGAACTACTTCGACGGACCCTATTTCGGTACATATTCCTTTTACACGAAGTCTTTGC
CACGCAATCTACGGTAAGACGTATTTCTTCAGCGCTTAGAAAACGCCTAGAACACCTAAG
GTGCGTTAGATGCCATTCTGCATAAAGAAGTCGCGAATCTTTTGCGGATCTTGTGGATTC
Primer LINT2R->
CTCTGACTTTTGGGCTTTTTGCQCTTOPTATQTTAQQCATTGTCTTGGCCAACCTGGAGG
GAGACTGAAAACCCGAAAAACGCGAAAAATACAATCCGTAACAGAACCGGTTGGACCTCC
'AAGTGTAATGACCATGAA'TGGTCACTGTGATTGACAGTATOTTGCTTAAAGTTATCTGAA'
TTCACATTACTGGTACTTACCAGTGACACTAACTGTCATAGAACGAATTTGAATAGACTT
CAATGGTAGAACTGGCTCATATTTATCCCCTCTATGATTGTTTATGTTTTTCACCATAAA
GTTACCATCTTGACCGAGTATAAATAGGGGAGATACTAACAAATAGAAAAAGTGGTATTT
AAGTATCAGGGGCTACTCAGGGCTACATAAAGATATTTATCTACTTTTACTGATTGATAA
TTCATAGTCCCCGATGAGTCCCGATGTATTTCTATAAATAGATGAAAATGACTAACTATT
GTAGCATCAGTCCATCCGCAGGACTGGTGGTGCCGCAAATGCTGACCC
+---------------+--------------- +---------------+---------------+------------- 1007
CATCGTAGTCAGGTAGGCGTCCTGACCACCACGGCGTTTACGACTGGG
239
299
359
419
479
539
599
659
719
779
839
899
959
Fig. 3.3 Sequence derived from left end clones and synthetic primers, as described in the text. 
Sequences corresponding to the synthetic primers are indicated.
iP  E
v c
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CAGCTGTGTTCAGAACGTACGTCCGAATTCCAGACTATGTCGAACTAGATAACGCGGAGG
GTCGACACAAGTCTTGCATGCAGGCTTAAGGTCTGATACAGCTTGATCTATTGCGCCTCC
AGCTGGCCGACGCAATCATTCGAGAGGTTGAGTTAAAGGAGGCATGGCTCACAAGGGTCT
TCGACCGGCTGCGTTAGTAAGCTCTCCAACTCAATTTCCTCCGTACCGAGTGTTCCCAGA
TGGGGAACTCAGCCGATCCTGACGCTTCTGTGGGCAAGTGGGACCGGCGCCTAGCGAGTG
5 0 2 7  -------+ ---------------------- + ---------------------- + ----------------------+ ----------------------+ ----------------------+ --------------
ACCCCTTGAGTCGGCTAGGACTGCGAAGACACCCGTTCACCCTGGCCGCGGATCGCTCAC
P
v
u
I
I
CGTGGTATTGATGAGATGTCAAGTGGGGTGCAGGCAACATACTTCAGTCCAAACGGTCAG
5 0 8 7  ------ + ------------------------+ ---------------------+ ---------------------- + ----------------------- + ---------------------- + -------------
GCACCATAACTACTCTACAGTTCACCCCACGTCCGTTGTATGAAGTCAGGTTTGCCAGTC
CTGGTCGGCTTAGTGGCATACATTGATGCCGAATGGATGGATGAATAGCTCTGACGTTAC
GACCAGCCGAATCACCGTATGTAACTACGGCTTACCTACCTACTTATCGAGACTGCAATG
GATTCAGGTGAGACAACCAGATGGGCATTGCGTACAAGCTCAGTTGCCACCGATGTGGCT
5 2 0 7  ------ + ------------------------+ ---------------------+ ---------------------- + ------------------------+ ---------------------- + -------------
CTAAGTCCACTCTGTTGGTCTACCCGTAACGCATGTTCGAGTCAACGGTGGCTACACCGA
ACGAGTCTGATCTTCTTTACCTAGGCCAAGGTATGGCGATGCTTCCTGAGCAATAGTCGG
TGCTCAGACTAGAAGAAATGGATCCGGTTCCATACCGCTACGAAGGACTCGTTATCAGCC
AACGTGCACATGCTGCGACAATCTAACGACGATTTCTATAAATGAAAGCTACGGAGTATG
TTGCACGTGTACGACGCTGTTAGATTGCTGCTAAAGATATTTACTTTCGATGCCTCATAC
CTCACTTTGTGGGGCTAAGGATCGTGTGATATTTACAAGCTATCAGCATGAGGCAAGGCC
GAGTGAAACACCCCGATTCCTAGCACACTATAAATGTTCGATAGTCGTACTCCGTTCCGG
X
b
a
I
AAG AAATCCC TGG TATC T AGAGAGAAGTTTC AAATATC AATGC CC AAGATGCC ATGC CTT
TTCTTTAGGGACGATAGATCTCTCTTCAAAGTTTATAGTTACGGGTTCTACGGTACGGAA
A
v
a
I
CAGTATGGAGCCTCCGGATCTACCGGAGATGCTTTGGGACTAATCGTCCGCTTTGCCTCG
GTCATACCTCGGAGGCCTAGATGGCCTCTACGAAACCCTGATTAGCAGGCGAAACGGAGC
GGTATCCGTTCAGCCTATGTTTAAGAGGAAACGCACGTGTCTGCCGCCAAAGCTCTTGCC
CCATAGGCAAGTCGGATACAAATTCTCCTTTGCGTGCACAGACGGCGGTTTCGAGAACGG
TATGGACTTTGTGACAAGTTGGAAAGCAAAAAAGTTGATGAAGTCGTACGAAATCTTGTT
ATACCTGAAACACTGTTCAACCTTTCGTTTTTTCAACTACTTCAGCATGCTTTAGAACAA
H
i
n
d
I
I
I
TC TAGCGGC TGGAATATTAGGGAAGTGGC C TGGAAGC TTC
5 6 8 7  -  — + ---------------------- + ----------------------+ ---------------------- + --------------  5 7 2 6
AGATCGCCGACCTTATAATCCCTTCACCGGACCTTCGAAG
4 9 6 6
5 0 2 6
50 86
5 1 4 6
5 2 0 6
5 2 6 6
5 3 2 6
5 3 8 6
5 4 4 6
5 5 0 6
5 5 6 6
5 6 2 6
5 6 8 6
Fig. 3.4 Sequence I determined of the inner part of Tn7, see Fig. 3.1, restriction sites are highlighted
University. It was never possible to derive any sequence when this primer 
was used. An examination of the sequence derived from the LINT2R, 
which overlapped this region revealed several discrepancies between this 
sequence and that which I was given. This created several mismatches at 
the potential LE2L binding site which may have prevented primer 
hybridising to the denatured double stranded DNA. Regrettably there was 
insufficient time available for me to design, synthesise and use another 
primer to take the place of LE2L.
The sequences determined are shown in figures 3.3 and 3.4. These data 
enabled the compilation of the entire Tn7 sequence, this is listed in Fig. 
3.5.
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TGTGGGCGGACAAAATAGTTGGGAACTGGGAGGGGTGGAAATGGAGTTTTTAAGGATTAT
1------------- i------------------------ 1------------------------1------------------------ 1----------------------- 1------------------------ (. go
ACACCCGCCTGTTTTATCAACCCTTGACCCTCCCCACCTTTACCTCAAAAATTCCTAATA
TTAGGGAAGAGTGACAAAATAGATGGGAACTGGGTGTAGCGTCGTAAGCTAATACGAAAA
6 1 ----------------- +---------------- +---------------- +--------------- +---------------- +----------------+ 120
AATCCCTTCTCACTGTTTTATCTACCCTTGACCCACATCGCAGCATTCGATTATGCTTTT
H
i  
n 
c
I
I
TTAAAAATGACAAAATAGTTTGGAACTAGATTTCACTTATCTGGTTAACTAATCTAGCTA
1 2 1 -----------------+----------------- 1--—------------ H-------------- 4----------------- h---- ---------- + 180
AATTTTTACTGTTTTATCAAACCTTGATCTAAAGTGAATAGACCAATTGATTAGATCGAT
ACCTGCCGCTCAGCTTAGTACGATCGATATCCAACTGATATAATCCTTTCATCAGTATCC
1 8 1 ------------ • --+ ---------------- +---------------- +---------------- +---------------- +---------------- + 240
TGGACGGCGAGTCGAATCATGCTAGGTATAGGTTGACTATATTAGGAAAGTAGTCATAGG
CAAATTAAATGCCCTCCTAGGACTGCCTCACCAACACTTTACAGTGATCCCGTATTTGTA
241 ----------------+-----------------+---------------- +---------------- +-------------- -+ ---------------- + 300
GTTTAATTTACGGGAGGATCCTGACGGAGTGGTTGTGAAATGTCACTAGGGCATAAACAT
TTTCCGGACAGGTGATTGATTTTTTTCGCTTGTACAGGTGTTAAGCCACAGTTATCTTGA
3 0 1 ------------------ 1-----------------k-----------------1------------------ 1----------------- h-----------------1- 360
AAAGGCCTGTCCACTAACTAAAAAAAGCGAACATGTCCACAATTCGGTGTCAATAGAACT
TGTGGACATTATGCATTGTAATAGCCCATTAACATGCGCTAAGAGCATAAATTAATATAC
361 —  -------------- + -------------------------4---------------------- + ---------------------- 4*---------------------- + -----------------------+ 420
ACACCTGTAATACGTAACATTATCGGGTAATTGTACGCGATTCTCGTATTTAATTATATG
AGTAACAAGCATTACGAGGTGCTAATGTTTGGAAAGCAGCCTCTTCCAACTACAATAATA
4 2 1 -----------------+---------------- +---------------- +-------- _— +------------------- +---------------- + 480
TCATTGTTCGTAATGCTCCACGATTACAAACCTTTCGTCGGAGAAGGTTGATGTTATTAT
H
i  
n
C
I
I
AGTTAACTATCCTCCACCCACAAATAATTACAAATGACCCCTTTCCGCTATAACTCCGAT
481 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 540
TCAATTGATAGGAGGTGGGTGTTTATTAATGTTTACTGGGGAAAGGCGATATTGAGGCTA
A
v 
a
I
CTCACCAGTGGCTCGCTACAAACCCGAGAGTGTCGCATTATTACTGGCTTGTTACTCCAA
541 ----------------+-----------------+----------------+---------------- +---------------- +---------------- + 600
GAGTGGTCACCGAGCGATGTTTGGGCTCTCACAGCGTAATAATGACCGAACAATGAGGTT
GAGCTTGATGAAGCTGCCTGGGATAAAGCCATGTATAAGGAAAATGTGCTTCAGAAACGC
601  +---------------- +---------------- +---------------- +---------------- +---------------- + 660
CTCGAACTACTTCGACGGACCCTATTTCGGTACATATTCCTTTTACACGAAGTCTTTGCG
Fig. 3.5 Complete Sequence of Tn7
Integrase pseudogene nt. 1921-905
dhfr nt. 2268-2727
sat nt. 2821-3345
aadA nt. 3403-4192
Internal repeats nt 4389-4513
TnsE nt. 7828-6202 
TnsD nt. 7827-9349 
TnsC nt; 11023-9353 
TnsB nt. 13128-11024 
TnsA nt. 13936-13114
ACGCAATCTACGGTAAGACGTATTTCTTCAGCGCTTAGAAAACGCCTAGAACACCTAAGC
6 6 1 ---------------------- 4------------------------4----------------------- 4----------------- 1------------------1----------------- 4- 720
TGCGTTAGATGCCATTCTGCATAAAGAAGTCGCGAATCTTTTGCGGATCTTGTGGATTCG
TCTGACTTTTGGGCTTTTTGCGCTTTTTATGTTAGGCATTGTCTTGGCCAACCTGGAGGA
721 ---------------------- 4-------------------------- 1------------------------ 1----------------------- 4----------------------- 4------------------------4- 780
AGACTGAAAACCCGAAAAACGCGAAAAATACAATCCGTAACAGAACCGGTTGGACCTCCT
AGTGTAATGACCATGAATGGTCACTGTGATTGACAGTATCTTGCTTAAACTTATCTGAAC
7 8 1 ----------------------4----------------------- 4----------------------- 4----------- ' ----------4----------------------- 4------------------------4- 840
TCACATTACTGGTACTTACCAGTGACACTAACTGTCATAGAACGAATTTGAATAGACTTG
AATGGTAGAACTGGCTCATATTTATCCCCTCTATGATTGTTTATCTTTTTCACCATAAAA
841 ---------------------- 4------------------------- 4----------------------- 4---------------------- 4------------------------- 1------------------------+ 900
TTACCATCTTGACCGAGTATAAATAGGGGAGATACTAACAAATAGAAAAAGTGGTATTTT
AGTATCAGGGGCTACTCAGGGCTACATAAAGATATTTATCTACTTTTACTGATTGATAAG
901 ----------------------4------------------------ 4----------------------- 4-----------------------4----------------------- 4-------------------------4- 960
TCATAGTCCCCGATGAGTCCCGATGTATTTCTATAAATAGATGAAAATGACTAACTATTC
TAGCATCAGTCCATCCGCAGGACTGGTGGTGCCGCAAATGCTGACCCAACACATGCGTAT
961 ----------------------4------------------------4----------------------- 4-----------------------4----------------------- 4-------------------------4- 1020
ATCGTAGTCAGGTAGGCGTCCTGACCACCACGGCGTTTACGACTGGGTTGTGTACGCATA
AGATTTGCGTGGTCTTAACATCGTTATGCCCTAAGAGTTCTTGCACAGTGCGAATATCAC
1021 ----------------------4------------------------4----------------------- 4----------------------- 4----------------------- 4-------------------------4- 1080
TCTAAACGCACCAGAATTGTAGCAATACGGGATTCTCAAGAACGTGTCACGCTTATAGTG
GCCCCGCTTGTAATAGATGCGTAGCAAACGAGTGACGAAATGTATGACAAGTGACACGCT
1 0 8 1 ------------------------ 4---------------------- 4------------------------ 4----------------------- 4------------------------ 1------------------------4- 1140
CGGGGCGAACATTATCTACGCATCGTTTGCTCACTGCTTTACATACTGTTCACTGTGCGA
TGCTAACGATGCCTGCTTTTTGTACGGCTGCCTTCAATGCCTTTCGCGCAACGGAGTCAT
1 1 4 1 ---------------- 4-----------------4-----------------4-----------------4-----------------4------------------ 4- 1200
ACGATTGCTACGGACGAAAAACATGCCGACGGAAGTTACGGAAAGCGCGTTGCCTCAGTA
GCAGATGATGGCGGCATAATTTGCCGTTATACGGGTGGTTGCAGAGCGTGCTGGAGGGAA
1201 ----------------------4------------------------ 4----------------------- 4-----------------------4----------------------- 4-------------------------4- 1260
CGTCTACTACCGCCGTATTAAACGGCAATATGCCCACCAACGTCTCGCACGACCTCCCTT
AGACAAACATCCACGCCGCTTGTCGATAAGCAGAAGGGTATTTGTGATCTAAAGCAAAAG
1261 ----------------------4------------------------4----------------------- 4----------------------- 4-----------------------4-------------------------4- 1320
TCTGTTTGTAGGTGCGGCGAACAGCTATTCGTCTTCCCATAAACACTAGATTTCGTTTTC
GCAGCGATGGCCCTACGCCTTGTAAGTTGTCGTCTTGCTGAATAAGCCGCGCTTGCTCAA
1321 ----------------------4------------------------ 4----------------------- 4-----------------------+ ---------------------- 4------------------------ 4- 1380
CGTCGCTACCGGGATGCGGAACATTCAACAGCAGAACGACTTATTCGGCGCGAACGAGTT
TGAGTTATTTTATTGCTGGGATTAGGCGCGTGGGCAGTAGGCTGTTTCTGCTTTTCCCAC
1 3 8 1 -------------------------1-----------------------v----------------------- 4-----------------------1------------------------- 1------------------------ 1- 1440
ACTCAATAAAATAACGACCCTAATCCGCGCACCCGTCATCCGACAAAGACGAAAAGGGTG
CCTTACCGTCATGCACAGTGATGCAGCCATTATCAAAATCAAAATCTTTAACCCGCAAAC
1441 ----------------------4------------------------4----------------------- 4----------------------- 4----------------------- + ------------------------4- 1500
GGAATGGCAGTACGTGTCACTACGTCGGTAATAGTTTTAGTTTTAGAAATTGGGCGTTTG
GCAAGCATTCATTAATGCGCAAACCTGCACCATACAGCAGCGTAAAAATAACTTGGTTGC
1501 ----------------------4------------------------4----------------------- 4----------------------- 4----------------------- 4-------------------------+ 1560
CGTTCGTAAGTAATTACGCGTTTGGACGTGGTATGTCGTCGCATTTTTATTGAACCAACG
Fig. 3.5 Complete Sequence of Tn7
Integrase pseudogene nt. 1921-905
dhfr nt. 2268-2727
sat nt. 2821-3345
aadA nt. 3403-4192
Internal repeats nt 4389-4513
TnsE nt. 7828-6202 
TnsD nt. 7827-9349 
TnsC nt. 11023-9353 
TnsB nt. 13128-11024 
TnsA nt. 13936-13114
GAGTATCCATAACCTGCAAAATGCGTTGCACTTCATTTGCAGAGATAACAGAGGGTAGCC
1561 ----------------+----------------+---------------- +----------------+----------------+ + 1620
CTCATAGGTATTGGACGTTTTACGCAACGTGAAGTAAACGTCTCTATTGTCTCCCATCGG
GTCTAGGCTTGCTTGCAGGGATATAATCAATATCGCCCAACGGCTGTTGTAAAAACCTGT
1621  +-----------------+---------------- +---------------- +--------------- +----------------- + 1680
CAGATCCGAACGAACGTCCCTATATTAGTTATAGCGGGTTGCCGACAACATTTTTGGACA
TGTACAAAAAAGCTAGGGCATTTAAAGCGATTTTCTGCGTGTTTATGGCTACATGTCTGC
1681 ----------------+----------------- +---------------- +---------------- +--------------- +----------------- + 1740
ACATGTTTTTTCGATCCCGTAAATTTCGCTAAAAGACGCACAAATACCGATGTACAGACG
TGTTTGCTAAGCTGGATAAAAACAGCCTGACCTCTTCACTGCCCATGGTCTGAGGATGAC
1 7 4 1 -----------------1----------------- 1------ ;---------H------------------ 1----------------- 1------------------h 1800
ACAAACGATTCGACCTATTTTTGTCGGACTGGAGAAGTGACGGGTACCAGACTCCTACTG
GTTTTTTGTGAAACAGAATAAAACGCTTAATCCAGTGCAGGTAAGTTTTTTCAGTTTTCA
1801  +-----------------+---------------- +---------------- +--------------- +----------------- + 1860
CAAAAAACACTTTGTCTTATTTTGCGAATTAGGTCACGTCCATTCAAAAAAGTCAAAAGT
GCGCATAACCTTTTTGTCGCATATCCGTGCGTATAGAATTTAAAAATGGACTGTTAGACA
1 8 6 1 ------------------ 1---------------- b---------------- b----------------- 1---------------- h------------------b 1920
CGCGTATTGGAAAAACAGCGTATAGGCACGCATATCTTAAATTTTTACCTGACAATCTGT
TAAAACGCTCCTTGTCTTGCAACTGTCTGCCTATACAGCCTATTCTAGCTGGGATTTAAA
1921 ----------------+----------------- +---------------- +---------------- +--------------- + + 1980
ATTTTGCGAGGAACAGAACGTTGACAGACGGATATGTCGGATAAGATCGACCCTAAATTT
AAAGTGCCTGTTTTTTACGCCTAGAGATGCTTGTTTACCGGTAGAGTTTTAATTTAATGC
1 9 8 1 -----------------1----------------- 1--------- —------ 1----------------- 1----------------- 1----------------- +■ 2040
TTTCACGGACAAAAAATGCGGATCTCTACGAACAAATGGCCATCTCAAAATTAAATTACG
TAAATAAATTAAAATGTTATGAGTTCTTTGGGTGAGATAATGTGCATCGTGCAAGCAGGA
2041 -----------------1------------------ b----------------- (-----------------k-----------------1 1- 2100
ATTTATTTAATTTTACAATACTCAAGAAACCCACTCTATTACACGTAGCACGTTCGTCCT
TAGACGGCATGCACGATTTGTAATAACAGAGTGTCTTGTATTTTTAAAGAAAGTCTATTT
2 1 0 1 ---------------------------------- h-----------------------------------+ ---------------------------------- b --------------------------------- h------------------------------------1 1- 2 1 6 0
ATCTGCCGTACGTGCTAAACATTATTGTCTCACAGAACATAAAAATTTCTTTCAGATAAA
AATACAAGTGATTATATTAATTAACGGTAAGCATCAGCGGGTGACAAAACGAGCATGCTT
2161  1------------------- 1---------------- +-----------------1----------------- 1-----------------1- 2220
TTATGTTCACTAATATAATTAATTGCCATTCGTAGTCGCCCACTGTTTTGCTCGTACGAA
H
i  
n
C
I
I
ACTAATAAAATGTTAACCTCTGAGGAAGAATTGTGAAACTATCACTAATGGTAGCTATAT
2221 -----------------1-------------------H------------------1-----------------b----------------- h-----------------1- 2280
TGATTATTTTACAATTGGAGACTCCTTCTTAACACTTTGATAGTGATTACCATCGATATA
CGAAGAATGGAGTTATCGGGAATGGCCCTGATATTCCATGGAGTGCCAAAGGTGAACAGC
2281 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 2340
GCTTCTTACCTCAATAGCCCTTACCGGGACTATAAGGTACCTCACGGTTTCCACTTGTCG
TCCTGTTTAAAGCTATTACCTATAACCAATGGCTGTTGGTTGGACGCAAGACTTTTGAAT
2341 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 2400
AGGACAAATTTCGATAATGGATATTGGTTACCGACAACCAACCTGCGTTCTGAAAACTTA
Fig. 3.5 Complete Sequence of Tn7
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TnsE nt. 7828-6202 
TnsD nt. 7827-9349 
TnsC nt. 11023-9353 
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4CAATGGGAGCATTACCCAACCGAAAGTATGCGGTCGTAACACGTTCAAGTTTTACATCTG
2401 ----------------+-----------------+----------------+---------------- +----------------+---------------- + 2460
GTTACCCTCGTAATGGGTTGGCTTTCATACGCCAGCATTGTGCAAGTTCAAAATGTAGAC
ACAATGAGAACGTATTGATCTTTCCATCAATTAAAGATGCTTTAACCAACCTAAAGAAAA
2461 ----------------+-----------------+----------------+---------------- +----------------+---------------- + 2520
TGTTACTCTTGCATAACTAGAAAGGTAGTTAATTTCTACGAAATTGGTTGGATTTCTTTT
TAACGGATCATGTCATTGTTTCAGGTGGTGGGGAGATATACAAAAGCCTGATCGATCAAG
2521 -----------------1----------------- +----------------- 1----------------- 1----------------- 1---------------- + 2580
ATTGCCTAGTACAGTAACAAAGTCCACCACCCCTCTATATGTTTTCGGACTAGCTAGTTC
TAGATACACTACATATATCTACAATAGACATCGAGCCGGAAGGTGATGTTTACTTTCCTG
2581 ----------------------- 1----------------------- 4----------------------- 4----------------------- 4----------------------- 4------------------------4* 2640
ATCTATGTGATGTATATAGATGTTATCTGTAGCTCGGCCTTCCACTACAAATGAAAGGAC
AAATCCCCAGCAATTTTAGGCCAGTTTTTACCCAAGACTTCGCCTCTAACATAAATTATA
2641 -----------------1-------------------1----------------- 1---------------- y-------------------1-----------------1- 2700
TTTAGGGGTCGTTAAAATCCGGTCAAAAATGGGTTCTGAAGCGGAGATTGTATTTAATAT
H
i
n
C
I
I
GTTACCAAATCTGGCAAAAGGGTTAACAAGTGGCAGCAACGGATTCGCAAACCTGTCACG
2701 ----------------------4------------------------ + ---------------------- 4----------------------- 4----------------------- 4----------------------- 4- 2760
CAATGGTTTAGACCGTTTTCCCAATTGTTCACCGTCGTTGCCTAAGCGTTTGGACAGTGC
CCTTTTGTGCCAAAAGCCGCGCCAGGTTTGCGATCCGCTGTGCCAGGCGTTAGGCGTCAT
2761 ----------------4------------------- 1----------------- 1----------------- 4----------------- 1---------------- 4- 2820
GGAAAACACGGTTTTCGGCGCGGTCCAAACGCTAGGCGACACGGTCCGCAATCCGCAGTA
ATGAAGATTTCGGTGATCCCTGAGCAGGTGGCGGAAACATTGGATGCTGAGAACCATTTC
2821 ----------------------4-------------------------- 1----------------------- 4------------------------ 1------------------------ 1---------------------- 4- 2880
TACTTCTAAAGCCACTAGGGACTCGTCCACCGCCTTTGTAACCTACGACTCTTGGTAAAG
ATTGTTCGTGAAGTGTTCGATGTGCACCTATCCGACCAAGGCTTTGAACTATCTACCAGA
2881 ----------------4------------------4-----------------4-----------------4----------------- 4----------------- 4- 2940
TAACAAGCACTTCACAAGCTACACGTGGATAGGCTGGTTCCGAAACTTGATAGATGGTCT
AGTGTGAGCCCCTACCGGAAGGATTACATCTCGGATGATGACTCTGATGAAGACTCTGCT
2941 ----------------4------------------4-----------------4-----------------4-----------------4----------------- 4- 3000
TCACACTCGGGGATGGCCTTCCTAATGTAGAGCCTACTACTGAGACTACTTCTGAGACGA
TGCTATGGCGCATTCATCGACCAAGAGCTTGTCGGGAAGATTGAACTCAACTCAACATGG
3001 -----------------1-------------------1----------------- 4----------------- 1----------------- 1 1- 3060
ACGATACCGCGTAAGTAGCTGGTTCTCGAACAGCCCTTCTAACTTGAGTTGAGTTGTACC
AACGATCTAGCCTCTATCGAACACATTGTTGTGTCGCACACGCACCGAGGCAAAGGAGTC
3061 ---------------------- 4------------------------ h---------------------- 4----------------------- 4-------------------------4 4- 3120
TTGCTAGATCGGAGATAGCTTGTGTAACAACACAGCGTGTGCGTGGCTCCGTTTCCTCAG
GCGCACAGTCTCATCGAATTTGCGAAAAAGTGGGCACTAAGCAGACAGCTCCTTGGCATA
3 1 2 1 -------------------------1------------------------ 1----------------------- 4------------------------ 1----------------------- 4 4- 3180
CGCGTGTCAGAGTAGCTTAAACGCTTTTTCACCCGTGATTCGTCTGTCGAGGAACCGTAT
CGATTAGAGACACAAACGAACAATGTACCTGCCTGCAATTTGTACGCAAAATGTGGCTTT
3181 ----------------4------------------4-----------------4-----------------4-----------------4----------------- 4- 3240
GCTAATCTCTGTGTTTGCTTGTTACATGGACGGACGTTAAACATGCGTTTTACACCGAAA
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ACTCTCGGCGGCATTGACCTGTTCACGTATAAAACTAGACCTCAAGTCTCGAACGAAACA
3241 ----------------+---------------- +---------------- +----------------+----------------+---------------- + 3300
TGAGAGCCGCCGTAACTGGACAAGTGCATATTTTGATCTGGAGTTCAGAGCTTGCTTTGT
A
v
a
I
GCGATGTACTGGTACTGGTTCTCGGGAGCACAGGATGACGCCTAACAATTCATTCAAGCC
3301 ----------------+----------------- +---------------- +--------------- +---------------- + + 3360
CGCTACATGACCATGACCAAGAGCCCTCGTGTCCTACTGCGGATTGTTAAGTAAGTTCGG
GACACCGCTTCGCGGCGCGGCTTAATTCAGGAGTTAAACATCATGAGGGAAGCGGTGATC
3361 -----------------  h----------------- h----------------- 1----------------- h------------------h 3420
CTGTGGCGAAGCGCCGCGCCGAATTAAGTCCTCAATTTGTAGTACTCCCTTCGCCACTAG
GCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCG
3421 ----------------+----------------- +---------------- +--------------- +---------------- + + 3480
CGGCTTCATAGCTGAGTTGATAGTCTCCATCAACCGCAGTAGCTCGCGGTAGAGCTTGGC
ACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTGAAGCCACACAGT
3481 ----------------+----------------- +---------------- +--------------- +---------------- +---------------- + 3540
TGCAACGACCGGCATGTAAACATGCCGAGGCGTCACCTACCGCCGGACTTCGGTGTGTCA
GATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACGCGGCGAGCTTTG
3541 ----------------+-------------------1------------------1---------------- h----------------- h---------------- + 3600
CTATAACTAAACGACCAATGCCACTGGCATTCCGAACTACTTTGTTGCGCCGCTCGAAAC
ATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATTCTCCGCGCTGTA
3601 -----------------1-------------------H------------------1-----------------1------------------1---------------- + 3660
TAGTTGCTGGAAAACCTTTGAAGCCGAAGGGGACCTCTCTCGCTCTAAGAGGCGCGACAT
GAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCTAAGCGCGAA
3661 -----------------1------------------- 1----------------- H-----------------1----------------- h---------------- + 3720
CTTCAGTGGTAACAACACGTGCTGCTGTAGTAAGGCACCGCAATAGGTCGATTCGCGCTT
CTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCAGCCACG
3721 ----------------+----------------- +---------------- +--------------- +---------------- +---------------- + 3780
GACGTTAAACCTCTTACCGTCGCGTTACTGTAAGAACGTCCATAGAAGCTCGGTCGGTGC
ATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTGGTA
3781 -----------------1-------------------h------------------1------------------1----------------- h-----------------1- 3840
TAGCTGTAACTAGACCGATAGAACGACTGTTTTCGTTCTCTTGTATCGCAACGGAACCAT
GGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTA
3841 ----------------+--------- - — +--------------- +----------------+---------------- +---------------- + 3900
CCAGGTCGCCGCCTCCTTGAGAAACTAGGCCAAGGACTTGTCCTAGATAAACTCCGCGAT
AATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTA
3901 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 3960
TTACTTTGGAATTGCGATACCTTGAGCGGCGGGCTGACCCGACCGCTACTCGCTTTACAT
GTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGAT
3961 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4020
CACGAATGCAACAGGGCGTAAACCATGTCGCGTCATTGGCCGTTTTAGCGCGGCTTCCTA
GTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAA
4021 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4080
CAGCGACGGCTGACCCGTTACCTCGCGGACGGCCGGGTCATAGTCGGGCAGTATGAACTT
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6GCTAGGCAGGCTTATCTTGGACAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAA
4081 ----------------+---------------- +--------- -^-----+----------------+----------------+---------------- +- 4140
CGATCCGTCCGAATAGAACCTGTTCTTCTAGCGAACCGGAGCGCGCGTCTAGTCAACCTT
GAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGTCTAACA
4141 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 4200
CTTAAACAAGTGATGCACTTTCCGCTCTAGTGGTTCCATCAGCCGTTTATTACAGATTGT
ATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGAGAGCTGGGG
4201 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4260
TAAGCAAGTTCGGCTGCGGCGAAGCGCCGCGCCGAATTGAGTTCGCAATCTCTCGACCCC
AAGACTATGCGCGATCTGTTGAAGGTGGTTCTAAGCCTCGTACTTGCGATGGCATCGGGG
4261 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4320
TTCTGATACGCGCTAGACAACTTCCACCAAGATTCGGAGCATGAACGCTACCGTAGCCCC
CAGGCACTTGCTGACCTGCCAATTGTTTTAGTGGATGAAGCTCGTCTTCCCTATGACTAC
4321 ----------------+-----------------+----------------+---------------- +---------------- +---------------- + 4380
GTCCGTGAACGACTGGACGGTTAACAAAATCACCTACTTCGAGCAGAAGGGATACTGATG
TCCCCA TCCAACTACGACATTTCTCCAAGCAACTACGACAACTCCATAAGCAATTACGAC
4381 ----------------+---------------- +-------- t----- +---------------- +----------------+---------------- + 4440
AGGGGTAGGTTGATGCTGTAAAGAGGTTCGTTGATGCTGTTGAGGTATTCGTTAATGCTO
AATAGTCCATCAAATTACGACAACTCTGAGAGCAACTACGATAATAGTTCATCCAATTAC
4441 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 4500
TTATCAGGTAGTTTAATGCTGTTGAGACTCTCGTTQATGCTATTATCAAGTAGGTTAATG
GACAATAGTCGCAACGGAAATCGTAGGCTTATATATAGCGCAAATGGGTCTCGCACTTTC
4501 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4560
CTGTTATCAGCGTTGCCTTTAGCATCCGAATATATATCGCGTTTACCCAGAGCGTGAAAG
GCCGGCTACTACGTCATTGCCAACAATGGGACAACGAACTTCTTTTCCACATCTGGCAAA
4561 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 4620
CGGCCGATGATGCAGTAACGGTTGTTACCCTGTTGCTTGAAGAAAAGGTGTAGACCGTTT
AGGATGTTCTACACCCCAAAAGGGGGGCGCGGCGTCTATGGCGGCAAAGATGGGAGCTTC
4621 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4680
TCCTACAAGATGTGGGGTTTTCCCCCCGCGCCGCAGATACCGCCGTTTCTACCCTCGAAG
TGCGGGGCATTGGTCGTCATAAATGGCCAATTTTCGCTTGCCCTGACAGATAACGGCCTG
4681 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4740
ACGCCCCGTAACCAGCAGTATTTACCGGTTAAAAGCGAACGGGACTGTCTATTGCCGGAC
AAGATCATGTATCTAAGCAACTAGCCTGCTCTCTAATAAAATGTTAGGCCTCAACATCTA
4741 ---------------- h----------------- +---------------- +----------------- h---------------- 1----------------- + 4800
TTCTAGTACATAGATTCGTTGATCGGACGAGAGATTATTTTACAATCCGGAGTTGTAGAT
GTCGCAAGCTGAGGGGAACCACTAGTGTCATACGAACCTCCAAGAGACGGTTACACAAAC
4801 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4860
CAGCGTTCGACTCCCCTTGGTGATCACAGTATGCTTGGAGGTTCTCTGCCAATGTGTTTG
GGGTACATTGTTGATGTCATGTATGACAATCGCCCAAGTAAGTATCCAGCTGTGTTCAGA
4861 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 4920
CCCATGTAACAACTACAGTACATACTGTTAGCGGGTTCATTCATAGGTCGACACAAGTCT
Fig. 3.5 Complete Sequence of Tn7
Integrase pseudogene nt. 1921-905 TnsE nt. 7828-6202 
TnsD nt. 7827-9349 
TnsC nt. 11023-9353 
TnsB nt. 13128-11024 
TnsA nt. 13936-13114
dhfr nt. 2268-2727 
sat nt. 2821-3345 
aadA nt. 3403-4192
Internal repeats nt 4389-4513
7E
c
0 
R
1
ACGTACGTCCGAATTCCAGACTATGTCGAACTAGATAACGCGGAGGAGCTGGCCGACGCA
4921 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 4980
TGCATGCAGGCTTAAGGTCTGATACAGCTTGATCTATTGCGCCTCCTCGACCGGCTGCGT
ATCATTCGAGAGGTTGAGTTAAAGGAGGCATGGCTCACAAGGGTCTTGGGGAACTCAGCC
4981 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 5040
TAGTAAGCTCTCCAACTCAATTTCCTCCGTACCGAGTGTTCCCAGAACCCCTTGAGTCGG
GATCCTGACGCTTCTGTGGGCAAGTGGGACCGGCGCCTAGCGAGTGCGTGGTATTGATGA
5041 ----------------+-----------------+-------------- -+ ---------------- +---------------- +---------------- + 5100
CTAGGACTGCGAAGACACCCGTTCACCCTGGCCGCGGATCGCTCACGCACCATAACTACT
GATGTCAAGTGGGGTGCAGGCAACATACTTCAGTCCAAACGGTCAGCTGGTCGGCTTAGT
5 1 0 1 -----------------+---------------- +---------------- +---------------- +---------------- +---------------- + 5160
CTACAGTTCACCCCACGTCCGTTGTATGAAGTCAGGTTTGCCAGTCGACCAGCCGAATCA
GGCATACATTGATGCCGAATGGATGGATGAATAGCTCTGACGTTACGATTCAGGTGAGAC
5161 ---------------- (-------------------1--------------- 1---------------------1------------------1-----------------1- 5220
CCGTATGTAACTACGGCTTACCTACCTACTTATCGAGACTGCAATGCTAAGTCCACTCTG
AACCAGATGGGCATTGCGTACAAGCTCAGTTGCCACCGATGTGGCTACGAGTCTGATCTT
5221 ---------------- f------------------ -i--------------- h--------------------h---------------- +---------------- + 5280
TTGGTCTACCCGTAACGCATGTTCGAGTCAACGGTGGCTACACCGATGCTCAGACTAGAA
CTTTACCTAGGCCAAGGTATGGCGATGCTTCCTGAGCAATAGTCGGAACGTGCACATGCT
5281 ---------------- H------------------h--------------- h— -------------- +----------------- h---------------- + 5340
GAAATGGATCCGGTTCCATACCGCTACGAAGGACTCGTTATCAGCCTTGCACGTGTACGA
GCGACAATCTAACGACGATTTCTATAAATGAAAGCTACGGAGTATGCTCACTTTGTGGGG
5341 ----------------+----------------- 1--------------- h--------------------1---------------- 1----------------- +■ 5400
CGCTGTTAGATTGCTGCTAAAGATATTTACTTTCGATGCCTCATACGAGTGAAACACCCC
CTAAGGATCGTGTGATATTTACAAGCTATCAGCATGAGGCAAGGCCAAGAAATCCCTGCT
5401 ----------------+----------------+--------------- +------------------+---------------- +---------------- +- 5460
GATTCCTAGCACACTATAAATGTTCGATAGTCGTACTCCGTTCCGGTTCTTTAGGGACGA
X
b
a
I
ATCTAGAGAGAAGTTTCAAATATCAATGCCCAAGATGCCATGCCTTCAGTATGGAGCCTC
5461 ----------------+-----------------+-------------- +------------------+---------------- +---------------- + 5520
TAGATCTCTCTTCAAAGTTTATAGTTACGGGTTCTACGGTACGGAAGTCATACCTCGGAG
A
v
a
I
CGGATCTACCGGAGATGCTTTGGGACTAATCGTCCGCTTTGCCTCGGGTATCCGTTCAGC
5521 ----------------+-----------------+-------------- +------------------+---------------- +---------------- + 5580
GCCTAGATGGCCTCTACGAAACCCTGATTAGCAGGCGAAACGGAGCCCATAGGCAAGTCG
CTATGTTTAAGAGGAAACGCACGTGTCTGCCGCCAAAGCTCTTGCCTATGGACTTTGTGA
5581 ----------------+-----------------+-------------- +------------------+---------------- +---------------- + 5640
GATACAAATTCTCCTTTGCGTGCACAGACGGCGGTTTCGAGAACGGATACCTGAAACACT
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CAAGTTGGAAAGCAAAAAAGTTGATGAAGTCGTACGAAATCTTGTTTCTAGCGGCTGGAA
5641 ----------------+---------------- +---------------- +----------------+---------------- + + 5700
GTTCAACCTTTCGTTTTTTCAACTACTTCAGCATGCTTTAGAACAAAGATCGCCGACCTT
H
i  
n
D
I
I
I
TATTAGGGAAGTGGCCTGGAAGCTTCGTCCTTTGATCATGAAATGCCCTACTTTGACACG
5701 ----------------+---------------- +---------------- +----------------+----------------+ + 5760
ATAATCCCTTCACCGGACCTTCGAAGCAGGAAACTAGTACTTTACGGGATGAAACTGTGC
GGGCGGGACTTCGATATTGGATTTCCTGACACGCTGTCATCCAAGATTGAGTTTTTGACC
5761 ----------------+----------------- + --------------- +---------------- +----------------+---------------- + 5820
CCCGCCC-TGAAGCTATAACCTAAAGGACTGTGCGACAGTAGGTTCTAACTCAAAAACTGG
GCGAATGGATCAATCGTCCAAGCACGTGCTCGCCTGCACTTCAAGCAGGCTCTAATTTTT
5821 ----------------+-----------------+--------------- +---------------- +----------------+---------------- + 5880
CGCTTACCTAGTTAGCAGGTTCGTGCACGAGCGGACGTGAAGTTCGTCCGAGATTAAAAA
GCCAAGGCGTCCAAACATGTCGCCGCGCTCAAGAACTCATTGGATTACTACTATGGATCG
5881 ----------------+-----------------+--------------- +---------------- +---------------- +---------------- + 5940
CGGTTCCGCAGGTTTGTACAGCGGCGCGAGTTCTTGAGTAACCTAATGATGATACCTAGC
TCTGTAATCCCCCCTCAAAACCACGGAGGCTATTTGTAGAAAATTCCATTAATATGAACT
5941 ----------------+-----------------+--------------- +---------------- +----------------+---------------- + 6000
AGACATTAGGGGGGAGTTTTGGTGCCTCCGATAAACATCTTTTAAGGTAATTATACTTGA
CAAGGTGTTCCCTACGGACGAATCAGCGATGAAGGTGGTGTACCTGGCTATCCAGGCGGC
6001 -----------------1------------------ h---------------- 4----------------- k----------------- 1-----------------1- 6060
GTTCCACAAGGGATGCCTGCTTAGTCGCTACTTCCACCACATGGACCGATAGGTCCGCCG
GACCAAGAAATGGACGATGCCGATCCGCAACTGGAAGCCGGCCATGAACCGTTTTATGAT
6061 ---------   + - ---------------------4---------------•  4-—  — — — —  — — + ----------------------+ ---------------------- +  6120
CTGGTTCTTTACCTGCTACGGCTAGGCGTTGACCTTCGGCCGGTACTTGGCAAAATACTA
CGAATTTGGTGACCGTTTAAATGGCCACCTTTAACTGACCGGCAAAAGCACTTACACAAA
6 1 2 1 -----    1----------------- 4---------------- 4--------   4----  4- 6180
GCTTAAACCACTGGCAAATTTACCGGTGGAAATTGACTGGCCGTTTTCGTGAATGTGTTT
AGGGTTTACAGGCTCTTTCAGTCATTCCTTTAATGCGTAAATTGCTCTCTAACCACTCTC
6 1 8 1 ------------------------- 1------------------------ 1--------------------- 4--------------------------1----------------------- h-----------------------4- 6240
TCCCAAATGTCCGAGAAAGTCAGTAAGGAAATTACQCATTTAACGAGAGATTGGTGAGAG
TCAGCCCACCCTTCCATATCCTCTCTCGATACTTGCAGCTCCCCCAACCCCTTTGGATGA
6241 ----------------4------------------4---------------- 4----------------- 4-----------------4----------------- 4- 6300
AGTCGGGTGGGAAGGTATAGGAGAGAGCTATGAACGTCGAGGGGGTTGGGGAAACCTACT
TTCACCCCTCTATGCCCGTCTTGTCCATATAATTGATCAAACAAACTATTTGGCCAATTC
6301 ---------------------- 4-------------------------- 1---------------------- 4------------------------ 1------------------------- 1----------------------- 1- 6360
AAGTGGGGAGATACGGGCAGAACAGGTATATTAACTAGTTTGTTTGATAAACCGGTTAAG
AATGAGCTCTTCACCACTCCACGCCGTATCTTTTCAAAATCATTCCGCCATGTTTCGCTA
6361 ----------------4------------------4---------------- 4----------------- 4-----------------4----------------- 4- 6420
TTACTCGAGAAGTGGTGAGGTGCGGCATAGAAAAGTTTTAGTAAGGCGGTACAAAGCGAT
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9TCAACGCCACTCAACACTTTGGTAGAAAGCATTTTCACCCCATCCGATGCATCCACCTCT
6421 ---------------- H------------------- 1----------------- H------------------1---------------- H------------------1- 6480
AGTTGCGGTGAGTTGTGAAACCATCTTTCGTAAAAGTGGGGTAGGCTACGTAGGTGGAGA
AGCAATACAAATTCACTGCCATTACGTTGCACCCCAACGGCTTTAATCACTCTTGGTGAG
6481 ----------------+----------------- +---------------- +---------------- +--------------- +----------------- + 6540
TCGTTATGTTTAAGTGACGGTAATGCAACGTGGGGTTGCCGAAATTAGTGAGAACCACTC
CCATCTTTACACAGATGTAATCGGCTACGCCCAACTTTTGGCAAAACCAAGGTTTCTTCA
6541 ----------------+----------------- +---------------- +---------------- +--------------- +----------------- + 6600
GGTAGAAATGTGTCTACATTAGCCGATGCGGGTTGAAAACCGTTTTGGTTCCAAAGAAGT
AAAAGCACCCGACATGCAAATTTAGTTTTTAGAATTGAAAGTAGCTCATCAAAAGCAGCA
6601  +-----------------+---------------- +---------------- +--------------- +----------------- + 6660
TTTTCGTGGGCTGTACGTTTAAATCAAAAATCTTAACTTTCATCGAGTAGTTTTCGTCGT
AATCGATTAGCAAAAATAGAGTTGTAATTGGTTGCATCCTGCTTCCCACCCACATCTGCC
6661 ---------------- h------------------- 1----------------- 1----------------- 1-----------------1----------------- + 6720
TTAGCTAATCGTTTTTATCTCAACATTAACCAACGTAGGACGAAGGGTGGGTGTAGACGG
GCTGCTAGGACACCACCTAAGTGTGGCTCATCAGTACTAACCAAATTACTATTTTCACTT
6721 -----------------1------------------+---------------- +---------------- h---------------- h----------------- + 6780
CGACGATCCTGTGGTGGATTCACACCGAGTAGTCATGATTGGTTTAATGATAAAAGTGAA
GTTGTTGCTTCTTCTTTTTCTAAAATAGTTTGGCTACTTTTTCTTGCCCTGCGAGATTTT
6781 ----------------+----------------- +---------------- +---------------- +--------------- +----------------- + 6840
CAACAACGAAGAAGAAAAAGATTTTATCAAACCGATGAAAAAGAACGGGACGCTCTAAAA
TCAATTCGACTAGGTCTACTAAAACTTATCCATGTCGGCTCAGCCTCTATGACTCGTGTG
6841 ----------------+-----------------+---------------- +---------------- + --------------- +----------------- + 6900
AGTTAAGCTGATCCAGATGATTTTGAATAGGTACAGCCGAGTCGGAGATACTGAGCACAC
TCTGTGTCTATATTGGCTGTTTCCTCATCGTCCAACTGTAGATGCTCATCATCAACAACT
6901 ----------------+----------------- +---------------- +---------------- +--------------- +■---------------- + 6960
AGACACAGATATAACCGACAAAGGAGTAGCAGGTTGACATCTACGAGTAGTAGTTGTTGA
GACTCTGTTGAAACCGCTATGTGCTGCGTACTACCATCACCTGCCTCCTTTTCCTGAAAA
6961 ----------------+-----------------+---------------- +---------------- +--------------- +----------------+ 7020
CTGAGACAACTTTGGCGATACACGACGCATGATGGTAGTGGACGGAGGAAAAGGACTTTT
GAGGCATGGCTAATAGCTGTTGTGCTAGGAAGCATAGCGTTGATTTCTAAACCTACTATT
7021 ---------------- k------------------ 1------------------1------------------1----------------- 1-----------------h 7080
CTCCGTACCGATTATCGACAACACGATCCTTCGTATCGCAACTAAAGATTTGGATGATAA
TCCTCAACTAAATAATCCTTATCCTCGTTAGAAGAACGTCCTTTTACATGTAATTTCCAA
7081 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7140
AGGAGTTGATTTATTAGGAATAGGAGCAATCTTCTTGCAGGAAAATGTACATTAAAGGTT
CCCTGCATGGGCGGAGGGTCAAAGCTAAAGCACCAGCTTTCAACGCCGTTCTTAATTTCT
7141 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7200
GGGACGTACCCGCCTCCCAGTTTCGATTTCGTGGTCGAAAGTTGCGGCAAGAATTAAAGA
CTATTTTGTTGATAGTGCCTAAAAATACTTTCATACGAATCCATAACATCTTGATCCGAA
7201 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7260
GATAAAACAACTATCACGGATTTTTATGAAAGTATGCTTAGGTATTGTAGAACTAGGCTT
AACAACCAAACCAAAAGCTGCACTACGGCCGACTGCTCTAACGCCCCTTTAGGAAACGAT
7261 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7320
TTGTTGGTTTGGTTTTCGACGTGATGCCGGCTGACGAGATTGCGGGGAAATCCTTTGCTA
Fig. 3.5 Complete Sequence of Tn7
Integrase pseudogene nt. 1921-905
dhfr nt. 2268-2727
sat nt. 2821-3345
aadA nt. 3403-4192
Internal repeats nt 4389-4513
TnsE nt. 7828-6202 
TnsD nt. 7827-9349 
TnsC nt. 11023-9353 
TnsB nt. 13128-11024 
TnsA nt. 13936-13114
GAACTGGGTAAGATCCTTATCTCTAAATGATCTCGCTCAACCTCATACTGAACGTCGAAC
7321 ----------------+---------------- +----------------+----------------+---------------- +---------------- + 7380
CTTGACCCATTCTAGGAATAGAGATTTACTAGAGCGAGTTGGAGTATGACTTGCAGCTTG
TCTTGCTGTAAAGCGGTACTGCTCAAACAGCTTCGACAGAAATAGGAGTTAATTAAAAAT
7381 ----------------+-----------------+---------------- +---------------- +---------------- +--------------- + 7440
AGAACGACATTTCGCCATGACGAGTTTGTCGAAGCTGTCTTTATCCTCAATTAATTTTTA
AATGACCGAGCTAGCTCTAACTGTGGGATGTGATAACGAGTCTTGCTATATGGTGTTTCA
7441 ----------------+----------------- +---------------- +---------------- +---------------- +--------------- + 7500
TTACTGGCTCGATCGAGATTGACACCCTACACTATTGCTCAGAACGATATACCACAAAGT
GCTTCGTAAATAAATGAACTCTGCGCTCCATCCTTGTTGCGTACGGAAGCAAAGGACGAG
7501 ----------------+-----------------+---------------- +---------------- +---------------- +----------------+ 7560
CGAAGCATTTATTTACTTGAGACGCGAGGTAGGAACAACGCATGCCTTCGTTTCCTGCTC
AGATTAGGAAAATCGATTATTTTGGCTCGTTGAAGATCCGATGCTTCAAACTCAATCACA
7561 ----------------+----------------- +---------------- +---------------- +----------------+ + 7620
TCTAATCCTTTTAGCTAATAAAACCGAGCAACTTCTAGGCTACGAAGTTTGAGTTAGTGT
H
i
n
C
I
I
CGATCCGCCTTATTTATTTGCTTTGTTGTACTGTTAACCACCTTAGCTCGACTTAATAAA
7621 -----------------1----------------- 1------------ - —-h-----------------h-----------------1----------------- + 7680
GCTAGGCGGAATAAATAAACGAAACAACATGACAATTGGTGGAATCGAGCTGAATTATTT
GGCAAATGAGTAAATCGAGTCCATTTCCGTTCTTGCATTGGATTAAACCAAACAAAAATA
7681 ----------------+---------------- +----------------+----------------+----------------+---------------- + 7740
CCGTTTACTCATTTAGCTCAGGTAAAGGCAAGAACGTAACCTAATTTGGTTTGTTTTTAT
A
v
a
I
CGCCACTCCTTATGACCCGAGTTACGGAATAAATGACCAATATGTACAACCTGCACATTG
7741 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7800
GCGGTGAGGAATACTGGGCTCAATGCCTTATTTACTGGTTATACATGTTGGACGTGTAAC
TCATTAAATGTAGCTAGCCTAACCACTCACTCTTCCCCATAAACCATTTCCAAGAATCTT
7801 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7860
AGTAATTTACATCGATCGGATTGGTGAGTGAGAAGGGGTATTTGGTAAAGGTTCTTAGAA
TGTGCTTCCTCAGTTATCCGCTCTTTAGATAACGTTGCACTTCTTAATAATCGCCAGCGC
7861 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 7920
ACACGAAGGAGTCAATAGGCGAGAAATCTATTGCAACGTGAAGAATTATTAGCGGTCGCG
H H
i i
n n
D D
I I
I I
I I
CTAAGCTCAACATCTTCCTGTTTAAGCTTAATAAAAGCTTGGCTAATCCGTCTAATTTGA
7921 ----------------+---------------- +----------------+----------------+---------------- +---------------- + 7980
GATTCGAGTTGTAGAAGGACAAATTCGAATTATTTTCGAACCGATTAGGCAGATTAAACT
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TAATCTTCCACACTCTCTGAGTAACGCTTTAAGCAAAGCGCTACCAAAGGCAGTTTCTGT
7981 ----------------+----------------+----------------+----------------+---------------- + + 8040
ATTAGAAGGTGTGAGAGACTCATTGCGAAATTCGTTTCGCGATGGTTTCCGTCAAAGACA
AGATTTTTTGCAAGAGAGGTTCCGTTAGGAGTTTGCTTTAACAGCCAGCTCGATGTCGCT
8041 ----------------+----------------+----------------+----------------+----------------+---------------- + 8100
TCTAAAAAACGTTCTCTCCAAGGCAATCCTCAAACGAAATTGTCGGTCGAGCTACAGCGA
CTTGGGTGATCAAGGCTACTATCTAGACGCTTTATGATTCTTAATAGTTGTCGTACAGCA
8 1 0 1 ------------------ 1----------------1------------------1-------------------h----------------- 1-----------------b 8160
GAACCCACTAGTTCCGATGATAGATCTGCGAAATACTAAGAATTATCAACAGCATGTCGT
ATTCGATCTCTTTGGTTCCAATCAACTCTAGGGGCGGGTGCCAGACGCTCTTGTTGATGC
8 1 6 1 ------------------h----------------1------------------1------------------ b---------------- 1------------------b 8220
TAAGCTAGAGAAACCAAGGTTAGTTGAGATCCCCGCCCACGGTCTGCGAGAACAACTACG
TGTTGATTCCAGTGAACTAGCCAATCCCTGTCATGTCGGTAAAGCCAAGCGTATAGCACC
8221 -----------:----- 1----------------- b-----------------1----------------- 1----------------- 1------------------h 8280
ACAACTAAGGTCACTTGATCGGTTAGGGACAGTACAGCCATTTCGGTTCGCATATCGTGG
CCACCCTCTAAAGACTGTCTTGCCGCCTTAATTCCTTGGTATTTATGCACTAGTTGCTGC
8281 — ------------- +--------------- +---------------- +----------------- +---------------- +---------------- + 8340
GGTGGGAGATTTCTGACAGAACGGCGGAATTAAGGAACCATAAATACGTGATCAACGACG
CAGTCTTTATGCTTAACAGATAAATCTTCAGAGTTAGGTTGCACAGACTGGCTAACAGGT
8341 ----------------+----------------+-------------  +------------- +---------------- +---------------- + 8400
GTCAGAAATACGAATTGTCTATTTAGAAGTCTCAATCCAACGTGTCTGACCGATTGTCCA
CTTGTCGTTATAGAGTGCTCAGTAAGAGCACTTGCCTGCTGTAGCGCTTCTATAACCGTT
8401 ---------------- b-----------------h----------------- 1-------------------1-----------------1------------------b 8460
GAACAGCAATATCTCACGAGTCATTCTCGTGAACGGACGACATCGCGAAGATATTGGCAA
AGTTTTGGCAATAAGGCTTGCCACACAATACTATGCTGTAAATAACTAAAGGCTTTTCTA
8461 ----------------+-----~ h -----------+-----------------+--------------- +------------------b 8520
TCAAAACCGTTATTCCGAACGGTGTGTTATGATACGACATTTATTGATTTCCGAAAAGAT
TGCTTACGGAATATACTTTTCAGCCAACACGTGTCCTTGTTCTCTGCCAACTTTAAATCC
8521 ---------------- h------------------1----------------- 1----------------- +-----------------1----------------- + 8580
ACGAATGCCTTATATGAAAAGTCGGTTGTGCACAGGAACAAGAGACGGTTGAAATTTAGG
AGTTTCTCTAGTGCCTCATCACTAAAAGTCTGCCTCACTCTCTCCGCCACCAAGTCATGA
8581 ---------------- h------------------1----------------- 1------------------ h-----------------1----------------- + 8640
TCAAAGAGATCACGGAGTAGTGATTTTCAGACGGAGTGAGAGAGGCGGTGGTTCAGTACT
. CGAATGTGCTTGCTTTTGGTTAGCCCTAGATCCTGCGCTAAGCGCTGATAAAACAGCGTC
8641 -----------------1----------------- 1----------------- b------------------h-----------------1----------------- + 8700
GCTTACACGAACGAAAACCAATCGGGATCTAGGACGCGATTCGCGACTATTTTGTCGCAG
CACTGCTCAAGGCTTGGGGAAAGCTCTTGCGCTCGTGGAGCATCTAACAGAGGGGCTATA
8701  ----------------- h------------------+------------------1--------------------1----------------- 1-------------------b 87 60
GTGACGAGTTCCGAACCCCTTTCGAGAACGCGAGCACCTCGTAGATTGTCTCCCCGATAT
TAAGCAGCTAGTGCTGTTAATTGAGATAGGGAGTCTTTGGGGTAGTCTGAAAGCAGCTCA
87 61 ---------------- b----------------+—  -----------+---------------- b---------------- h----------------- + 8820
ATTCGTCGATCACGACAATTAACTCTATCCCTCAGAAACCCCATCAGACTTTCGTCGAGT
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GTATGACCCAAAGCCCAAAATTGATGTCGGTGATCATCTACAGCTCTATCAAAGAAGACT
88 2 1   +  +  +  +  +  + 8880
CATACTGGGTTTCGGGTTTTAACTACAGCCACTAGTAGATGTCGAGATAGTTTCTTCTGA
AAAGCACCGTGTTTTGGACAATATGGCAAAGCGGGCAAATACCAATCTCGTTGCCAAAAG
8881 ----------------+-----------------+-------------- +------------------+---------------- +---------------- + 8940
TTTCGTGGCACAAAACCTGTTATACCGTTTCGCCCGTTTATGGTTAGAGCAACGGTTTTC
GCTTCCCCATACCTATTTAGCTGAAGAGCAACGCAATCAGGGCAGTATCTAAAGCGGTTA
8941 ----------------+-----------------+-------------- +------------------+---------------- +---------------- + 9000
CGAAGGGGTATGGATAAATCGACTTCTCGTTGCGTTAGTCCCGTCATAGATTTCGCCAAT
X
_b 
a
I
TCGCTCTTAACTCTAGAAGCAGCGACTCCTAGCATTAAATGCACCGCACCTTGCGCTTGG
9001 ----------------+-----------------+-------------- +------------------+---------------- +---------------- + 9060
AGCGAGAATTGAGATCTTCGTCGCTGAGGATCGTAATTTACGTGGCGTGGAACGCGAACC
TACTCCATTAACCGAATAGCTTCGTCTCGGCGCTCCTTGCCTACAAACGGAGCATATAAA
9061 ----------------+-----------------+--------------- +-----------------+---------------- +---------------- + 9120
ATGAGGTAATTGGCTTATCGAAGCAGAGCCGCGAGGAACGGATGTTTGCCTCGTATATTT
GGGAATAAGGTATGCTCATAAATAAGCTGCTGAACAGCGTAACGTCCTGTTTGATGTAGA
9 1 2 1 ---------------- +---------------- +--------------- +-----------------+---------------- +---------------- + 9180
CCCTTATTCCATACGAGTATTTATTCGACGACTTGTCGCATTGCAGGACAAACTACATCT
TGTCTTGCTATCACACCTAAATGCGAGGGCAGACCTAAGGTAGCGACCACCTTGCGGTTG
9 1 8 1 ---------------- +---------------- +--------------+ --- '----------- +---------------- +---------------- + 9240
ACAGAACGATAGTGTGGATTTACGCTCCCGTCTGGATTCCATCGCTGGTGGAACGCCAAC
CCATACACCTCATCCAACAGCTGCTTAGGACTAACAATCCCTTGATAAACGCCTGCCCGT
9241 ----------------+-----------------+--------------- +-----------------+---------------- +---------------- + 9300
GGTATGTGGAGTAGGTTGTCGACGAATCCTGATTGTTAGGGAACTATTTGCGGACGGGCA
GCAATAGTGCTATAAATCAGCTCATTCGAGTACGGAACAGGAAAGTTTCTCATGGCTAAC
9301 ----------------+-----------------+--------------- +----------------- +---------------- +---------------- + 9360
CGTTATCACGATATTTAGTCGAGTAAGCTCATGCCTTGTCCTTTCAAAGAGTACCGATTG
CTGCTTGTTTAAATAAGCTCGCCATATCCACTATTACCCCTTTCCGTTTTAACCGTTCAT
9361 ----------------+----------------- +-------------- +-----------------+------   +----------------- + 9420
GACGAACAAATTTATTCGAGCGGTATAGGTGATAATGGGGAAAGGGAAAATTGGCAAGTA
GCATGGTTTTTTCAGGTTGGCGTTGTGAATAGATATAACGTAAATCCGTATCAGGCAAGC
9421 ----------------+----------------- +-------------- +----------------- +---------------- + + 9480
CGTACCAAAAAAGTCCAACCGCAACACTTATCTATATTGCATTTAGGCATAGTCCGTTCG
TATCCCAGTCGCTGGGCTTGACTACCTTTATAGCCGAAACCTTTTTACTCTTGGAGGGCT
9481 ----------------+----------------- +-------------- +-----------------+---------------- +---------------- + 9540
ATAGGGTCAGCGACCCGAACTGATGGAAATATCGGCTTTGGAAAAATGAGAACCTCCCGA
TTTCTAGTTCTGACACTACCGTTTCGCCTTCCATCAACCACTGCAAAACAAGAGGCAGTA
9541 ----------------+----------------- +-------------- +-----------------+---------------- +---------------- + 9600
AAAGATCAAGACTGTGATGGCAAAGCGGAAGGTAGTTGGTGACGTTTTGTTCTCCGTCAT
ACTTTTGTCTTGTCATCGTTGGATTCTGGCTAAACGCTTTTTTAATAGTGGGAATTAACA
9601 ---------------- (■------------------ h-------------- +----------------- 1------------------ h---------------- + 9660
TGAAAACAGAACAGTAGCAACCTAAGACCGATTTGCGAAAAAATTATCACCCTTAATTGT
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GGCTTGAATCGTAATCCTCTTTCAGCATCAGATATAAATGACGCTGATCTTCGGTATCTA
9661 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 9720
CCGAACTTAGCATTAGGAGAAAGTCGTAGTCTATATTTACTGCGACTAGAAGCCATAGAT
ACTCTTGAAGGGCTTTTTCTTCTGGTGTTTGTTCTTGTATCGCTGCGATATCTAGCTGAA
9721 ----------------+----------------- +---------------- +---------------- +---------------- + + 9780
TGAGAACTTCCCGAAAAAGAAGACCACAAACAAGAACATAGCGACGCTATAGATCGACTT
A
v
a
I
GTTGGATTAACCGTTTATCAATCTCGGGAACGACTAGATCAGAATAACGAGCAATGCGTT
9781 ----------------+-----------------+---------------- +---------------- +----------------+ + 9840
CAACCTAATTGGCAAATAGTTAGAGCCCTTGCTGATCTAGTCTTATTGCTCGTTACGCAA
A
v
a
I
CTGGGATACCCGAGCGTAATGCCTCTAGCATGGGGTGCACAGGCTTTAACTCATCTTGAT
9841 ----------------+-----------------+---------------- +---------------- +---------------- + + 9900
GACCCTATGGGCTCGCATTACGGAGATCGTACCCCACGTGTCCGAAATTGAGTAGAACTA
ACACTTGCCGCAATAAACCAGCGGTAATACGCTCATTGCCTAAAGCTAGCGCACGGAGCT
9901 ----------------+-----------------+---------------- +---------------- +----------------+ + 9960
TGTGAACGGCGTTATTTGGTCGCCATTATGCGAGTAACGGATTTCGATCGCGTGCCTCGA
GAGCGAGTACAAAAAGTTTTACTACAATGTCCATCACTCCTTGGCTTAGCTCATACCACA
9961 ----------------+-----------------+---------------- +---------------- +---------------- + + 10020
CTCGCTCATGTTTTTCAAAATGATGTTACAGGTAGTGAGGAACCGAATCGAGTATGGTGT
CATCACGGACCTCATCCGATAACAGCGCATCTTTGCGTTGTAAAAGCTGTAATTGCCAAA
10021  +-----------------+---------------- +---------------- +---------------- +---------------- + 10080
GTAGTGCCTGGAGTAGGCTATTGTCGCGTAGAAACGCAACATTTTCGACATTAACGGTTT
GATTATCCGTAAAAGCGATCCACTCTTGATTGGGCTTTCCACGTTGCGTTTGTTGTATAG
10081 -----------------1------------------- 1------------------1------------------1----------------- h----------------- h 10140
CTAATAGGCATTTTCGCTAGGTGAGAACTAACCCGAAAGGTGCAACGCAAACAACATATC
GATCCCAGAATATAGCTCCAAACCCTGCCCCTCTACGTGCAGACCGCAAATCAGCCTCAA
10141 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 10200
CTAGGGTCTTATATCGAGGTTTGGGACGGGGAGATGCACGTCTGGCGTTTAGTCGGAGTT
AAATCTCTCGTGCTTTAGGGGTACCAATCAACATCACTGGTACGCCAATAATATTCACCA
10201  +---------------- +---------------- +---------------- +--------------- +----------------- + 10260
TTTAGAGAGCACGAAATCCCCATGGTTAGTTGTAGTGACCATGCGGTTATTATAAGTGGT
TCGTCACAAAAAAGTTCAGCATCTCTTGAGATCCACCCGAACGAGAGCGGCTTAAATGCT
10261 ----------------+----------------- +---------------- +---------------- +--------------- +----------------- + 10320
AGCAGTGTTTTTTCAAGTCGTAGAGAACTCTAGGTGGGCTTGCTCTCGCCGAATTTACGA
GAATTTCATCAATAACCAACAACCCTAAAGCATGTGCATTGGCTATTTGCGACATCAAAG
10321 ----------------+-----------------+---------------- +---------------- +--------------- +----------------- + 10380
CTTAAAGTAGTTATTGGTTGTTGGGATTTCGTACACGTAACCGATAAACGCTGTAGTTTC
CCAACATGGTTTCTATACCATGACGTTTTAAGCCATAACGACGCTCATAGTTCGAGCCCA
10381 ----------------+----------------- +---------------- +---------------- +--------------- +----------------- + 10440
GGTTGTACCAAAGATATGGTACTGCAAAATTCGGTATTGCTGCGAGTATCAAGCTCGGGT
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AGGCTCGATCCAACGCTCTGAAAAAATTCAAGCAGATTTCTTTTAGCGAACCATTATGCG
10441 ----------------+---------------- +----------------+----------------+---------------- +---------------- + 10500
TCCGAGCTAGGTTGCGAGACTTTTTTAAGTTCGTCTAAAGAAAATCGCTTGGTAATACGC
AGCAGTCTATTTTCAAATACACCACCTGCTCTACATTGAGTTCACGATGGTAAATCACCT
10501 ----------------+----------------- +---------------- +-------------- +------------------+ + 10560
TCGTCAGATAAAAGTTTATGTGGTGGACGAGATGTAACTCAAGTGCTACCATTTAGTGGA
GAGGATACGTGGCTAGAATACGATGAAGAGAGGTCGTCTTCCCACTACCAGAACAACCAA
10561 -------------- +-----------------+---------------- +-------------- “i— -------------- + + 10620
CTCCTATGCACCGATCTTATGCTACTTCTCTCCAGCAGAAGGGTGATGGTCTTGTTGGTT
n
D
I
I
I
TTAACAATAAGCTTTGTGCCGTAGATCGTGCCTCCTCAAAGCGAAATGTCTCCAACTCTC
10621  +---------------- +---------------- +--------------- +----------------- +---------------- + 10680
AATTGTTATTCGAAACACGGCATCTAGCACGGAGGAGTTTCGCTTTACAGAGGTTGAGAG
CCGTTTGAACACGCTCATAACCATTTTGTAAATGCTTTTGTAAATCTCCTGTTTTAGGAT
10681 ----------------+-----------------+---------------- +--------------- +----------------- +---------------- + 10740
GGCAAACTTGTGCGAGTATTGGTAAAACATTTACGAAAACATTTAGAGGACAAAATCCTA
TTCTGCCTACGTAGCCACCTCGAATCATGACCGAAATACGCTCACTTAGTAGCAAATGCG
10741 ----------------+-----------------+---------  +---------------- +----------------- +---------------- + 10800
AAGACGGATGCATCGGTGGAGCTTAGTACTGGCTTTATGCGAGTGAATCATCGTTTACGC
TACCTAATGGCTGAAAATAGTCATCTGGAATACGACAAATGGTATGAGCTCTGATAACAC
10801  +—-—------------ +------------  — h------ ----------f-— — ----- +------------- — + 10860
ATGGATTACCGACTTTTATCAGTAGACCTTATGCTGTTTACCATACTCGAGACTATTGTG
GGGACTTTTGCAAGTCAGAGGAAGTAAGCTGTAAAGAGGATTTCAGTGATGCAGCACTAT
10861 ----------------+-----------------+---------------- +--------------- +----------------- +---------------- + 10920
CCCTGAAAACGTTCAGTCTCCTTCATTCGACATTTCTCCTAAAGTCACTACGTCGTGATA
TCACTGACTCTTGTAATGGTGGTAAGGCCTCGATAAAAGGATTATCACGATAAGCCTCTA
10921 ----------------+-----------------+---------------- +--------------- +----------------- +---------------- + 10980
AGTGACTGAGAACATTACCACCATTCCGGAGCTATTTTCCTAATAGTGCTATTCGGAGAT
CCCCCGTATCACGATAAACTGCTTGAATCCGGGTAGCACTCATGACTCATCCTTTTCTGG
10981 ----------------+-----------------+---------------- +--------------- +----------------- +---------------- + 11040
GGGGGCATAGTGCTATTTGACGAACTTAGGCCCATCGTGAGTACTGAGTAGGAAAAGACC
TGGATCCTGAAATAATTCAGGCACGTATGTGGGTAGGCTGTAATCTTCTTGATCATCCGC
1 1 0 4 1 -----------------+---------------- +---------------- +--------------- +----------------- +---------------- + 11100
ACCTAGGACTTTATTAAGTCCGTGCATACACCCATCCGACATTAGAAGAACTAGTAGGCG
TTCCACTGCGTTGAAAGGAATAACTTTAGCCTCATCACCTGAAGAGCTTGGCTTCAAATG
1 1 1 0 1 ---------------- +---------------- +---------------- +--------------- +----------------- +---------------- + 11160
AAGGTGACGCAACTTTCCTTATTGAAATCGGAGTAGTGGACTTCTCGAACCGAAGTTTAC
CTCCGCACGTTTTTTACGCTCCGAGGTCACGGCTTCTTTTTTATTAGTTTTAATCTGCTT
1 1 1 6 1 ---------------- +---------------- +---------------- +--------------- +----------------- +---------------- + 11220
GAGGCGTGCAAAAAATGCGAGGCTCCAGTGCCGAAGAAAAAATAATCAAAATTAGACGAA
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AATGCGTGTTGATTTGGGCTCAGTAGTACTGGGCGTTAACTTATTCGCTTTCTGAATGGT
1 1 2 2 1 -----------------1----------------- 1----------------- 1-----------------H----------------- 1----------------- + 11280
TTACGCACAACTAAACCCGAGTCATCATGACCCGCAATTGAATAAGCGAAAGACTTACCA
H
i
n
C
I
I
TTGCTGAATAAACGCCTCAAGCTCCCTGCGTTTAGTTAACTCATCCTGCTTCGCATTGGC
11281 -------------- +-----------------+----------------+---------------- +----------------+---------------- + 11340
AACGACTTATTTGCGGAGTTCGAGGGACGCAAATCAATTGAGTAGGACGAAGCGTAACCG
TTTATTGTGTTTTTCTTGTGCTTGTATATCCCAAACCTCCCAAAATGAGAGACCTTTAAA
1 1 3 4 1 ----------------- (------------------ h----------------+----------------- 1----------------- h---------------- + 11400
AAATAACACAAAAAGAACACGAACATATAGGGTTTGGAGGGTTTTACTCTCTGGAAATTT
CTGCCGACTACGTTCCGTCAGATTACAGCGCCAAAATACACGGCTGCCAACTTGCGGAAA
11401 -•-------------- H------------------1----------------- 1----------------- 1------------------1-----------------1- 11460
GACGGCTGATGCAAGGCAGTCTAATGTCGCGGTTTTATGTGCCGACGGTTGAACGCCTTT
CAAATAAATCGTATCAACCAGCACTGGGTCATAAGCCGCTTCTAAATGTTGAGGTCTAGC
1 1 4 6 1 ----------------+----------------+---------------------  +----------------+---------------- + U 520
GTTTATTTAGCATAGTTGGTCGTGACCCAGTATTCGGCGAAGATTTACAACTCCAGATCG
A
v
a
I
TATATCAGTGCTCCGCTGCAACCAACCCTCACGCAGAATCTCTGACCCCGAGTAATACAA
11521 ----------------+------------------+--------------- +---------------- +---------------- +---------------- + 11580
ATATAGTCACGAGGCGACGTTGGTTGGGAGTGCGTCTTAGAGACTGGGGCTCATTATGTT
ACCCCACAAATTAACGCCAAATGAAGAAATAGAGACCTTTCGGCGAGGCAGTAACGCTAC
11581 ----------------+----------------- +--------------- +---------------- +------  +----------------- + 11640
TGGGGTGTTTAATTGCGGTTTACTTCTTTATCTCTGGAAAGCCGCTCCGTCATTGCGATG
TCGCAACTGCTCTTGCTCCACAGCCCTTAAACTACCTGTACGATGCTGCATACCCCATTG
11641 ----------------+----------------- +--------------- +---------------- +----------------+---------------- + 11700
AGCGTTGACGAGAACGAGGTGTCGGGAATTTGATGGACATGCTACGACGTATGGGGTAAC
CCATAGCTGGACAGGAATAGACGGTAAATCTGTAGGAAAATCAGCATCTCGATCGTATTT
1 1 7 0 1 ----------------- +----------------+--------------- +---------------- +---------------- +---------------- + 1L760
GGTATCGACCTGTCCTTATCTGCCATTTAGACATCCTTTTAGTCGTAGAGCTAGCATAAA
ATCCATCACCAGATGGTTATTTCTGAATAAGATCGTACGCAAAATAATTTGTGTGAACTC
1 1 7 6 1 -----------------+---------------- +--------------- +---------------- +---------------- +---------------- + 1L820
TAGGTAGTGGTCTACCAATAAAGACTTATTCTAGCATGCGTTTTATTAAACACACTTGAG
AAATACCGACAGAGATGCATCTAACCTATAGTCTGTTTCACCATGGCTTTTGATCCGACT
1 1 8 2 1 -------------------------------------- 1---------------------------------------- 1---------------------------------------- 1----------------------------------------1---------------------------------------h--------------------------------------- +■ 1 _ 8 8 0
TTTATGGCTGTCTCTACGTAGATTGGATATCAGACAAAGTGGTACCGAAAACTAGGCTGA
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GCCCTCTACAATGCCAGGTGCAAAGGACTTAAACTCGGCTTGTAGTGTTCTAAAAGTGCT
11881 ----------------+---------------- +----------------+----------------+---------------- +---------------- + 11940
CGGGAGATGTTACGGTCCACGTTTCCTGAATTTGAGCCGAACATCACAAGATTTTCACGA
TTCCACTATGCCTTTAGCATCGCCACGTCTAGGTGGAGCACTTTCCACTCGCACATTAAA
11941 ----------------+----------------- +---------------- +---------------- +---------------- + + 12000
AAGGTGATACGGAAATCGTAGCGGTGCAGATCCACCTCGTGAAAGGTGAGCGTGTAATTT
ACTAGAAACTAAGGCTTCGACCTGATGACTCATTAATTCGCCACGGTCCGCTAGCAACAC
12001  +---------------- +---------------- +---------------- +---------------- +---------------- + 12060
TGATCTTTGATTCCGAAGCTGGACTACTGAGTAATTAAGCGGTGCCAGGCGATCGTTGTG
ATCTGGCAAACCTACACACGGCCAGTCTGAGCTACTAATCTCAATATCATGCTGGGCACA
12061  + - -------------- +-+   +---------------------------------+--------------- + 12120
TAGACCGTTTGGATGTGTGCCGGTCAGACTCGATGATTAGAGTTATAGTACGACCCGTGT
AATGGCCGTTTTGTCAGAGCAAGCATTTACAAAAGCCTGCATCGCCACCACATAAGACGG
1 2 1 2 1 -----------------+---------------- +---------------- +---------------- +---------------- +---------------- + 12180
TTACCGGCAAAACAGTCTCGTTCGTAAATGTTTTCGGACGTAGCGGTGGTGTATTCTGCC
ATTTTCAAAGCCGATATAAAAGCCCGTGATCATCCGACTAAACACATCAATCACAATGTA
12181 ---------- 7- - + -----------------+---------------- +---------------- +---------------- +---------------- + 12240
TAAAAGTTTCGGCTATATTTTCGGGCACTAGTAGGCTGATTTGTGTAGTTAGTGTTACAT
AAGCGTTGGTCTTCCTATGATTTTTTGGCGATCATGATGATCCACTAAATAAATATCAGC
12241 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 12300
TTCGCAACCAGAAGGATACTAAAAAACCGCTAGTACTACTAGGTGATTTATTTATAGTCG
AATCGTGGCATCAATCTCATAACGACTCCCAGGGCCTAACGCCTGAGAAGTGGCTGTACT
12301 ---------------- b------------------ 1--------  1-------------------h---------------- +----------------- (■ 12360
TTAGCACCGTAGTTAGAGTATTGCTGAGGGTCCCGGATTGCGGACTCTTCACCGACATGA
X
b
a
I
ACTTAAGGGTCGTACGTCTTTTTTATATACCCCTGCTTTAACTCTAGACTTTAAGCGCTG
12361 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 12420
TGAATTCCCAGCATGCAGAAAAAATATATGGGGACGAAATTGAGATCTGAAATTCGCGAC
AGCTTTAGGGTATTCTCGATCATAAAAATAACGAAACTGACGTAGTGTTGGGTAATCCTC
12421 ----------------+-----------------+---------------- +---------------- +------  +------------------+ 12480
TCGAAATCCCATAAGAGCTAGTATTTTTATTGCTTTGACTGCATCACAACCCATTAGGAG
TTGGGGAATGCGAGGAAAATACTGAGCAAACAAGTCCACAAATCGTCTATAGGCAACGGT
12481 ----------------+-----------------+---------------- +---------------- +---------------- + + 12540
AACCCCTTACGCTCCTTTTATGACTCGTTTGTTCAGGTGTTTAGCAGATATCCGTTGCCA
H
i
n
c
I
I
GGTCTTTGTACCTTTTTGATTTAACAGGTGCTTTTCTATGGTCAACCTAAAAAGGCGTTC
12541 ---------------- h-------------------1----------------- h-----------------(------------------ h 1- 12600
CCAGAAACATGGAAAAACTAAATTGTCCACGAAAAGATACCAGTTGGATTTTTCCGCAAG
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AATCTCGGGCGTTACCTTGGTTCCTTCACCCTTACCATATTCTCTGGCTCGGCCAATCTT
12601  +-----------------+---------------- +---------------- +---------------- +---------------- + 12660
TTAGAGCCCGCAATGGAACCAAGGAAGTGGGAATGGTATAAGAGACCGAGCCGGTTAGAA
TGCTGTTCCTGTCGCTGAACGTCTTTCCCCTGGTGCACCGCTGTTTTTGTAGTCAGGAAT
12661 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 12720
ACGACAAGGACAGCGACTTGCAGAAAGGGGACCACGTGGCGACAAAAACATCAGTCCTTA
TAATGCATTAGGCGTTTGACCACGCTGCCAGTAACGGCGTAACAACTTATAAACTGTAGC
12721 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 12780
ATTACGTAATCCGCAAACTGGTGCGACGGTCATTGCCGCATTGTTGAATATTTGACATCG
CTTAGTAACCTTATGTTCTTGGACCACATGCTCAACGAGTTCGCTTCTGACTTTAGGGTC
12781 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 12840
GAATCATTGGAATACAAGAACCTGGTGTACGAGTTGCTCAAGCGAAGACTGAAATCCCAG
GAAACGATCCTTACTATTAATAATAGGAAGAATTTTTCGATAATCCTCCTCGCGCTTCTG
12841 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 12900
CTTTGCTAGGAATGATAATTATTATCCTTCTTAAAAAGCTATTAGGAGGAGCGCGAAGAC
GAAGCTGACAGAATCTACAGACGGCTCTTCTAAATCAAGATGTACATAAGGGTCATCAGT
12901 -----------------1------------------- 1------------------1----------------- h----------------- h-----------------1- 12960
CTTCGACTGTCTTAGATGTCTGCCGAGAAGATTTAGTTCTACATGTATTCCCAGTAGTCA
TCTAACTAAGCGGCCTTCATCTAAATACTGCATTAGCAACAACTCAGCCCTAGCTTGTGG
12961 ----------------+-----------------+----------------+---------------- +---------------- +---------------- + 13020
AGATTGATTCGCCGGAAGTAGATTTATGACGTAATCGTTGTTGAGTCGGGATCGAACACC
AACTCCTTTATCAGCGCTTATTTGCATCCAGACAACTTGGCCATCCTCTATAGCCAAAAT
13021 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13080
TTGAGGAAATAGTCGCGAATAAACGTAGGTCTGTTGAACCGGTAGGAGATATCGGTTTTA
GCGATACGGATCATTATCAAATAGCACAACCTCATTAATTTGCCACATAGCGCAACTCCT
13081 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 13140
CGCTATGCCTAGTAATAGTTTATCGTGTTGGAGTAATTAAACGGTGTATCGCGTTGAGGA
CCATATTCACTACTTGGCTAATACAGAGATCTGCACACTTATTTGCCCTGAAAGACTTAT
13141 ----------------+-----------------+----------------+---------------- +---------------- +---------------- + 13200
GGTATAAGTGATGAACCGATTATGTCTCTAGACGTGTGAATAAACGGGACTTTCTGAATA
AAATATTGAACTTAATAAAACCATTTGCGGTTAAGGCTCGTATCTCACTCAATGTTTTGC
13201 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13260
TTTATAACTTGAATTATTTTGGTAAACGCCAATTCCGAGCATAGAGTGAGTTACAAAACG
CTAACTCCAAATCATAAGCAATATCAACCTGCTTACAGACATTGATAATGTTTTCATCTC
13261 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13320
GATTGAGGTTTAGTATTCGTTATAGTTGGACGAATGTCTGTAACTATTACAAAAGTAGAG
CTTTTTCTTGCAGGATATGGGCCAATGGGGATAGTTGTGCTAAAAGCTCCGCAGAAACTT
13321 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13380
GAAAAAGAACGTCCTATACCCGGTTACCCCTATCAACACGATTTTCGAGGCGTCTTTGAA
CTTCTGTTTTCACTGAATAAAGCCATTCAATATTTTCTTTTACTACGGGATTTATTTCTT
13381 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13440
GAAGACAAAAGTGACTTATTTCGGTAAGTTATAAAAGAAAATGATGCCCTAAATAAAGAA
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AATCTCGGGCGTTACCTTGGTTCCTTCACCCTTACCATATTCTCTGGCTCGGCCAATCTT
12601  +-----------------+----------------+---------------- +---------------- +---------------- + 12660
TTAGAGCCCGCAATGGAACCAAGGAAGTGGGAATGGTATAAGAGACCGAGCCGGTTAGAA
TGCTGTTCCTGTCGCTGAACGTCTTTCCCCTGGTGCACCGCTGTTTTTGTAGTCAGGAAT
12661 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 12720
ACGACAAGGACAGCGACTTGCAGAAAGGGGACCACGTGGCGACAAAAACATCAGTCCTTA
TAATGCATTAGGCGTTTGACCACGCTGCCAGTAACGGCGTAACAACTTATAAACTGTAGC
12721  ------------ +-----------------+---------------- +---------------- +---------------- +---------------- + 12780
ATTACGTAATCCGCAAACTGGTGCGACGGTCATTGCCGCATTGTTGAATATTTGACATCG
CTTAGTAACCTTATGTTCTTGGACCACATGCTCAACGAGTTCGCTTCTGACTTTAGGGTC
12781 ----------------+-----------------+----------------+---------------- +---------------- +---------------- + 12840
GAATCATTGGAATACAAGAACCTGGTGTACGAGTTGCTCAAGCGAAGACTGAAATCCCAG
GAAACGATCCTTACTATTAATAATAGGAAGAATTTTTCGATAATCCTCCTCGCGCTTCTG
12841 ------------* — +----------------+--------------- +----------------+---------------- +---------------- + 12900
CTTTGCTAGGAATGATAATTATTATCCTTCTTAAAAAGCTATTAGGAGGAGCGCGAAGAC
GAAGCTGACAGAATCTACAGACGGCTCTTCTAAATCAAGATGTACATAAGGGTCATCAGT
12901 ----------------+---------------- +----------------+----------------+---------------- +-------- » + 12960
CTTCGACTGTCTTAGATGTCTGCCGAGAAGATTTAGTTCTACATGTATTCCCAGTAGTCA
TCTAACTAAGCGGCCTTCATCTAAATACTGCATTAGCAACAACTCAGCCCTAGCTTGTGG
12961 ----------------+---------------- +----------Z — + --------------- +----------------+---------------- + 13020
AGATTGATTCGCCGGAAGTAGATTTATGACGTAATCGTTGTTGAGTCGGGATCGAACACC
AACTCCTTTATCAGCGCTTATTTGCATCCAGACAACTTGGCCATCCTCTATAGCCAAAAT
13021 ----------------+-----------------+---------------- +---------------- +---------------- + + 13080
TTGAGGAAATAGTCGCGAATAAACGTAGGTCTGTTGAACCGGTAGGAGATATCGGTTTTA
GCGATACGGATCATTATCAAATAGCACAACCTCATTAATTTGCCACATAGCGCAACTCCT
13081 ----------------+-----------------+---------------- +---------------- +---------------- + + 13140
CGCTATGCCTAGTAATAGTTTATCGTGTTGGAGTAATTAAACGGTGTATCGCGTTGAGGA
CCATATTCACTACTTGGCTAATACAGAGATCTGCACACTTATTTGCCCTGAAAGACTTAT
13141 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13200
GGTATAAGTGATGAACCGATTATGTCTCTAGACGTGTGAATAAACGGGACTTTCTGAATA
AAATATTGAACTTAATAAAACCATTTGCGGTTAAGGCTCGTATCTCACTCAATGTTTTGC
13201 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 13260
TTTATAACTTGAATTATTTTGGTAAACGCCAATTCCGAGCATAGAGTGAGTTACAAAACG
CTAACTCCAAATCATAAGCAATATCAACCTGCTTACAGACATTGATAATGTTTTCATCTC
13261 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 13320
GATTGAGGTTTAGTATTCGTTATAGTTGGACGAATGTCTGTAACTATTACAAAAGTAGAG
CTTTTTCTTGCAGGATATGGGCCAATGGGGATAGTTGTGCTAAAAGCTCCGCAGAAACTT
13321 ----------------+-----------------+----------------+---------------- +---------------- +---------------- + 13380
GAAAAAGAACGTCCTATACCCGGTTACCCCTATCAACACGATTTTCGAGGCGTCTTTGAA
CTTCTGTTTTCACTGAATAAAGCCATTCAATATTTTCTTTTACTACGGGATTTATTTCTT
13381 ----------------+-----------------+---------------- +---------------- +----------------+---------------- + 13440
GAAGACAAAAGTGACTTATTTCGGTAAGTTATAAAAGAAAATGATGCCCTAAATAAAGAA
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TATCAGTAAAAATGAACCAAGGAATTTGCTTTTGCTGCCAATAGCGACGCTCTAGTTCTA
13441 ----------------+---------------- +----------------+----------------+---------------- +---------------- + 13500
ATAGTCATTTTTACTTGGTTCCTTAAACGAAAACGACGGTTATCGCTGCGAGATCAAGAT
P
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GTTTTTCTAAGGTACGCTCGTCTTGTAAGGCTGCTGCAGGTTTGACTTGAATAGCAAACT
13501 ----------------+----------------- +---------------- +---------------- +---------------- +---------------- + 13560
CAAAAAGATTCCATGCGAGCAGAACATTCCGACGACGTCCAAACTGAACTTATCGTTTGA
GCTCAAAAGGACCATCTTTGCAGTCCACTAAAAAATCAGTAGACATAACCTGATCTACAC
13561 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13620
CGAGTTTTCCTGGTAGAAACGTCAGGTGATTTTTTAGTCATCTGTATTGGACTAGATGTG
CACGAATAACAGGATGCTTAATACCACTATCTATTGCAATCTGCCTGGTATCACTAGGTA
13621 -----------------1------------------ (-------------------1----------------- 1----------------- 1---------------- + 13680
GTGCTTATTGTCCTACGAATTATGGTGATAGATAACGTTAGACGGACCATAGTGATCCAT
ATAAGGGGAACTGCTCGCGTATATCTAGCACGCTGCTCTCCCACTCAAGACTGAGAAAAA
13681  - - -  +--------------- +----------------+----------------+---------------- +---------------- + 13740
TATTCCCCTTGACGAGCGCATATAGATCGTGCGACGAGAGGGTGAGTTCTGACTCTTTTT
CAGCAAGCTCTAAGTCAGATAGCAAATGATGGACTCGTCCCGTCTTATGAGAATAAATAC
13741 -----------------1-------------------1------------------1----------------- 1----------------- 1-----------------1- 13800
GTCGTTCGAGATTCAGTCTATCGTTTACTACCTGAGCAGGGCAGAATACTCTTATTTATG
GGTGGGAACGACCTGAAGAAGGAACTTCTTGTACTGTTAGCCATGGAATATAGTCTTTAC
13801 ---------------- y ----------------- y----------------- 1------------------1----------------- 1-----------------1- 13860
CCACCCTTGCTGGACTTCTTCCTTGAAGAACATGACAATCGGTACCTTATATCAGAAATG
CATGCCCTTGGCCACGCCCCTCTTTAATACGACGGGCAATTTGCACTTCAGAAAATGAAG
13861 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13920
GTACGGGAACCGGTGCGGGGAGAAATTATGCTGCCCGTTAAACGTGAAGTCTTTTACTTC
AGTTTGCTTTAGCCATAACAAAAGTCCAGTATGCTTTTTCACAGCATAACTGGACTGATT
13921 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 13980
TCAAACGAAATCGGTATTGTTTTCAGGTCATACGAAAAAGTGTCGTATTGACCTGACTAA
TCAGTTTACAACTATTCTGTCTAGTTTAAGACTTTATTGTCATAGTTTAGATCTATTTTG
13981 ----------------+-----------------+---------------- +---------------- +---------------- +---------------- + 14040
AGTCAAATGTTGATAAGACAGATCAAATTCTGAAATAACAGTATCAAATCTAGATAAAAC
TTCAGTTTAAGACTTTATTGTCCGCCCACA
14041 ----------------+-----------------+---------------- + 14070
AAGTCAAATTCTGAAATAACAGGC9GGTGT
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CGAATTCCAGACTATGTCGAACTAGATAACGCGGAGGAGCTGGCCGACGCAATCATTCGA
GCTTAAGGTCTGATACAGCTTGATCTATTGCGCCTCCTCGACCGGCTGCGTTAGTAAGCT
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GAGGTTGAGTTAAAGGAGGCATGGCTCACAAGGGTCTTGGGGAACTCAGCCGATCCTGAC
CTCCAACTCAATTTCCTCCGTACCGAGTGTTCCCAGAACCCCTTGAGTCGGCTAGGACTG
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GCTTCTGTGGGCAAGTGGGACCGGCGCCTAGCGAGTGCGTGGTATTGATGA
+----------------+----------------+---------------- +----------------+---------------- + 5100
CGAAGACACCCGTTCACCCTGGCCGCGGATCGCTCACGCACCATAACTACT
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Fig. 3.7 Sequence of short open reading frame downstream from URF1.
3.3 Analyses of sequence
The complete, compiled sequence of Tn7 is 14070 base pairs in length. It's 
composition is 55.4% A/T and 44.6% G/C. The nucleotide composition of 
the Tns genes (nts 5720-14070) had been previously determined as 56.5% 
A/T and 43.5% G/C ( Flores, Quadri et al. 1990). Therefore the left end of 
the element (ntsl-5179, 53.9% A/T), is marinally less A/T rich than the 
right but still considerably higher than E.coli, 48.3% A/T.
3.4 Restriction Map of Tn7
A restriction map of Tn7 has been previously published (Gosti-Testu, 
Norris et al. 1983 ). When the restriction map of Tn7, predicted from the 
compiled sequence, is compared with this work a good agreement is 
observed. (See Fig. 3.6)
One discrepancy appears in the left end of the element. The published 
work places a Bell site between the two Hpal sites in the first 500 nt of the 
left end. This site, TGATCA, does not appear in the predicted restriction 
map of the compiled Tn7 sequence. Examination of this region of the 
sequence reveals, however, a highly related sequence, TGATCC at 
coordinates 285-291. This difference presumably due to a polymorphism in 
the different isolates of Tn7 used in the different laboratories. The only 
other discrepancy is in the presence of an additional Ball site in the 
sequence of the 3'end of the tnsE gene determined by Flores et al.
3.5 Open reading frames
No major open reading frames were found in addition to the previously 
characterised tns genes, drug resistance and integrase pseudo genes in the 
compiled Tn7 sequence. An open reading frame has been found 
downstream of the aadA gene (Fling, Kopf et al. 1985 ), this putative ORF 
is shown as URF1 in Fig. 3.6. The sequence of the putative product of this 
gene was used in a TFASTA search, no significant homologies were 
found. Another short open frame starting with a GTG codon is found 
downstream of URF1, the potential product of this region is only 90 amino 
acids long, (Fig. 3.7), and again shows no significant homologies on a 
TFASTA search against the GenBank and EMBL databases.
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3.6 TnsB:: The Tn7 transposase ?
As discussed in the introduction the transposase of a given element is a 
protein which generally binds to sequence motifs at the transposon 
termini and catalyses the strand exchange reaction. Despite the similarities 
in reaction mechanism catalysed by these proteins there is often very little 
obvious homology between them. One striking recent observation 
however, was of a strong similarity between the transposases of the IS3 
family of bacterial insertion sequences and the IN protein of retroviruses 
(Fayet, Ramond et al. 1990 ). This similarity was also found in p480, the 
transposase of Tn552, a Staphyloccocus aureus transposon (Rowland and 
Dyke 1990 ). The strongest similarity lies between 2 absolutely conserved 
amino acids, an aspartate and a glutamate residue. The sequence between 
these residues also shows considerable sequence conservation and the 35 
amino acid spacing is extremely highly conserved. Recent work has shown 
that mutation of the conserved aspartate or glutamate vastly reduces the 
ability of the HIV IN protein 3' processing, strand exchange and 
disintegration reactions (Engleman and Craigie, 1992).
Another feature shared by elements with transposases containing this D- 
35-E motif is that their 3' terminal nucleotides are 5’ CA 3f. These 
nucleotides are generally not required for transposase binding but may be 
important for cleavage. Because Tn7 also has 3' termini of CA it was of 
interest to see if any of the Tn7 proteins possed a D-35-E motif, the best 
candidate for a Tn7 transposase is TnsB, the protein shown to bind the 
terminal 22bp motifs of Tn7. The amino acid sequences of this protein 
along with various members of the IS3 and retrovirus families were 
compiled and aligned using the GCG program PILEUP (Devereux, Haeberli 
et al. 1984 ). The aligned sequences are shown in Fig 3.8. A similar region 
to the D-35-E exists in TnsB, with the important difference that the spacing 
is 34 and not 35 amino acids between the conserved aspartate and 
glutamate. However, the most highly conserved residues of the D-35-E are 
also found inthe TnsB sequence. It is possible therefore that TnsB is the 
Tn7 transposase. Perhaps, the altered spacing in the motif in TnsB is 
indicative of the fact that additional Tn7 proteins are involved in the 
transposition reaction.
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GACAAWAWAGTYBKRAACTRRR CONSENSUS (Mizuuchi, 1992)
CAACTAC
GACATTTCTCCAAGCAACTAC
GACAACTCCATAAGAAATTAC
GACAATAGTCCATCCAATTAC
GACAACTCTGAGAGCAACTAC
GATAATAGTTCATCCAATTAC
GACAATAGTCGCAA
W=AT B=GCT K=GT
INTERNAL
GACAATAAAGTCTTAAACTGA
ACAAAATAGATCTAAACTAT
GACAATAAAGTCTTAAACTA
GACAGAATAGTTGTAAACTG
RIGHT END
GACAAAATAGTTGGGAACTGGG
GACAAAATAGATGGGAACTGGG
GACAAAATAGTTTGGAACTAGA
LEFT END
Fig. 3.9 Comparison of the sequence of the internal repeats (Tn7 nt. 4389-4513) 
with the sequence of the terminal repeats. The sequence listed for both internal and 
right end repeats is continuous sequence, the left end repeats are discontinuous. 
Matches to the consensus are underlined.
3.7 Tn7 Internal Repeats
An unusual feature of the Tn7 sequence is the presence of a number of 
directly repeated motifs downstream of the dhfrl gene. These repeats bear 
considerable similarity to the terminal 22 bp repeats. The similarity is 
strongest at the ends of each repeats, the inner portion is more divergent 
(See Fig. 3.9). The terminal repeats have been demonstrated to be the 
binding sites for TnsB (Morrell 1990 ; Arciszewska, Mckown et al. 1991 ; 
Tang, Lichtenstein et al. 1991 ). The following work attempted to address 
whether the Internal Repeats might also function as binding sites for 
TnsB.
Studies of phage Mu have revealed the importance of a series of internal 
repeats, the internal activating signal (IAS), in the transposition reaction. 
Mu A which, like TnsB, binds the terminal repeats of the element also 
binds the IAS. In the case of MuA the IAS sequences are distinct from the 
terminal motifs and separate domains of the protein are required for 
binding to the two sets of repeats. Recent work has demonstrated that the 
net effect of this series of interactions is to facilitate synapsis of the ends of 
Mu. (Mizuuchi and Mizuuchi 1989; Surette and Chaconas 1992 ) Deletion 
of the Mu IAS has shown it is not essential for transposition, indeed 
transposition is only reduced 5-10 fold. Analysis of Tn7 has shown that 
deletion of a fragment containing the internal repeats has no effect on the 
apparent transposition frequency; however, as discussed previously, this 
may simply reflect the insensitivity of the transposition assay itself.
The similarity between the terminal and internal repeat sequences 
suggests that the internal repeats may function as binding sites for TnsB. If 
they do bind TnsB then it is possible, by analogy with Mu, that these 
repeats may be a Tn7 transpositional enhancer.
3.9 TnsB binding to Internal Repeats
The internal repeats were subdoned from pMR12::Tn7-l as a 511bp Nael 
fragment and ligated into Smal digested pUC18. Fig. 3.10 shows a series of 
gel retardation assays carried out using labelled Hindlll-EcoRI pEN200, Tn7 
right end, and labelled Hindlll Rsal digested pSBlOO as DNA substrates. 
The source of TnsB was a crude extract of DS941 pMR207. lpg of Salmon
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Fig. 3.10 Binding to internal repeats
Lanes 1-4 End-labelled pSBlOO (H indlll/R sal) digest 
Lane 5 labelled EcoR I/H indlll digested pNE200 
Incubated with:-
Lane 1. 2 m g DS941 pMR207 extract 
Lane 2. 1 m g DS941 pMR207 extract 
Lane 3. 0.5 m g DS941 pMR207 extract 
Lane 4. N o extract
Lane 5. 0.5 m g DS941 pMR207 extract
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Sperm DNA was induded as competitor. It is clear from this figure that 
the right end motifs are bound by the extract, the internal repeats however 
are apparently not bound at the extract concentrations used.
In subsequent experiments the source of internal repeat DNA was pSBllO. 
This plasmid was made by Hindlll Rsal digestion of pSBlOO, gel isolation 
of the appropriate 297bp fragment and ligation to Hindlll Smal cut pUC18. 
The insert in pSBllO was confirmed by DNA sequencing.
The experiment above demonstrated that under standard binding 
conditions no TnsB binding activity directed to the internal repeats could 
be detected. The experiment was therefore repeated with binding carried 
out at a variety of salt concentrations. The result of this is shown in Fig. 
3.11, once again binding to the right-end controls was detected . At high 
concentrations of TnsB the internal repeat DNA was retarded. However, 
the DNA was smeared up the gel, furthermore, at these extract 
concentrations the pUC backbone sequences are also observed to be 
retarded. It seems likely, therefore, that the retardation observed is a non- 
TnsB-specific interaction.
Final possibilities are that TnsB may only transiently interact with the 
internal repeats or that interactions with the internal repeats may be 
dependent on binding to the terminal repeats.
A series of TnsB retardations were set up using standard conditions with 
labelled EcoRI-Hindlll digested pNE200. A 2 fold dilution series of pSB84 
extract (TnsABCD) was added . One set of assays contained 500ng of 
Salmon Sperm DNA as competitor, the other 500ng of EcoRI-Hindlll 
digested pSBllO. The latter set of reactions therefore contained unlabelled 
internal repeat DNA at approximately 100 times the concentration of the 
labelled Right end sequences. If there is any competition between Internal 
and terminal repeat DNA, or formation of sandwich complexes between 
the two fragments, distinct patterns of retardation will be observed for the 
reactions with specific and non-specific competitor. However, as can be 
seen in Fig. 3.12, the retardation patterns are essentially identical for both 
sets.
An analogous experiment used radiolabelled internal repeat DNA with 
various TnsB concentrations. Competitor DNA in these experiments was 
either 100,1 or O.Olng of EcoRI-Hindlll digested pM Rll (pUC18::Tn7-l) or
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Fig. 3.12 Do the internal repeats compete for binding to the right end ?
Lanes 1-5 : 500ng Salmon sperm D N A  as competitor 
Lanes 6-10: 500ng pSBllO D N A  as competitor
D N A  substrate was end labelled, EcoRI/HindEI digested pNE200
Lanes 1&5: 2gg CSH50 pG Pl-2 pSB84 (TnsABCD) extract
Lanes 2&6: l |ig  CSH50 pG Pl-2 pSB84 (TnsABCD) extract
Lanes 3&7: 0.5|ig CSH50 pG Pl-2 pSB84 (TnsABCD) extract
Lanes 4&8: 0.25(ig CSH50 pG Pl-2 pSB84 (TnsABCD) extract
Lanes 5&9: 0.13|ig CSH50 pG Pl-2 pSB84 (TnsABCD) extract
Lanes 6&10: 0.06(ig CSH50 pG Pl-2 pSB84 (TnsABCD) extract 
Lane 11: no extract
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100, 1 or O.Olng of supercoiled pMRll. The aim of this experiment was to 
detect potential interactions between end and internal repeats; none were 
observed (See Fig. 3.13).
Taken together with the published data showing no loss of transposition 
activity on deletion of this region, the experiments described above do not 
support the idea that the internal repeats are functionally related to the 
Mu IAS. Precisely what role, if any, these repeats play is unclear. In view of 
the strong similarity between this sets of motifs and the sequence of the 
terminal 2 2  bp repeats it seems highly unlikely that the similarity is just 
co-incidental. An obvious feature of the internal repeats is that they lie in 
the same orientation as the left end repeats, yet the directly abutting nature 
of the repeats is more reminiscent of the organisation of the right end. It is 
possible, therefore, that these motifs represent a redundant left end, 
isolated in the evolutionary history of Tn7. If an insertion event took 
place in the left end of a primordial Tn7 within the terminal repeats , then 
the repeats to the right of the insertion event would be internalised.. 
Because these repeats would no longer be adjacent to the terminal 8 bp of 
Tn7 they could not be used in transposition events. There would, 
therefore, be no selective pressures for them to retain a TnsB binding 
activity. Indeed, if binding activity was retained the motifs might serve as 
a "sink" for TnsB and could even bring about incorrect synapsis of the 
right end with the centre, thus inhibiting transposition. It is interesting to 
note that whilst an artificial mini-Tn7 with two right ends can transpose, 
one with two left ends cannot. This lack of functional redundancy may 
manifest itself in defining the unique polarity of insertion in the attTn7 
site. It may also reflect the recent aquisition of the left end.
3.10 Integrons as Transposable Elements
If the internal repeats in Tn7 do represent a redundant left end then what 
could have occured to isolate them during the development of the present 
day Tn7 ? As mentioned in Chapter 1 the drug resistance determinants in 
Tn7, which lie between the left end and the internal repeats, lie within a 
structure which has considerable similarity to the integron structure 
found in the Tn21 family of transposons (Sundstrom, Roy et al. 1991 ). A 
recent theory has suggested that the integron itself may be, or have been, a 
transposable element (Bissonnette and Roy 1992 ). Therefore insertion of
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the integron may have been the event which internalised the internal 
repeat.
3.11 A Summary of Evidence on Tn21 type Integrons
As discussed in Chapter 1 integrons are genetic elements which mediate 
the integration of discrete gene cassettes into a common structure. The 
following discussion will summarise the data derived from the Tn21 
family on integrons.The integron comprises a 5' conserved segment, the 
inserted gene(s) and a 3' conserved segment. The 5' conserved segment 
contains an open reading frame with homology to lambda type integrases, 
a promoter for the integrase gene and a promoter on the opposite strand 
which transcribes the inserted genes. The inserted gene cassettes all have a 
similar structures, they generally comprise the open-reading frame and a 
conserved element with considerable dyad symmetry at the 3' end of the 
cassette. A consensus sequence of 60 bp has been derived for this element, 
however,for historical reasons the element is is known as the 59bp 
element (Hall, Brookes et al. 1991). There have been several instances 
where the same gene has been found in different integrons, in all these 
cases the same 59bp element is found with the gene, thus it appears that 
the gene plus 3' 59 bp element is the mobile unit. The 3' conserved 
segment comprises an open reading frame or/4, a sulphonamide resistance 
determinant, and a 2.7 kb fragment, in a number of examples a further 
sequence is inserted between the sulphonamide resistance determinant 
and the 2.7 kb fragment (Bissonnette and Roy 1992). This region is 
discussed in greater detail below.
Studies of recA independant, integrase dependant co-integrate structures 
formed by integrase mediated recombination between replicons 
containing two different 59 bp elements showed that recombination occurs 
within the sequence GTT at the 3' end of the 59 bp element (Martinez and 
de la Cruz 1988 ; Martinez and de la Cruz 1990 ). This GTT is contained 
within a larger consensus, GTTRRRY. Intriguingly a dyad related site is 
found at the 5' end of the 59bp element. This site, however, is apparently 
never used as recombination site. A GTTRRRY sequence is found at the 3' 
end of the 5' conserved segment (See Fig. 3.14 for clarification). In addition 
to the 59bp element, this site too can serve as a recombination site. Thus
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all inserted genes in an integron are flanked by direct repeats of potential 
recombination site.
Excision of gene cassetes from an integron has been observed and the 
sequence of the novel junction in the integron was compatible with the 
proposal that a recombination event had occurred between the directly 
repeated GTTRRRY motifs flanking the excised gene cassette (Collis and 
Hall 1992).
Recent work has also shown that over-expression of the integrase gene can 
lead to excision of covalently closed circular molecules of the correct size 
to be the products of recombination between the directly repeated 
GTTRRRY flanking one or more integrated gene cassettes. It has not yet 
been shown that the recombination event which produced these 
molecules has occured between these sites or that these circular products 
do represent true intermediates in the dissemination of gene cassettes 
(Collis and Hall 1992 ).
The current model for the integration of gene cassettes proposese that an 
ancestral integron existed, this integron contained a single GTTRRRY site , 
not associated with a 59bp repeat. Circular gene cassettes corresponding to 
gene+59 bp element, from an unknown source, then underwent an int 
mediated recombination reaction in integrated into the ancestral integron. 
Recent work has identified such a putative ancestral integron, InO 
from Pseudomonas aeruginosa, This element comprises of the predicted 5' 
conserved region and 3' conserved region separated by a single GTTRRRY 
site. The authors of the paper identifying this structure propose this is an 
ancestor of more complex integrons. However, the discovery of the 
precise, int mediated excision of gene cassettes from such complex 
integrons makes the validity of this proposal doubtful.
This work also demonstrated that the Tn21 family integrons are delimited 
by 29 bp inverted repeats known as Brown's repeats. It was also stated that 
the 3' conserved region of these integrons contains an open reading frame 
with homology to the transposase of Tn552 and the tnsB gene of Tn7. 
These facts coupled with the observation that one integron, Tn402, has 
been observed to transpose to two different sites in bacteriophage lambda 
led to the propsoal that the Tn21 family integrons may themselves be 
transposable elements (Bissonnette and Roy 1992 ).
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1 1 1 . 1 : 1 1 . 1 1  I I I .  I I I .  I .  I .  : .  I :  : I I .  I I I : I .  :  .  I .  I .
Tn21 51 RHPATLGSSEVEAFLSWLANERKVSVSTHRQALAALLFFYGKVLCTDLPW 100
Tn7 91 IDYIPASKP. RRLPSVISANEVQRILQVMDTRNQVIFTLLYGAGLRINEC 139 
::  I .  . :  I I I I I I :  .  : :  I I I I I . . : : .  :  .  : :  I I I I .  I :  I I .  I .
Tn21 101 LQEIGRPRPSRRLPWLTPDEWRILGFLEGEHRLFAQLLYGTGMRISEG 150
Tn7 140 LRLRVKDFDFDNGCITVHDGKGGKSRNSLLPTRLIPAIK*LIEQARLIQQ 189 
I .  I I I I I :  I I I :  I .  I .  I :  :  I I I :  I .  I .  :  I I .  .  I I .  : :  :  .  .  I I
Tn21 151 LQLRVKDLDFDHGTIIVREGKGSKDRALMLPESLAPSLREHVSRARAWWL 200
Tn7 190 DDNLQG. VGPSLPFALDHKYPSAYRQAAWMFVFPSSTLCNHPYNGKLCRH 238  
.  I .  : I I .  .  I I I I : : I I I .  I : :  I :  : I I : I :  .  .  I .  I :  I I
Tn21 201 KDQAEGRSGVALPDALERKYPRAGHSWPWFWVFAQHTHSTDPRSGWRRH 250
Tn7 239 HLHDSVARKALKAAVQKAGIVSKRVTCHTFRHSFATHLLQAGRDIRTVQE 288  
I :  .  I .  .  :  I :  I I I :  .  I I I .  I .  .  I • I I : I I I I I I I I .  .  I M I N I :
Tn21 251 HMYDQTFQRAFKRAVEQAGI. TKPATPHTLRHSFATALLRSGYDIRTVQD 299
Tn7 289 LLGHNDVKTTQIYTHVLGQHLRHHQSCGWTDATYQSVKVDKYLYVALSSP 338  
I I I I .  I I .  I I I I I I I I • .  • .  :  I : .  . .  : I .  I .
Tn21 300 LLGHSDVSTTMIYTHVL................................KVGGAGVRSPLDALPPLTSE 336
Tn7 339 * 340
Tn21 337 R* 338
Fig. 3.15 Comparison of integrase protein sequence from Tn7 and Tn21
3.12 The Tn7 Integron-like Structure
The aadAl and sat drug resistance determinants in Tn7 both possess 59bp 
elements, the dhfrl gene also has an imperfect inverted repeat at its 3' end 
(Fling and Richards 1983 ; Fling, Kopf et al. 1985 ). This element contains 
GTTRRRY sequences at its ends but the interior is not homologous to the 
59bp element. Both the aadAl and the dhfrl genes have been found with 
their associated inverted repeats in several Tn21 like integrons 
(Sundstrom and Skold 1990 ). Two relatives of Tn7, Tnl825 and Tnl826, 
have been identified which possess identical restriction maps to Tn7 apart 
from within the drug resistance coding regions. Characterisation of these 
elements has revealed that they possess different resistance determinants 
each with their own associated 59 bp element (Tietze, Brevet et al. 1987 ). 
Thus it would appear that an integron is present within Tn7.
However, Tn7 does not possess the conserved 5' and 3' segments 
associated with the Tn21 type integrons. There is a sequence with 
considerable homology to the Tn21 lambda type integrase found in Tn7's 
analogous 5' segment, however the open reading frame is interupted by a 
stop codon. If the stop codon is ignored and the putative full length 
reading frame is aligned with that of the Tn21 family integrases, the 
alignment reveals 44% amino acid sequence identity between the two 
sequences, Fig. 3.15. Intriguingly the same stop codon is found in the 
sequence of the integrase in Tnl826. This suggests that this mutation was 
present prior to the divergence of these two members of the Tn7 family. If 
this is the case was the insertion of the respective, different resistance 
cassettes brought about by the integrase of a second integron from which 
the cassettes excised or was it due to suppression of the stop codon in the 
ancestral Tn7 integrase ?
3.13 Codon Usage in Tn7 encoded genes
It has been demonstrated that different organisms use different subsets of 
synonymous codons, thus, by comparing the differential use of codons 
between different genes it is possible to determine the relatedness of the 
genes. Two important caveats must be stressed prior to this form of 
analysis. Firstly the different amino-acid composition of proteins, 
particularly in small proteins, may bias the initial determination of codon 
usage. Secondly, within a given organism, different genes have been
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shown to use different subsets of codons depending on the level of 
expression of the gene.
A previous work compared the codon usage in the integron conserved 
regions and the inserted gene cassettes. The methodology used was to 
determine the frequency of use of codons in the various reading frames by 
using the GCG program CODONFREQUENCY. These were then compared 
using the GCG program CORRESPOND (Devereux, Haeberli et al. 1984 ). 
D-square values are calculated by this program, values lower than 3 are 
taken to suggest a common origin for the genes. The conclusion of this 
work on the InO integron was that the integrase and sull open reading 
frames were derived from the same or similar organisms, the inserted 
genes however displayed different codon biases suggesting they were 
derived from diverse origins (Bissonnette and Roy 1992 ).
A similar analysis was attempted for the Tn7 open reading frames, codon 
usage in these genes were compared with each other and also the E. coli 
low expression and high expression codon frequency tables, and the codon 
usage table for the Tn21 family integrase and sull genes. The D-square 
values determined in this study are shown in Fig. 3.16.
These results show similar codon usages in all 5 tns genes, in addition to 
this the tns genes also have similar codon biases to dhfr and aadA genes, 
the Tn7 integrase pseudogene and the table of codon usages of low 
expression level E. coli genes. The Tn7 sat gene had similarity to the E. coli 
low expression genes, Tn21 sul gene and the aadA gene. The codon bias of 
the sat gene also had similarity to that of tnsD but not the other tns genes. 
Bearing in mind the caveats mentioned above these results suggest the sat 
gene originated from a different organism from the other Tn7 genes.
The most intriguing result from this analysis is in the comparison 
between the codon usage of the Tn21 integrase gene and the Tn7 integrase 
pseudogene. The D-squared value of 5.30 suggests that these genes arose 
from different organisms. The Tn7 integrase gene is interrupted by a stop 
codon and therefore presumably non-functional. It is possible that the 
difference in codon usage reflects the accumulation of mutations in the 
Tn7 pseudogene. It is interesting to note that the Tnl826 integrase 
pseudogene has complete identity with the Tn7 pseudogene. Thus, unless
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Tn7 and Tnl826 diverged very recently it might be expected that different 
random mutations would have arisen in the two elements.
It is possible that the integron like structure in Tn7 either evolved 
independently from the Tn21 family or that the two structures diverged 
early in the evolution of integrons.
No homologies between Tn7 and the non-coding portion of the Tn21 
integron family 5' conserved region exist. In addition, in the Tn21 family 
integrons the GTTRRRY recombination site is approximately 140 nt from 
the start of the integrase open reading frame, in Tn7 the dhfr gene is 
integrated at a GTTRRRY site 340 nt from the start of the integrase 
pseudogene. Therefore, in addition to possessing a different integrase gene 
the structure of the Tn7 integron is distinct from the Tn21 family. 
However, until more members of the Tn7 family are identified and 
characterised it is impossible to draw firm conclusions about the 
relationships between the Tn7 and Tn21 integrons.
It is clear, however, that the Tn7 integron does not lie within the inverted 
repeat structures known as Brown's repeats. Therefore if the Tn7 integron 
did insert in a primordial Tn7', isolating the internal repeats in the 
process, either considerable further re-arrangements have occurred to 
delete portions of the initial integron, or the integron inserted by another 
mechanism.
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Chapter 4
Tn7 Transposition in vivo and in vitro
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4.1 Introduction
In order to address questions regarding the biochemical mechanisms of 
the Tn7 transposition reaction it is neccessary to develop an in vitro 
transposition assay. Two approaches to developing such anm vitro system 
suggest themselves. Firstly, fractions containing individual Tns proteins 
could be isolated and subsequently used to partially purify the various Tns 
proteins. Such fractions could then be combined and used in assays. 
Alternatively it may be possible to exploit the operon-like structure of 
tnsA-E  to co-ordinately overexpress all of the proteins. This latter 
approach would have the advantage that only one extract would be 
required. It is also possible that this method will ensure that the various 
proteins will be present in the appropriate relative amounts. Previous 
work using p lac and p tac transcriptional fusions has shown that, of the 
Tns proteins, only TnsB can be over-expressed to a level such that it is 
visible on Coomassie blue stained Laemmli gels. It was deemed important 
to over-express the proteins to a readily visible level as no biochemical 
assay existed for TnsA and C. The only way purification of these proteins 
could be monitored would be to follow their fate on Laemmli gels.
The system of choice to achieve such high expression is that developed by 
S. Tabor, using bacteriophage T7 RNA polymerase and the T7 gene 10 
promoter.
Induction of expression of a gene cloned downstream of the gene 10 
promoter is modulated by controlling the level of T7 RNA polymerase 
present in the cell. Theoretically, as there is no cross reaction between E. 
coli RNA polymerase and T7 promoters, if there is no T7 pol in the cell 
then there should be no expression of the target gene(s). As detailed below 
this was found not to be the case.
Tabor has developed a two plasmid system to allow inducible expression 
of cloned genes (Tabor and Richardson 1985 ). The gene of choice is cloned 
into a ColEl based plasmid which has the T7 gene 10 promoter upstream 
of a polylinker. The T7 RNA pol gene is present on a second, compatible, 
plasmid, pGPl-2, under the control of the lambda pL promoter. pGPl-2 
also encodes the temperature sensitive clg5 7  allele of the lambda repressor,
under the control of placUV5. Thus, induction of the target gene is 
obtained by shifting the growth temperature of the culture from 30°C to 
42°C.
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Construction of pSB58 as described in text. 
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rbs=Ribosome Binding Site
Fig. 4.2 Sequence of oligonucleotide 
used in creation of pSEL-MUT.
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Differs from Tn7 Q T  
sequences by
Tabor has developed expression vectors for transcriptional fusion, pT7- 
3,4,5,6 , and translational fusion, pT7-7. pT7-7 has a polylinker with an 
Ndel site (CATATG) optimally placed adjacent to a strong Shine-Dalgarno 
ribosome binding site.
Two strategies were adopted to over-express tnsABCD, using both 
transcriptional and translational fusions.
4.2 pSB58 Construction
The translational fusion was constructed as shown in Fig. 4.1.
Site directed mutagenesis was used to introduce a novel Ndel site at the 
TnsA start codon, the mutagenesis method was that developed by 
Promega for use with their Altered Sites kit (Lewis and Thompson 1990 ). 
The 5' half of the tns A gene was subdoned as an 600nt EcoRI-PstI fragment 
into the phagemid pSelect-1 to give pSel-ant. This plasmid has a 
tetracycline resistance gene and an ampicillin resistance gene which 
contains a frame-shift mutation. Single stranded DNA of the recombinant 
phagemid was prepared as detailed in Materials and Methods. An oligo­
nucleotide (Fig. 4.2.) complementary to the region surrounding the 
presum ptive tnsA  start codon, but introducing an Ndel site was 
synthesised on an Applied Biosystems PCR mate DNA synthesiser. The 
oligo-nucleotide was phosphorylated and annealed to the single stranded 
pSel-ant, as was the ampicillin repair oligo-nucleotide. T4 DNA 
polymerase was used to extend from the 3'-OH of the oligo-nucleotides 
and DNA ligase added to covalently close the nascent strand. This was 
transformed into a mut-S strain of E. coli which was then subjected to 
selection in ampicillin containing medium. After overnight growth 
plasmid DNA was isolated by the alkaline lysis mini-prep method and 
used to transform competent JM109. Transformants were plated on L-agar 
containing ampicillin and tetracycline. Individual colonies were used to 
inoculate cultures and DNA was mini-prepped. Plasmids which contained 
the required mutation were identified by restriction with Ndel. Eight out 
of ten colonies tested contained the extra Ndel site. The mutant plasmid 
was designated pSel-mut.
The plasmid was then digested with Ndel and PstI, the novel ~500nt 
fragment isolated from agarose gel and ligated to Ndel-PstI digested pT7-7, 
this gave pT7-ant. pT7-ant was then cut with PstI and ligated to the ~6 kb
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Lanes 1&2: BL21 pGPl-2 pT7-5
Lanes 3&4: BL21 pGPl-2 pAG411 
Lanes 5&6: BL21 pGPl-2 pT7-5 
Lanes 7&8: BL21 pGPl-2 pSB58
Lane 9: Markers
Lanes 2,4,6,8 Rifampicin treated 
cultures, as described in Materials 
and Methods. Lanes 1,3,5,7 labelled 
without rifampicin treatment.
Fig. 4.4 Autoradiograph of a Laemmli gel of whole 
cell extracts prepared following protocol for 
35S labelling of cells, as described in the text.
tnsBCD containing fragment of PstI digested pMR84. The orientation of 
the PstI fragment in pT7-ant was checked by restriction with Hindlll and 
BamHI (Data not shown). The plasmid which restored the tnsA  open 
reading frame was named pSB58.
pSB58 DNA was prepared and sequenced using a primer complementary 
to the T7 genelO promoter. This primer was a kind gift from Sally 
Rowland. This step was carried out to ensure that the mutagenesis 
procedure had only introduced the required mutation. The resultant 
sequence encompassed 250nt from the primer, corresponding to pT7-7 
vector sequence and positions 134 to 358 in wild type Tn7 (Fig. 4.3). No 
mutations other than those creating the Ndel site were found. Although 
the sequence did not cover the entire fragment cloned in pSel-mut it was 
felt it was reasonable to assume there were no second site mutations 
created during the mutagenesis.
4.3 pSB84 Construction
The transcriptional fusion pSB84 was made by cloning a EcoRI-Clal 
fragment containing tnsABCD, from pMR9, into EcoRI-Clal cut pT7-5. 
This construct contains all the Right end 22 base pair motifs.
4.4 Protein Expression
A major advantage of the T7 based expression systems is that, unlike the E 
coli RNA polymerase, the T7 RNA polymerase is insensitive to the 
antibiotic rifampicin. By inducing expression of T7 RNA polymerase for 15 
minutes then supplementing the growth medium with Rifampicin this 
will ensure that the only transcription occuring in the cell is by T7 RNA 
polymerase. Bacterial mRNA’s generally have a short half life, thus a 
short time after exposure to rifampicin the only gene being expressed will 
be that transcribed by T7 RNA polymerase. This has the advantage of 
reducing competition with endogenous mRNA's for ribosomes and 
charged tRNA’s. This may be particularly important if the target gene 
possesses a large number of rare codons. A second advantage of this 
system is that it enables unique radiolabelling of nascent target proteins 
using 35S Methionine. This method is, of course, dependant on the 
presence of methionine in the target protein. Tns A has 3 methio.nines,
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TnsB has 8 , TnsC has 14 and TnsD has 4. Figure 4.4 shows the results of 
radiolabelling experiment using CSH50 pSB58 pGPl-2. This figure shows a 
high level of expression of a ~33 kD species, TnsA, a ~80kD species, Tns B, 
and several smaller species. It is not possible to absolutely ascribe any of 
the novel 50-65 kD species to tnsC or D gene products because of the 
extensive proteolysis undergone by TnsB. Nevertheless, it is very clear 
that a hitherto unattainable level of TnsA expression has been achieved. 
Fig. 4.5 shows a pulse chase experiment using the strains BL21 pGPl-2 pT7- 
7 and BL21 pGPl-2 pSB58. In the latter strain both TnsA and TnsB appear 
to be stable over the time course of the assay, however in the final time 
point a number of novel, but faint bands appear, these species range in size 
from 40-60 kD
The rifampicin/35S Methionine method is useful for identifying the size 
of target proteins. However, because it preferentially labels these species it 
is not possible to draw conclusions as to the level of expression of these 
proteins. Thus in order to determine the expression of the tns gene 
products relative to endogenous cellular proteins the following 
experiment was carried out.
Cells containing either pSB58, pSB84 or pT7-5 in addition to pGPl-2 were 
induced and 400|il samples collected at 1 hour intervals. These cells were 
lysed in Laemmli loading buffer and electrophoresed on a 10% Laemmli 
gel. After electrophoresis the gel was stained with Coomassie. The result is 
shown in Fig. 4.6.
Growth curves were determined for CSH50 pGPl-2 p3B58 and 84. They 
clearly demonstrate a rapid slowing of the growth rate on induction of the 
constructs. No drop in the OD600 of the cultures, indicative of cell death, is 
observed (data not shown).
4.5 Transposition in vivo
In order to confirm that the two constructs supported transposition of a 
Tn7-1 in vivo, mate-out assays were carried out between CSH50::Tn7-l 
(pEN300, pGPl-2, pSB58/84) and DS916. The results are shown in Fig. 4.7. 
The figures stated are the average of 5 independent assays for each 
plasmid.
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Assays were also carried out for CSH50::Tn7-l pSB58 or 84, in the absence 
of pGPl-2, and thus T7 RNApol. Transposition was supported in these 
cells. This presumably reflects the expression of tnsABCD  from the 
endogenous Tn7 promoter, PI, in the Tn7 right end, however pSB58 has 
no associated promoter other than the T7 promoter. Presumably the basal 
expression of this construct is caused by read-through from promoters at 
the plasmid origin of replication.
While this work was in progress a similar approach to over-express 
tnsABCD was being employed by Conrad Lichtenstein's group in London 
(Flores, Cotterill et al. 1992 ). The pET3c vector (Studier, Rosenberg et al. 
1990 ) developed by Studier was used to create translational fusions to the 
start codons of tnsA, B, C and D. The source of T7 RNA polymerase in 
their experiments was from the DE3 prophage containing the gene for T7 
RNA pol under control of plac UV5. Expression of the target gene is, 
therefore, IPTG inducible. An additional level of control can be exerted by 
the presence of T7 lysozyme, encoded on pACYC184 derivatives; pLysS, 
expressing low levels of T7 lysozyme and pLysE, expressing higher levels. 
T7 lysozyme binds to T7 RNA polymerase and inhibits transcription, thus 
any basal activity of T7 RNA polymerase is reduced in cells containing 
either of these plasmids. It should be noted that it was found impossible to 
transform BL21 (DE3) pLysE with pSB58, presumably even the very low 
basal expression of this construct was highly toxic to these cells. It was 
however found to be possible to transform BL21 with pSB58 and then 
subsequently introduce pGPl-2.
The results of Flores et al show over-expression of the individual tns 
genes on induction of T7 RNA polymerase. In order to confirm that these 
proteins are functional a novel construct was made which contained all of 
the four genes each with its own T7 promoter and ribosome binding site. 
The order of genes in the construct was thus:-
T7 promoter rbs tnsA  T7 promoter rbs tnsB T7 promoter rbs tnsC T7 promoter rbs tn s D  T7 
terminator.
Flores et al assayed this construct for its ability to complement 
transposition of a mini-Tn7 element from a plasmid to the chromosomal 
attTn7 site. The transposition event was assayed by Southern blot analysis
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of restricted total DNA isolated from cells containg the appropriate 
plasmids. Transposition was observed to be supported by the 
TnsATnsBTnsCTnsD construct. Intriguingly despite the fact that no Tns 
gene products are visible prior to induction it was observed that 
"transposition appears more or less as efficient in an uninduced culture as 
in cultures where TnsA, B, C and D expression were induced." It was also 
noted that the nature of this assay did not permit accurate comparison of 
transposition frequencies. Therefore this group also detected transposition 
even in the absence of induction.
The results I obtained for pSB84 suggest that as the expression of the 
tnsABCD genes is induced by T7 RNA polymerase there is a rapid increase 
in the apparent rate of transposition. This presumably correlates with an 
increase in expression of the Tns proteins.
However, the results of the assays of pSB58 supported transposition are 
not as readily explained. These indicate a reduction in the level of 
recovery of pEN300::Tn7-l over the time course of the assay. It should be 
stressed that the reduction of recovery of pEN300::Tn7-l could be due to 
effects in either the donor or recipient cells. Due to the absence of Tns 
functions in the recipient and because such effects are not seen with other 
TnsABCD plasmids in the donor, the following work is based on the 
assumption that the phenomenon occurs in the donor cell.
The drop in recovery of pEN300::Tn7-lcould be explained by the selective 
loss of pEN300::Tn7-l from donor cells or by the selective blockage of 
conjugative transfer of these molecules. It should be noted that there is no 
effect on the transfer rate of the pEN300 plasmids. A number of potential 
mechanisms whereby the recombinant pEN300::Tn7-l could be lost or 
sequestered are possible.
The over expression of the tns gene products could be leading to very high 
levels of transposition, transposition could occur more rapidly than 
division of the host replicon. As Tn7 transposes conservatively this would 
lead to the loss of donor molecules from the donor cells. Another related 
possibility is that nicks are produced at the ends of the Tn7-1, if nicks are 
made on opposite strands at either end of the molecule it will be 
impossible to replicate pEN300::Tn7-l, thus preventing transfer of these 
molecules, see Fig. 4.8. A problem with this interpretation is that in the
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Normal Transposition Pathway
Tn7-1
I
Potential Cleavage Products 
which would be incapble of transfer
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O------ -------1
Product 1
Tn7-1
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Fig.4.8 Potential points in the transposition pathway where conjugative transfer of 
pEN300::Tn7 could be prevented. In addition to the production of the broken 
molecules shown on the right half of the diagram the initial product, Product 1, will 
be incapable of transfer as both strands are nicked.
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Fig. 4.9a Ethidium bromide stained 0.7% agarose gel.Lanes are 
alternately Hindlll and EcoRI digests of chromosomal DNA prepared 
from the following strains.
Lanes 1&2: Un-induced CSH50 pGPl-2 pT7-7 
Lanes 3&4: Un-induced CSH50 pGPl-2 pSB58 
Lanes 5&6: CSH50 pGPl-2 pT7-7 induced for 30 mins.
Lanes 7&8: CSH50 pGPl-2 pSB58 induced for 30 mins.
Lanes 9&10: CSH50 pGPl-2 pT7-7 induced for 2 hrs.
Lanes 11&12: CSH50 pGPl-2 pSB58 induced for 2 hrs.
Lane 13: Lambda Hindlll digest
>i5kb-
12.5kb-
llk b -
2.5 kb-
1 2 3 4 5 6 7 8
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T7 1 58 1 T7 58
10 11 12 
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Fig. 4.9b Southern blot of agarose gel in Fig. 9a.
Probed w ith probe specific for attTn7  sequences.
Lanes are alternately H indm  and EcoRI digests of 
chromosomal D N A  prepared from the follow ing strains.
Lanes 1&2: Un-induced CSH50 pG Pl-2 pT7-7 
Lanes 3&4: Un-induced CSH50 pG Pl-2 pSB58 
Lanes 5&6: CSH50 pG Pl-2 pT7-7 induced for 30 mins. 
Lanes 7&8: CSH50 pG Pl-2 pSB58 induced for 30 mins. 
Lanes 9&10: CSH50 pG Pl-2 pT7-7 induced for 2 hrs. 
Lanes 11&12: CSH50 pG Pl-2 pSB58 induced for 2 hrs. 
Lane 13: Lambda H indlll digest
donor cells the chromosomal attTn7  site is occupied. If Tn7-1 is 
transposing into pEN300 then undergoing a second transposition event 
prior to plasmid replication, then where is it moving to? The in vitro 
studies of Bainton et al have revealed that Tn7 transposition is dependant 
on the presence of target site. As pSB58 only encodes tnsABCD the most 
likely explanation is that pseudo att sites in the bacterial chromosome are 
being used. However, insertion into pseudo att sites is only observed at 
very low frequencies.
An alternative explanation could be that the abnormal relative 
abundancies of TnsA,B,C and D, combined with their gross over­
expression, allow an un-coupling of transposon excision from insertion.
A more mundane explanation could be that the overexpression of the 
proteins is so high that they are forming insoluble aggregates within the 
cell. This could lead to a physical sequestration of pEN300::Tn7-l if TnsB 
retains its DNA binding activity.
4.7 Double Strand Breaks?
In order to test the first hypothesis, that excessively high levels of 
transposition are occurring, an attempt was made to identify the proposed 
double strand breaks created by transposition. Studies of both TnlO 
transposition and double strand break mediated meiotic recombination in 
yeast have allowed the detection of such breaks (Haniford, Chelouche et al. 
1989; Cao, Alani et al. 1990).
The detection method in the above works was restriction digestion of total 
DNA, followed by Southern blotting
A similar analysis was attempted for pSB58 mediated Tn7-1 transposition 
by preparing total DNA from induced and non-induced CSH50::Tn7-l 
(pEN300, pGPl-2, pSB58). The DNA was restricted with Hindlll or EcoRI 
and electrophoresed on a 0.7% agarose gel. The DNA was transferred to 
Hybond-N membrane by "Posi-Blotting" (Stratagene). The membrane was 
pre-hybridised and then hybridised with probe prepared by Random 
Priming (Boeringer) of the lkb attsite containing EcoRI fragment of 
pMR12.
In the southern blot shown in Fig. 4.9 , genomic DNA from the un- 
induced and induced CSH50::Tn7-l pEN300 pGPl-2 pSB58 and
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CSH50::Tn7-l pEN300 pGPl-2 pT7-7 cells was prepared as detailed in 
Materials and Methods. The DNA was digested with EcoRI or Hindlll and 
electrophoresed and transferred to Hybond-N as above. The membrane 
was then hybridised with the attsite probe. The predicted hybridisation 
signals are at 35 and 37 kb for Hindlll digested pEN300 and pEN300::Tn7-l 
respectively, the chromosomal attTn7::Tn7 locus gives a 15 kb Hindlll 
fragment. If double strand breaks were produced at the chromosomal site 
the predicted Hindlll-end fragments would be of approximately 6.5kb and 
6 kb. The EcoRI fragments would be lkb and lOkb ( See Fig. 4.10). The 
results of this and several other blottings did not show any novel bands 
appearing following induction of the pSB58 construct. On the basis of this 
assay there does not appear to be a sufficient level of transposition to 
explain the "loss" of pEN300::Tn7-l.
A second prediction which could be made, assuming high levels of 
transposition, is that the generation of double strand breaks would be 
deleterious to the host cells. This may manifest itself in a comparison of 
the growth curves following induction of pSB58 in isogenic cells, differing 
only in the presence or absence of Tn7-1. This experiment was carried out 
using CSH50(+/- ::Tn7-l) pGPl-2 pSB58 pEN300. It can be seen from Fig. 
4.11 that following induction the growth curves of the various strains 
demonstrate a rapid drop in the growth rate of the cultures. However, the 
effect is apparently the same regardless of the presence of Tn7-1 in the 
strains. Thus, a Tn7-1 containing strain is not more sensitive to induction 
of pSB58 than a strain lacking the element.
A major problem with the interpretation of data derived from the mate- 
out assay is that the assay is unable to discriminate between a single 
transposition events which occurs early in culture growth and multiple 
events which occur late in growth. Thus the assay samples a population 
average.
Presumably the apparent transposition frequencies measured from pSB84 
and pSB^fc containing cells reflect this combination of events. It is 
apparent that the measured transposition frequency in non-induced pSB58 
containing cells is at least 10 fold lower than in the non-induced pSB84 
containing cells.
This lower apparent rate may simply reflect a decreased transposition rate 
throughout culture growth. It could alternatively be brought about by
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Fig. 4.11 A comparison of the growth curves of induced and non-induced CSH50::Tn7-l 
pEN300 pG Pl-2 pSB58 and CSH50 pEN300 pGPl-2 pSB58
500|il aliquots of overnight cultures of both strains were used to innoculate 50mls 
L-broth. These cultures were grown at 3(P C for 5 hours then divided into 2 equal 
volum es one aliquot of each strain was induced for 25 m inutes at 42° C, then grown at 
37° C. The absorbance at 600 nm of 1ml samples of the various cultures w as m easured a 
the indicated time points.
For clarity the graph was plotted with a linear vertical scale.
Exconjugants/ml initial cultures
Induced
Donor Strain Non-induced Induced Noninduced
CSH50::Tn7-l pEN300::Tn7-l pGPl-2 pSB58 6 .8 x1 0 7 3.2x108 4.7
CSH50::Tn7-l pEN300 pGPl-2 pSB58 2 .0 x1 0 8 5.6x108 2.4
Fig. 4.12 Congugation supported by induced and non induced 
CSH50::Tn7-l pEN300::Tn7-l pGPl-2 pSB58 and CSH50::Tn7-l pEN300 
pGPl-2 pSB58.
Liquid cultures were grown at 3CP C over night then 2 , 1 0 ml aliquots of 
each strain were separately added to 10 ml fresh pre-warmed L-broth. One 
aliquot of each strain was then induced 42° C, 25 mins, 3 ^ C  2  hrs, the 
other aliquot was grown at 30 (t .  Conjugation was then carried out with 
DS916 as recipient, matings with non-induced cultures were performed at 
30°C, matings with induced cultures were performed at 37° C. The figures 
represent the average of two experiments.
It is important to stress that in the absence of viable cell counts 
for the donor strain these figures do not represent rates of 
conjugation and thus it is not possible to draw conclusions 
about the relative rates of conjugation in the various strains.
instability of pSB58 mediated Tn7-1 insertion into pEN300. If the pSB58 
generated pEN300::Tn7-l are unstable then it is possible that the only 
pEN300::Tn7-l detected in the mate out assay are those which arise during 
or just prior to conjugation. Such instability could be mediated by excision 
of the element, as described above. The studies of Tn7 transposition in 
vitro have shown that the initial insertion product has only the 3f ends of 
the element covalently linked to the recipient molecule DNA, short gaps 
exist at the 5’ ends of the element (Bainton, Gamas et al. 1991 ). These gaps 
are then presumably repaired by host DNA polymerase. Thus the initial 
product would require a single strand cleavage, the reverse of the 
integration, to release the inserted Tn7-1. The later, repaired product 
would require a double strand cut. It is possible that the abnormal ratios of 
TnsA,B,C and D may favour excision of either of these products. The 
induction of the construct may further enhance this process.
Alternatively, pSB58 may stabilise the gapped intermediate. Such a doubly 
gapped plasmid would be unable to replicate. Thus, both its propagation 
and conjugation would be inhibited.
To test if pSB58 can mediate the apparent retension of fully covalently 
closed pEN300::Tn7-l the following experiment was performed.
pEN300::Tn7-l was transferred from DS916 pEN300::Tn7-l to CSH50::Tn7-l 
pSB58 pGPl-2 and CSH50 pSB58 pGPl-2. This generated the two novel 
donor strains CSH50::Tn7-l pSB58 pGPl-2 pEN300::Tn7-l and CSH50 
pSB58 pGPl-2 pEN300::Tn7-l. In the latter strain the chromosomal attTn7 
site is un-occupied. This means that Tn7-1 in pEN300 can potentially 
transpose at a high frequency to this chromosomal site. If the reduction in 
pEN300::Tn7-l transfer initially observed is dependant on the on-going 
transposition of Tn7-1 from pEN300::Tn7-l then it would be predicted that 
conjugation of pEN300::Tn7-l from this strain should be dramatically 
reduced on pSB58 induction.
Overnight cultures were grown at 30°C. 10ml aliquots of overnight were 
added to 10ml of fresh L-broth and either kept at 30°C or induced (42°C for 
25 min., then 37°C for 2 hours). Matings were then performed using 
DS916 as recipient. The results are shown in Fig. 4.12. Contrary to 
prediction the level of conjugation appears to increase on induction, 
however a similar increase is observed with the control pEN300
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conjugation. Thus, the only conclusion that can be drawn from this 
experiment is that pEN300 conjugation is more efficient at 37°C.
Clearly pSB58 induction is not causing the expected 100 fold decrease in 
detection of the pEN300::Tn7-l in the exconjugants. Thus it appears that 
the apparent prevention of transfer caused by pSB58 induction is 
somehow dependent on the recent transposition of Tn7-1 into pEN300. It 
is possible therefore that the bizarre effects of pSB58 are exerted on the 
gapped molecules that are the first Tn7 insertion product. This is still an 
untested hypothesis. It should be noted, however, that Nancy Craig's 
group have recently shown (Nancy Craig, personal communication to 
Dave Sherratt) that a synthetic structure analogous to a single end 
insertion can excise. This in vitro reaction requires TnsA,B and C. It may 
be significant that the most highly overexpressed pSB58 species are TnsA 
and B.
Because of the number of peculiar features of the transposition events 
supported by the pSB58 construct it was deemed unsuitable for use in 
attempts to develop an in vitro transposition assay.
The attempts to establish an in vitro assay therefore used pSB84 extracts.
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_5.5kb p M R 1 1 
—5.2kb pEALI
Fig. 4.13a Ethidium bromide stained gel of attempted 
in vitro transposition assay.
Reactions were carried out as detailed in Materials and 
Methods.
The lanes in the gel alternate uncut and H indlll 
digested reaction products. The protein extract used  
was freshly prepared CSH50 pGPl-2 pSB84 extract, 
prepared as detailed in Materials and Methods.
Lanes 1&2: Reactions with no protein extract.
Lanes 3&4: 5 |il (55|ig) extract
Lanes 5& 6:10 |il (110|!g) extract
Lanes 7&8: 20 |il (220pg) extract
Lanes 9&10: 30 jil (330|ig) extract
Lanes 11&12: 40 |il (440pg) extract 
M = Markers 1 kb ladder (BRL)
1 2  3  4 5  6  7  8 9  10  11 12
Fig. 4.13b Southern blot of the gel in Fig. 4.13a
The Southern blot was performed as detailed in 
Materials and Methods. The membrane was 
hybridised with a pM R ll specific probe generated 
by random priming on gel isolated p M R ll 0.6kb PstI 
fragment.
Lanes 1&2: Reactions with no protein extract.
Lanes 3&4: 5 pi (55pg) extract 
Lanes 5& 6:10 |il (llOpg) extract 
Lanes 7&8: 20 pi (220pg) extract 
Lanes 9&10: 30 pi (330pg) extract 
Lanes 11&12: 40 pi (440pg) extract
4.8 Attempts to establish a Tn7 in vitro transposition assay
The conditions for a Tn7 in vitro assay were published just as this section 
of the work was started. All the attempts described below use the basic 
reaction conditions described in Bainton, 1991.
Initial experiments were carried out using a variable amount of crude cell 
extract prepared from induced CSH50 pGPl-2 pSB84. The transposition 
donor molecule used in these assays was pMRll, (pUC8  containing Tn7-1) 
and the recipient was pEALl. An initial experiment was carried out using 
0,55,110,220,330 and 440 micrograms of protein extract, amounts of protein 
were determined by Bradford's Assay. Reactions were incubated at 30°C 
for 7 minutes then MgAcetate added to 15mM and incubation continued 
at 30°C for a further 30 minutes. DNA was recovered from the reaction by 
phenol extraction and ethanol precipitation. The DNA was resuspended 
in lOp.1 of TE and a 3|il aliquots digested by Hindlll. The digest was then 
run on a 0.7% agarose gel. After ethidium staining and photography, the 
contents of the gel were transferred to Hybond-N by Posiblotter. The 
transferred DNA was linked to the membrane using a Stratalinker. After 
pre-hybridisation the membrane was hybridised with a probe made by 
random priming of a 600nt PstI fragment of pMRll. Thus both the donor 
pMRll and any transposition product should be detected by this probe.
The predicted size of the Hindlll restricted transposition product 
pEALl::Tn7-l is 8.1 kb. No species of this size was observed on ethidium 
staining of the gel. Similarly, an overnight exposure of the Southern Blot 
derived from this gel showed no apparent product (Fig 4.13). However, a 
gross over-exposure of the blot did reveal the presence of a very weak 
signal at approximately 8 kb species, weak signals are also seen at 
approximately 2.6kb and 2.8 kb, the size of Tn7-1. The level of these signals 
were dependent on the amount of protein extract added. However, it is 
also apparent at this level of exposure that the probe is cross hybridising 
with pEALl sequences. It is highly possible therefore that these potential 
product bands may be artefactual.
A very obvious feature of the reaction is the extensive topoisomerization 
of the substrate plasmids. This phenomenon appeared to be independent
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pM R ll - + + + + - - + + + + + - + -
pEALl - +  + + + - -  + + + + + - -  +
pMR64 extract 10 10 5 l - - 10 10 5 i .........................
figures represent .^1 of 
a 5mg/ml extract, as 
assayed by Bradfords 
assay
Fig. 4.14: Ethidium bromide stained gel of H indlll digested  
products of attempted in vitro assays with additional TnsD  
extract.
Assays 1-5 used 30pl of the extract used in the experiment 
shown in Fig. 4.13, stored at -70 C. Assays 6-15 used 30 pi of a 
fresh 8m g/m l CSH50 pGPl-2 pSB84 extract.
Assays were performed with additional, varying amounts of a 
5 m g/m l TnsD extract (from DS941 pMR64) as detailed above.
Other aspects of reaction conditions were as detailed in 
Materials and Methods.
p M R ll 
pEALl 
pMR64 extract
figures represent pi of 
a 5mg/ml extract, as 
assayed by Bradfords 
assay
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
- + + + + - - + + + + + - + -
- + + + - - + + + + + - - +
10 10 5 1 -  . 10 10 5 1
8.1 kb -
Fig. 4.14b: Southern blot of gel in Fig. 4.14a
The Southern blot was carried out as described in the Legend to 
Fig. 4.13b
of whether the plasmid contained any Tn7 sequences and is thus unlikely 
to be significant (data not shown).
Fresh pSB84 extract was prepared, as was a DS941 pMR64 (TnsD) extract. 
The Craig lab had found that the in vitro reaction was highly dependent 
on the level of TnsD. Reactions were carried with 300pg of pSB84 extract 
supplemented with 0,5,25 or 50 pg of pMR64 extract. Assays were also 
performed using the initial pSB84 extract, which had been stored at -70°C. 
The reactions were carried out as before, the results are shown in Fig. 4.14. 
Once again, gross over-exposure of the blot reveals a faint signal at ~8 kb, 
this is not detected in the pMRll+extract, pEALl+extract and extract alone 
controls. It is possible that this ~8 kb band is a genuine reaction product. To 
test if this product could be isolated, lp l of reaction I DNA was used to 
transform competent E. coli. The cells were plated on Tetracycline (for 
pEALl selection) and chloramphenicol (Tn7-1) containing medium. 50 
colonies were analysed on Single Colony Gels, all 50 were double 
transformants containing both pEALl and pM Rll, no colonies were found 
to contain the predicted 8 .1 kb product (data not shown).
Another key feature of the in vitro assay developed in San Francisco is the 
requirement for ATP. All the assays described above contain 2mM ATP. 
However the use of a crude cell extract in these experiments adds a 
potential drain for ATP in the form of endogenous host ATPases present 
in the extract. In order to prevent the potential depletion of ATP an ATP 
regeneration system was added to a set of "in vitro" assays. 5 units of 
Pyruvate kinase and 20mM Phosphoenolpyruvate. Pyruvate kinase, an 
enzyme in the glycolytic pathway catalyses the conversion of 
Phosphoenolpyruvate to pyruvate with the concomitant conversion of 
ADP to ATP. The assays shown in Fig 4.15 were performed. The addition 
of ATP regeneration did not affect any potential reaction, no product bands 
were observed in any of the lanes. Numerous other attempts were made 
to develop an in vitro reaction; reactions were carried out at both pH7 and 
8  and also at varying salt concentrations (data not shown), it was never 
possible to get reproducible production of the 8 .1  kb potential product.
A similar lack of success has been experienced by Conrad Lichtenstein's 
group in London. As described above, this group has made translational 
fusions of TnsA,B,C and D. This has enabled them to purify TnsA,B and C
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pEALl + 
PK /PEP -
2 3 4 5 6
+ + + + +
+ + + + +
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12 13 14 15 16
+  -  -  -  -
+ + + + +
Fig. 4.15a Effect of ATP regeneration on in vitro reactions.
The lanes in the gel were loaded alternately with undigested and 
H in dlll digested reaction product. The reactions were carried out as
previously described, with 30fil of a 8 m g /m l pSB84 extract and 10 |il 
of a 5 m g /m l DS941pMR64 extract.
The reactions shown in lanes 7-16 differed from the standard by 
inclusion of 20mM PEP and 5 units pyruvate kinase.
p M R ll 5.5kb- 
pEALl 5.2kb-
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
p M R ll + + + + + + + + + + + + - -
pEALl + + + + + + + + + + - - + +
PK/PEP - - + + + + + + + +  +  +
Fig. 4.15b Effect of ATP regeneration on in vitro reactions.
The Southern blot was performed as detailed in the legend of Fig. 4.13
The reactions shown in lanes 7-16 differed from the standard by  
inclusion of 20mM PEP and 5 units pyruvate kinase.
to homogeneity and substantially purify TnsD. Using both Southern 
blotting and PCR detection methods they have failed to reconstitute a 
reproducible Tn7 in vitro reaction from these highly purified components. 
(C. Lichtenstein pers. comm.)
4.9 Discussion
This chapter has described the construction of two constructs, pSB58 and 
pSB84, designed to express high levels of the Tns proteins. The levels of 
protein expressed from these constructs was examined. The ability of these 
constructs to support transposition of a Tn7-1 element was tested. This 
gave the surprising discovery that induction of pSB58 apparently 
prevented the conjugative transfer of pEN300::Tn7-l. Tests were carried 
out to determine if this apparent loss was caused by excessive levels of 
transposition from the pEN300::Tn7-l by attempting to detect the proposed 
double strand breaks that would be generated by such reactions. No 
candidate species were found by Southern blotting of restricted genomic 
DNA. This could simply be a feature of the instability of such broken 
molecules, endogenous cellular nucleases will rapidly degrade molecules 
with exposed ends. It is also possible that the detection method employed 
was not sensitive enough to permit detection of these species. Thus firm 
conclusions cannot be drawn as to the presence or absence of such breaks. 
Work in Nancy Craigs lab supports the theory that double strand breaks 
are produced by in vivo transposition of Tn7. Work presented by Ann 
Hagerman at the FASEB conference (August. 1991) showed that 
homologous recombination is stimulated at the Tn7 transposition donor 
sites. Direct detection of the breaks has not been achieved.
Further in vivo experiments tentatively suggest that the pSB58 mediated 
effect may not be exerted on fully covalently closed pEN300::Tn7-l 
molecules. The potential relevance of to the Tn7 transposition has been 
discussed, it should be stressed that these conjectures are completely un 
tested. It would be of great interest to know if manipulation of protein 
concentrations in the in vitro reaction established by the Craig group could 
reproduce these proposed effects. In particular does a large excess of TnsA 
stabilise the intermediate in the reaction, and would an excess of TnsA 
stimulate the dis-integration assays?
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The attempts to generate an in vitro transposition assay, described in this 
chapter are similarly inconclusive. Candidate product molecules were 
occasionally detected, but never reproducibly, and always at the extreme 
limit of detection by Southern blotting. With the benefit of hindsight it 
would probably have been advantageous to couple the Southern blotting 
to a PCR based assay, using one primer specific to Tn7-1 and the other to 
the recipient, thus only transposition product would be amplified. PCR 
would have permitted a qualitative assay and the Southern blotting a 
more quantitative assay. Such an approach has been used by Conrad 
Lichtenstein's group, yet, even using highly purified Tns proteins, they 
too have failed to generate a reproducible in vitro reaction (C. Lichtenstein 
pers. com.).
A feature common to the attempts described and those of Lichtenstein's 
group is that the TnsB activity used in the assays generate a large number, 
>6 , of complexes with the Tn7 right end in gel retardation assays (See 
Chapter 3 Fig. 3.12). By way of contrast the TnsB activity used by the Craig 
group produces a maximum of 4 complexes in such assays. Work in our 
group has demonstrated that the additional complexes are generated by 
proteolytic cleavage products of TnsB which retain DNA binding activity. 
Initial results from this lab suggest that over-expression of these fragments 
leads to some inhibition of transposition of Tn7 in vivo. Thus, the quality 
of TnsB used in the reactions may be of key importance.
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Chapter 5
DNA Binding Activities in pSB84 Extracts
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5.1 Introduction
The previous chapter described unsuccessful attempts to establish a Tn7 in 
vitro transposition reaction. Extracts from pSB84 containing cells were 
used in these attempts. This chapter demonstrates that TnsB and TnsD 
activities are present in the extract, and also presents circumstantial 
evidence for the presence of TnsC. Previous works have demonstrated 
specific DNA binding activities for both TnsB and TnsD. as discussed in 
the introduction (Waddell and Craig 1989 ; Morrell 1990 ). TnsB binds to 
the terminal 22bp repeats of Tn7 while TnsD binds to the attTn7 site. The 
technique used to detect the activities of these proteins was that of gel 
retardation assays. The presence of these proteins in pSB84 extracts was 
determined using this methodology.
5.2 TnsB Activity in pSB84 extracts
TnsB activity in the pSB84 extract was detected by gel retardation assays, 
using pNE200 DNA, pUC8  containing the terminal right end motifs of 
Tn7, as substrate. This data is presented in Chapter 3, Fig. 3.12.
5.3 Assays for TnsD
Tn7 inserts at a specific location in the attTn7, between the phoS and glmS 
genes at minute 84 of the E. co/zchromosome (Lichtenstein and Brenner 
1981 ; Lichtenstein and Brenner 1982 ). Analyses have revealed that the 
architecture of the attTn7 site is quite complex. Studies using various 
deletions and point mutations in the site showed the sequences defining 
attTn7  activity lie to the right, glmS, side of the Tn7 insertion point 
(McKown, Orle et al. 1988 ; Qadri, Flores et al. 1989 ). The sequence at the 
actual insertion site can be varied with little or no effect on the efficiency 
of the site as a transposition recipient. In the nomenclature used in the 
literature the middle base pair of the five base pair sequence duplicated on 
Tn7 insertion is designated 0. Nucleotide positions to the right are given a 
positive sign, those to the left negative. Initial studies showed that a DNA 
molecule corresponding to +7 to +64 conferred near to wild-type activity 
(Waddell and Craig 1989 ).
A further feature of the TnsABCD directed pathway is that if the attTn7 
site is blocked then secondary sites can be used at a lower frequency,
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g a a t  t c c c c  gGATC AAAGG CACCG
ACGTT GACCA GCCGf GTAAC CTGGC
AAAAT CGGTT ACGGT TG1GT AATAA
ATGGA TGCCC TGCGT AAfCG GGdCA
Tn7 Insertion site
TTTTT CTTCC TGTTA TGTTT TTAAT
CAAAC ATCCT GCCAA CTCCA TGTGA
CAAAC CGTCA TCTTC GGCTA CTTTT
TCTCT GTCAC AGAAT GAAAA TTTTC
TGTCA TCTCT TCGTT ATTAA TGTTT
GTAAT TGACT GAATA TCAAC GCTTA
T T T g g g g a t c c g t c g a c c t g c a g c c a a g c
t t
Fig.5.1
Sequence of the attTn7 insert in pMR80.
Chromosomal sequence are in capitals, pUC18 polylinker in lowercase. 
The TnsD binding site detected by Waddell and Craig, 1989 is boxed
approximately 1000-10,000 fold lower, than hot site events. Sequence 
analysis of a number of such sites revealed that the nucleotides at the 
insertion site are completely diverged. However, a block of conserved 
sequence was observed corresponding to attTn7 +28 to +51 (Kubo and 
Craig 1990).
The most recent work to be published on the dissection of the hot site 
demonstrated that TnsD has a sequence specific DNA binding activity. An 
activity only present in tnsD+ cells was detected which bound to DNA 
containing attTn7 sequences. Analyses of various fragments of attTn7 
found the minimal region which could be bound corresponded to attTn7 
+28 to +55. Within this sequence is a region of dyad symmetry, from +32 
to +55. This region, however, did not bind TnsD, nor did it function as a 
attTn7 site in vivo (Waddell and Craig 1989 ).
It was also observed that an unidentified host factor bound to larger atttn7 
fragments. This activity was localised to +10 to +27, i.e. between the TnsD 
binding site and the insertion site. Intriguingly, although the +28 to +55 
directed strong TnsD binding, the same region did not confer wild type 
attTn7 activity. Instead a mini-Tn7 element transposed to this site at a 100 
to 1000 fold lower frequency than to a site comprising -25 to +64.
This reduced frequency could be due to a combination of the imposition of 
a novel insertion point, the presence of unusual sequence between the 
TnsD binding site and the insertion point and the loss of the host factor 
binding site. Work presented in Chapter 6  attempts to establish the 
identity and role of the host factor.
5.4 Assays of TnsD activity in pSB84 extracts
Crude cell extracts were prepared from strains containing either pSB84 or 
pSB58, in the hope of using them in attempts to establish an in vitro assay. 
In order to confirm the presence of the TnsD protein in these preparations, 
I employed the gel retardation assay established by Waddell and Craig 
(1989). The DNA substrate used was an end-labelled EcoRI-Hindlll 
fragment of pMR80. This 280 bp sequence contains the attTn7 DNA shown 
in Fig 5.1. It should be noted this molecule is considerably larger than that 
used by Waddell and Craig.
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Extracts of CSH50 pGPl-2 pT7-5 and DS941 pMR64 were also assayed as 
negative and positive controls respectively. pMR64 contains the tnsD gene 
cloned downstream of the ptac promoter.
As shown in Fig. 5.2, in good agreement with the published results, a 
species of retarded mobility was observed in all assays, independent of the 
presence of TnsD. In this figure this appears to be a single band, however, 
when electrophoresis is carried out for a further half hour this band 
resolves into a doublet. This is in contrast to the published results of 
Waddell and Craig and may reflect my use of a larger attTn7 fragment.
Two more highly retarded complexes are observed when pMR64 extracts 
are used in the assay. The lower complex was not always observed when 
different preparations of the pMR64 extract were assayed. This appeared to 
correspond to differing levels of host binding activity in different 
preparations. When high host factor binding is observed only the upper 
TnsD band is seen, if lower host factor binding is observed then both TnsD 
bands can be detected.
When pSB84 and pSB58 extracts are tested for TnsD activity none is 
observed under standard binding conditions.
Bainton et al showed ATP and Mg ions are required for the in vitro assay. 
However, the addition of Mg++ has a highly deleterious effect on the 
reaction unless a 7 minute preincubation is carried out prior to its 
addition. In order to determine if the addition of ATP and Mg has an effect 
on TnsD activity in pMR64, pSB84 and pSB58 extracts retardations were 
performed under a variety of conditions. Intriguingly, when 2mM ATP 
and lOmM Mg-Acetate are added to binding reactions the TnsD complexes 
seen with pMR64 extracts disappear, the host factor complex is untouched. 
A number of faint higher complexes appear in the pSB84 and pSB58 
extracts.
5.5 Effect of Mg++ on TnsD binding
The loss of TnsD binding activity can be shown to be due to Mg++ as 
shown in Fig. 5.3. When ATP alone is added to pMR64 binding reactions 
no alteration to binding is observed. As can be seen from Fig. 5.2 and 5.4 
lOmM Mg prevents binding, as does 5mM Mg, albeit to a lesser extent. The
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All binding reactions use lOpg DS941pMR64 
extract under standard TnsD binding 
conditions except for the following additions
Lane 1: 5mM Mg Acetate
Lane 2: 5mM Mg Cl 2
Lane 3: 5mM CaCl2
Lane 4: 5mM Spermine
Lane 5: 5mM M gAc for m in then
15mM EDTA for 5 min
Lane 6: N o addition
Lane 7: N o protein
Fig. 5.3 Effect of cations on TnsD binding to attTn7
effect is caused both by MgCl2  and MgAcetate but not by CaCl2 - 10 mM 
Spermine also prevents binding.
The loss of binding activity could be caused by prevention of TnsD 
binding, possibly by either altering the conformation of the protein or 
alternatively by activating a metalloproteinase which degrades the TnsD 
protein. In order to test these hypotheses, two series of TnsD binding 
reactions were carried out using pMR64 extracts. In each series two sets of 
conditions were used, "standard*' and "standard"+10mM MgAc. One series 
of reactions was incubated for 2 0  minutes, the other for 1 0  minutes prior 
to addition of EDTA to 20mM.
The results shown in Fig. 5.3 indicate that TnsD binding can be restored by 
the addition of EDTA. EDTA also appears to augment the binding activity 
under standard conditions, this may be due to removal of endogenous Mg 
in the cell extract.
In the published protocol for Tn7 in vitro reactions the importance of 
allowing a 7 minute pre-incubation prior to Mg addition is stressed. When 
a 10 minute pMR64 binding reaction is performed with such a pre­
incubation, binding is increased relative to a reaction with Mg added at the 
start. This is probably due to the short exposure of the presumptive DNA- 
protein complexes to Mg prior to electrophoresis. If the reaction is 
continued for a further 10 minutes after Mg addition then full inhibition 
is observed. Therefore it appears that Mg can not only prevent initial 
binding by TnsD but also cause dissociation of TnsD-DNA complexes. This 
effect may be caused by Mg directly disrupting complexes. Alternatively, if 
there is a equilibrium set up with TnsD constantly binding and 
dissociating, then Mg could act by preventing free TnsD from interacting 
with DNA.
5.6 TnsD Activity in pSB84 Extracts
The initial assays described above could detect no TnsD activity in pSB84 
extracts. Following the discovery of the inhibitory effects of lOmM Mg, the 
assays were repeated using 5mM Mg, added after a 7 minute preincubation 
in "standard" conditions + 2mM ATP.
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Fig. 5.5 Requirement for ATP hydrolysis
Either 10 or 5|ig of a CSH50 pG Pl-2 pSB84 extract or 5fig of a DS941 
pMR64 extract was assayed for binding to attTn7  by gel retardation. 
Binding was carried out under standard conditions or w ith the 
addition of ATP or ATPyS in the presence or absence of Mg.
Lanes 1&7: standard + 2mM ATPyS 
Lanes 2&8: standard + 2mM ATP 
Lanes 3,9&15: standard + 5mM Mg acetate
Lanes 4,10&13: standard + 2mM ATPyS + 5mM Mg acetate 
Lanes 5,11&14: standard + 2mM ATP+ 5mM Mg acetate 
Lanes 6&12: standard
Lane 16: no extract
U
nb
ou
nd
As can be seen in Fig. 5.4 in the control reactions using pMR64 extract a 
slight decrease in D binding can be observed compared to that seen under 
standard conditions. However, when a pSB84 extract was used an entirely 
different result was seen. In the absence of ATP and Mg no TnsD activity 
can be detected; by contrast when both ATP and Mg are added to the 
reaction a TnsD binding activity is seen.
5.7 Requirement for ATP Hydrolysis to allow detection of TnsD activity
The requirement for ATP and Mg suggests that ATP hydrolysis may be 
necessary to permit the appearance of the TnsD activity.
This was tested by using a non-hydrolysable analogue of ATP, ATPyS in 
the reaction. As can be seen in Fig. 5.5 the only strong TnsD activity is seen 
when both ATP and Mg are added, no activity is seen when ATPyS is 
substituted for ATP.
TnsD activity also appears when 5mM Mg++ alone is added to the 
reaction. The Mg may act to permit hydrolysis of ATP present in the 
extract. The fact that no activity is seen when ATPyS and Mg are added 
suggests that the ATPyS may be competing with the low levels of 
endogenous ATP in the crude extract thus preventing TnsD "release".
No such difference is seen when a pMR64 extract is used under the same 
variety of conditions. This suggests that in the pSB84, extract, TnsD is 
interacting in some way with one or more of TnsA,B and C.
5.8 TnsD is interacting with a component of TnsABC
This TnsD sequestration and ATP dependent release can be re-constructed 
by addition of a TnsABC extract to a TnsD extract. Fig 5.6 a and b show the 
effect of pre-mixing a pMR64 extract with a CSH50 pGPl-2 pSB70 (tnsABC) 
extract. A 1:1 mix of the two extracts was made and preincubated for 10 
minutes prior to addition to a binding reaction. 40ug of either individual 
or combined extract was added to each reaction as detailed in Fig. 5.6. 
Strong TnsD activity could be observed when pMR64 alone or pMR64 
mixed with CSH50 pGPl-2 pT7-5 (vector) extract was assayed in the absence 
of ATP/Mg. However no activity was seen in pSB84 or pMR64+pSB70 
extracts under these conditions. Contrastingly, these latter 2 mixed extracts
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1 2 3
N o Tns
4 5 6
TnsABC
7 8 9 10 11 12 13 14 15 16 17 18 19
TnsABCD TnsD
Lane 1: 20 fig CSH50 pGPl-2 pT7-5 extract 
Lane 2:10 |ig CSH50 pGPl-2 pT7-5 extract 
Lane 3: 5|ig CSH50 pGPl-2 pT7-5 extract
Lane 4: 20 fig CSH50 pGPl-2 pSB70 extract 
Lane 5:10 fig CSH50 pGPl-2 pSB70 extract 
Lane 6: 5 fig CSH50 pGPl-2 pSB70 extract
Lane 7: 20 fig CSH50 pGPl-2 pSB84 extract 
Lane 8:10 fig CSH50 pGPl-2 pSB84 extract 
Lane 9: 5 fig CSH50 pGPl-2 pSB84 extract
Lane 10: 10 fig DS941 pMR64 extract 
Lane 11: 5 fig DS941 pMR64 extract 
Lane 12: 25 fig DS941 pMR64 extract
N o Tns 
+ TnsD
TnsABC I 
+ TnsD
Lane 13:10 fig CSH50 pGPl-2 pT7-5 
extract + 10 fig DS941 pMR64 extract
U n e  14: 5 fig CSH50 pGPl-2 pT7-5 
extract + 5 fig DS941 pMR64 extract
Lane 15: 25fig CSH50 pGPl-2 pT7-5 
extract + 25 fig DS941 pMR64 extract
Lane 16:10 fig CSH50 pGPl-2 pSB70 
extract + 10 fig DS941 pMR64 extract
U n e  17:5 fig CSH50 pGPl-2 pSB70 
extract + 5 fig DS941 pMR64 extract
U n e  18: 25 fig CSH50 pGPl-2 pSB70 
extract + 25 fig DS941 pMR64 extract
U n e  19: No protein
Binding Conditions "Standard" TnsD conditions as 
described in Materials and Methods
Fig. 5.6a TnsD is interacting w ith a component of TnsABC
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
No Tns TnsABC TnsABCD TnsD
Lane 1: 20 |ig CSH50 pGPl-2 pT7-5 extract 
Lane 2: 10 |ig CSH50 pGPl-2 pT7-5 extract 
Lane 3: 5fig CSH50 pGPl-2 pT7-5 extract
Lane 4: 20 fig CSH50 pGFl-2 pSB70 extract 
Lane 5: 10 fig CSH50 pGPl-2 pSB70 extract 
Lane 6: 5 fig CSH50 pGPl-2 pSB70 extract
Lane 7: 20 fag CSH50 pGPl-2 pSB84 extract 
Lane 8; )0  jag CSH50 pGPl-2 pSB84 extract 
Lane 9:5 fijg CSH50 pGPl-2 pSB84 extract
Lane 10: 10  fig DS941 pMR64 extract 
Lane 11: 5 fig DS941 pMR64 extract 
Lane 12: 2,5 fig DS941 pMR64 extract
N o Tns 
+ TnsD
TnsABC 
+ TnsD
U n e  13:10 fig CSH50 pGPl-2 pT7-5 
extract + 10 fig DS941 pMR64 extract
U n e  14:5 fig CSH50 pGPl-2 pT7-5 
extract + 5 fig DS941 pMR64 extract
U n e  15: 2.5fig CSH50 pGPl-2 pT7-5 
extract + 2.5 fig DS941 pMR64 extract
U n e  16:10 fig CSH50 pGPl-2 pSB70 
extract + 10 fig DS941 pMR64 extract
U n e  17: 5 fig CSH50 pGPl-2 pSB70 
extract + 5 fig DS941 pMR64 extract
U n e  18: 2.5 fig CSH50 pGPl-2 pSB70 
extract + 2.5 fig DS941 pMR64 extract
U n e  19: No protein
Binding Conditions "Standard" TnsD conditions + 2mM ATP. Reactions were 
incubated for 7 minutes then MgAc was added to 5mM. Incubations were 
continued for 5 further minutes then loaded onto a running gel.
Fig. 5.6b TnsD is interacting with a component of 
TnsABC
1 2 3 4 5 6 7 8
Lane 1: DS941 
Lane 2: SB 10 
Lane 3: DS941 pMR64 
Lane 4: SB10 pMR64 
Lane 5: SB10 pMR51 
Lane 6: DS941 pMR51
Lane 7: DS941 
pMR51+2mM ATP, 7 min 
preincubation then 3 min 
with 5mM MgAc 
Lane 8: DS941 pMR51 no 
ATP, 7 min preincubation 
then 3 min with 5mM  
MgAc
Lanes 1-8 all contain 20pg of crude extract prepared as 
described in Materials and Methods.
Retardation reactions performed as described 
in Materials and Methods.
Binding conditions in Lanes 1-6 are "standard"
TnsD conditions.
Fig. 5.7 TnsD activity in a TnsCD extract
showed strong activity if ATP and Mg were added. Thus a component of 
the pSB70 (tnsABC) extract is capable of sequestering the TnsD activity.
The requirement for ATP hydrolysis implicates TnsC, an ATP binding 
protein, as the key molecule in this process.
Assays were therefore carried out using extracts prepared from cells 
harbouring pMR51, demonstrated in vivo to be tnsCD+. Thus, if TnsC 
alone was interacting with TnsD to prevent binding then a similar 
ATP/Mg dependent effect to that observed with pSB84 extracts should be 
detected. The result shown in Fig. 5.7 shows that TnsD binding activity in 
the pMR51 extract is ATP/Mg independent. Therefore, it appears that 
either TnsA and/or TnsB are required for sequestration of TnsD or, 
alternatively, the relative ratios of TnsC and TnsD differ between pSB84 
and pMR51 extracts.
This was tested by combining a pMR51 extract with extracts prepared from 
cells over expressing TnsA or TnsB. The combined extracts were assayed 
for TnsD binding activity in the presence and absence of ATP/Mg. This 
data is not shown. No ATP/Mg dependanc^ on TnsD activity is observed 
with TnsA + TnsCD extract. The presence of the TnsB extract caused a 
smearing of the radiolabelled DNA on the gel. regretably insufficient time 
was available to repeat this experiment at lower concentrations of TnsB to 
determine if this effect was significant.
5.9 Discussion
The initial observation presented in this chapter is that Mg++ ions have a 
deleterious effect on TnsD binding, such an effect has also been observed 
by the Craig group (R. Bainton, pers. comm.) The binding activity of TnsD 
can be rescued by the addition of EDTA following Mg+ + . This 
demonstrates that Mg is not bringing about any permanent alteration to 
either DNA or protein in the extract. It is unclear whether Mg++ exerts its 
effect on the TnsD protein or on the DNA substrate. By interacting with 
the charged phosphate groups on the DNA backbone, Mg++ can cause 
alterations to the conformation of the DNA. Clearly no major DNA 
changes can be occurring as the host factor binding is unaltered in the 
presence of the metal ion. It is intriguing that Mg++ bshould be inhibitory 
to formation of attTn7-TnsD complexes as a number of proteins have been
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shown to require Mg ions for their metabolic function e.g. restriction 
endonucleases, DNasel and ligase. Other proteins have also been shown to 
have a metal dependance for DNA binding, most notably the zinc finger 
proteins.
The data presented in this chapter also suggest an interaction between 
TnsD and components of TnsABC. No TnsD activity is detected by gel 
binding assays when a TnsABCD extract is assayed in the absence of ATP 
and Mg++. In the presence of ATP and Mg++ TnsD activity is restored. It 
was also demonstrated that ATPyS does not substitute for ATP in this 
effect. It is unclear which of the Tns proteins interacts with TnsD.
On the basis that TnsC has been demonstrated to be an ATP binding 
protein it is very tempting to suggest that this protein plays a key role in 
the effects described. However, it is apparent that the effect is not due to an 
interaction between only TnsD and TnsC, as TnsD activity in an extract 
prepared from cells containg pMR51 does not show an ATP/Mg 
dependance.
The Craig group have demonstrated that purified TnsC can interact with 
TnsD at the att site, this effect is dependent on ATP; in agreement with my 
initial observation they too have shown that Mg++ concentration in 
excess of lOmM prevent TnsD binding.
In my work I have never observed additional higher complexes in TnsD 
gel binding assays in the presence of TnsC. This may reflect my use of 
crude cell extracts, in particular a strong host factor complex is observed in 
these retardation assays, it is possible that binding by this factor inhibits 
TnsC interactions with TnsD in these crude cell extracts.
It would appear that the interaction between the Tns proteins may 
involve all four proteins. Because of the presence of chromosomal DNA 
in the crude extracts used it is not possible to determine if the interaction 
occurs on DNA or in solution; presumably both Tn7 right end, TnsB 
binding, motifs from pSB84 and attTn7 DNA, from sheared chromosomal 
DNA are present. There is no similar ATP dependance on TnsB binding 
observed in pSB84 extracts (data not shown), this, however, does not 
preclude a role for TnsB in this process. On the basis of western blotting 
(Orle and Craig 1991), and analysis of transcriptional and translational 
fusions to Tn7 genes (Ekaterinaki 1987) TnsB appears to be the most highly 
expressed levels of the various tns genes. It is possible, therefore that only 
a small fraction of TnsB in the pSB84 containing cells is involved in this
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putative interaction. In comparison, expression of TnsD is very low and it 
is possible that the higher levels of the other Tns proteins allow all the 
TnsD present in the cell to be sequestered in this way.
The observation of the Mg++ dependance of TnsD binding coupled with 
the requirement for ATP hydrolysis to detect its binding in pSB84 extracts 
suggest a reason for the inability to reconstruct a Tn7 in vitro system.
In the initial preincubation of Tns proteins, ATP and DNA substrates, the 
TnsD in the extract will be sequestered, on addition of Mg++ to 15mM, 
ATP hydrolysis will occur and TnsD will be released, however at these 
high concentrations of Mg++ TnsD does not bind to attTn7 and therefore 
no rection can occur. Unfortunately there was insufficient time available 
to test this hypothesis, by performing an in vitro reaction under the 
conditions similar to those used in the gel retardation assays. It is possible 
that the inclusion of ATP and 5mM Mg++ in the reaction from the start 
may allow TnsD to bind to attTn7 and allow transposition to occur.
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Chapter 6  
Host Factor Binding at attTn7
78
6.1 Introduction
Although the nicking and strand exchange reactions in transposition of 
an element are carried out by a transposon encoded protein, the 
transposase, a growing body of evidence suggests that several small host 
encoded proteins can play a stimulatory role in these processes. Bacteria 
possess a number of related small DNA binding proteins which, on 
binding, influence the local structure of DNA and play roles in diverse 
cellular processes. The best characterised of these proteins are Integration 
Host Factor (IHF), HU, FIS and H-NS. FIS and IHF show sequence 
specificity in their DNA binding (Craig and Nash 1984 ; Finkel and 
Johnson 1992 ), whereas HU and H-NS do not. Recent work has 
suggested that while H-NS may not show a sequence specificity it does 
preferentially associate with intrinsically bent DNA (Owen-Hughes, 
Pavitt et al. 1992 ). All of these proteins have been demonstrated to play 
roles in a variety of recombination reactions and, in several cases, have 
been shown to play structural rather than enzymatic roles.
Integration Host Factor (IHF) is a heterodimeric protein of approximately 
20kd, composed of an alpha and a beta subunit. It was, as its name 
suggests, first identified as an essential host encoded component in the 
in vitro lambda integration reaction. Lambda is unable to establish 
lysogens in cells mutant in either a  or p subunit, this enabled the 
identification of the two genes encoding the subunit proteins, himA and 
hip.(Friedman 1988 )
IHF belongs, along with HU, to a class of small "histone-like" proteins 
found in the bacterial nucleoid. IHF shows considerable sequence 
homology to HU. However, where HU is known to bind DNA non- 
specifically, IHF has been demonstrated to be a sequence specific DNA 
binding protein. A consensus sequence for binding has been derived 
(Craig and Nash 1984).
The similarity between IHF and HU has made possible the use of 
molecular modelling approaches based on the known HU 
crystallographic structure to suggest a structure for IHF. This proposed 
structure along with DNA footprinting data has led to the proposal that 
IHF makes contacts with DNA in the minor groove. In particular, studies 
of interference due to alkylation of bases have been highly informative.
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Alkylation of nearly all adenine in an IHF binding site, which occurs in 
the minor groove, is highly deterimental to IHF binding. By contrast 
alkylation of guanine bases, a major groove effect, shows only a few 
alkylated guanines interfere with binding (Yang and Nash 1989 ).
By analogy with the HU crystal structure contact with the minor groove 
may be mediated by a two stranded beta ribbon, on both subunits of the 
IHF. Some recent work, however, has revealed considerable differences 
in the interactions of HU and IHF with DNA. A single HU heterodimer 
interacts with only 9 bp of DNA, whereas IHF protects about 40bp from 
nuclease attack (Bonnefoy and Rouviere-Yaniv 1991 ). Analysis of the 
stoiciometry of IHF-DNA complexes have revealed that a single IHF 
heterodimer is responsible for this large region of protection (Yang and 
Nash 1989 ). It appears therefore, that IHF may make additional contacts 
with DNA outwith the conserved WATCAANNNNTTR region.
Whatever the mode of interaction of IHF with DNA, it is clear IHF is 
important in many other varied processes in addition to lambda 
integration. These processes include control of plasmid pSClOl DNA 
replication, F factor transfer, regulation of gene expression and 
transposition of a variety of elements (Friedman 1988 ; Freundlich, 
Ramani et al. 1992 ).
In vitro studies have shown IHF binding to preferred transposition target 
sites for both IS1 and y8  (TnlOOO) (Gamas, Chandler et al. 1987 ; Prentki, 
Chandler et al. 1987; Wiater and Grindley 1988 ). Also, IHF binds to the 
inverted terminal repeats of IS1 and also the ends of IS10 and y8 . For y8  it 
has also been demonstrated that there is mutual co-operativity in the 
binding of binding of transposase and IHF to the ends of the element 
(Wiater and Grindley 1990 ).
Despite these well characterised in vitro phenomena him A or hip 
mutations appear to have no effect on the level of transposition of IS1 in 
vivo (Galas and Chandler 1989 ).
Intriguingly, while transposition of a y5 derivative which lakcks the 
terminal IHF binding sites has been shown to be reduced about three fold 
in IHF" cells, transposition of the wild type transposon, with its terminal 
IHF sites, is actually stimulated about three fold in IHF" cells. How these 
effects are mediated is unclear. The principle effect that IHF has in vivo
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appears to be to stimulate the level of transposition immunity conferred 
by yS ends. This effect is presumed to be due to the stimulation of y8  
transposase binding (Wiater and Grindley 1990 ).
Finally, it has been shown that ISlO-induced rearrangements occur at a 5 
to 9-fold reduced frequency in hip or himA mutants relative to wild type 
cells (Kleckner 1989).
The relatively small loss of activity in vivo in IHF mutants may be 
because HU appears to be able to compensate for loss of IHF activity to a 
limited extent. This is reflected in the discovery that while IHF" cells and 
HU" cells are viable, mutations in both IHF and HU are conditionally 
lethal (Kano and Imamoto 1990 ). This partial functional redundancy is 
also true in vitro where it has been observed that HU can replace IHF, 
albeit relatively inefficiently, in a variety of reactions.
It initially appears puzzling that such a small protein can influence such a 
wide range of biological activities. However, the observation that IHF 
induces a sharp bend in DNA on binding suggests that its role in the 
above processes may be structural rather than enzymatic. In the case of 
lambda site specific recombination it has been demonstrated that an 
intrinsically bent stretch of DNA can functionally replace an IHF binding 
site (Goodman and Nash 1989 ). Whilst the effect that IHF has on altering 
the local DNA conformation may have direct effects on alignment of 
DNA sites; it is clear that IHF can also influence the binding of other 
proteins to DNA. It is possible that this effect is a consequence of the 
alteration of DNA structure, IHF binding may induce a conformation 
more easily recognised by a second protein, as stated above, positive 
cooperative binding interactions have been observed between IHF and 
the y8  transposase at the ends of y8  and also between lambda integrase and 
IHF at attL and attR. (Lee, 1992).
6.2 A role for IHF in Tn7 Transposition ?
Waddell and Craig, in their characterisation of TnsD binding to the hot- 
site, proposed that an unidentified host-factor bound specifically to attTn7 
sequences between the TnsD binding site and the Tn7 insertion site 
(positions +10 to +27, see Fig. 5.1) (Waddell and Craig 1989 ). No attempt 
was made to identify this factor, although it was noted to be heat-stable.
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Lane 1: lOjig DS941 extract 
Lane 2 : 10|ig DS978 extract 
Lane 3 : 10|ig D5940 extract 
Lane 4: lOfig GM230 extract 
Lane 5 : 10pg DS941 pMR64 extract
Reactions were carried out under 
standard TnsD binding conditions
Fig. 6.1 Identification of Host Factor 
binding to attTn7
As discussed in the previous chapter, I observe a doublet host factor 
dependent band in gel retardation assays using crude extracts from a TnsD 
overexpressing strain and attTn7 , -180 to +90. The additional retarded 
species is presumably due to my use of a larger DNA molecule containing 
an extra, unknown, binding site. At this stage in my studies I assumed 
that one of these bands was due to the interaction observed by Waddell 
and Craig, the other being due to an as yet uncharacterised binding 
activity. It should be stressed, however, that these complexes represent a 
specific binding; all binding reactions were carried out in the presence of 
2pg of Salmon Sperm DNA as competitor.
In order to try to identify the host factor(s) responsible for forming these 
complexes, gel retardation assays were performed using extracts prepared 
from DS941 (positive control), DS978, DS940 and GM230* These latter 3 
strains lacked FIS, IHF and HNS respectively. As can be seen from Fig 6.1 
the host-factor activity was unaffected in osmZ~, reduced in fis~ cells and 
completely absent in himA~ cells. This suggests that IHF may be the host 
factor responsible for both retarded complexes. The reduction in host 
factor binding in the fis~ strain may be a result of a direct involvement of 
FIS in expression of himA and/or hip.. There is, however, no published 
evidence to support this hypothesis. It is also possible that there is an in­
direct effect. IHF levels have been shown to increase as E. coli enters 
stationary phase. The growth rate of /is" cells is considerably reduced 
relative to DS941 (J. Roberts pers. comm.), this may account for the low 
level of host factor binding seen.
The various strains tested had diverse genotypes; therefore I introduced 
the himAr.TnlO allele into DS941 by PI transduction, thus generating 
otherwise isogenic IHF" and IHF+ strains. The DS941 (himAr.TnlO) strain 
was designated SB10. The IHF" phenotype was checked by preparing 
competent DS941 and SB10 and transforming with the spectinomycin 
resistant pSClOl derivative, pLA108. Plasmids with a pSClOl origin 
cannot be maintained in IHF" strains (Stenzel, Patel et al. 1987 ). The 
competent cells were separately transformed with pUC18 as a control. The 
inability to recover SB10 pLA108 transformants confirm that SB10 is IHF" 
(see Fig. 6.2)
SB10 and DS941 were then transformed with pMR64 (tnsD+). Extracts 
were prepared from the various strains and again assayed by gel 
retardation (Fig. 6.3). The result agrees with the previous finding that the
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Lane 1: DS941 Lane 5: Heat treated DS941 pMR64
Lane 2: Heat treated DS941 # Lane 6: DS941 (himA) pMR64
Lanes 1-6 all contain 20|ig of crude extract prepared as 
described in Materials and Methods.
Retardation reactions performed as described 
in Materials and Methods.
Binding conditions are "standard" TnsD 
conditions
Lane 3: DS941 (himA) 
Lane 4: DS941 pMR64
Lane 7: 20 ngPurified IHF 
Lane 8: 2ng of IHF 
Lane 9: N o extract
Fig. 6.3 H ost Factor Binding
Strain
Plasmid^^v^.
DS941 SB10
pUC18 2 .1 x1 0 s 4.6x10s
pLA108 ' 1.9x10s 0
Fig. 6.2 Transformation of DS941 and SB10 
by pUC18 or pLA108. Figures in transformants 
per jig of DNA
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host factor binding is not present in himA mutants. In addition to this it 
can be seen that whilst two TnsD specific complexes are detected with 
DS941 pMR64 extract, only the lower of these is observed with 
DS941 (/zimA) pMR64 extract. This suggests that the lower D-specific 
complex may be TnsD interacting with naked DNA whereas the upper 
complex may be due to both TnsD and host factor binding to DNA.
IHF has a wide range of activities, therefore it is possible that IHF itself 
may not be the factor binding to attTn7. Rather, it may be required for the 
expression of a separate factor which is responsible for this host binding 
activity.
Strong evidence for a direct role in IHF binding is shown in figure 6.3. 
IHF has the unusual property of being highly heat resistant, retaining 
activity even after 10 minutes at 100°C, this feature is shared by several 
small DNA binding proteins including Fis. DS941 extract retained host 
binding activity after a 1 0  minute immersion in boiling water. 
Furthermore, a partially purified IHF preparation showed a high level of 
binding activity. Finally, on the basis of sequence analysis, there are 
several potential IHF binding sites in the pMR80 sequence (Fig 6.4). This 
is discussed in more detail below. Put together these data strongly support 
the idea that IHF itself binds attTn7.
As stated above, it is observed that the host factor band resolves as a 
doublet on extended electrophoresis. It should be noted however, that this 
is not always the case(eg see Fig. 6.5) However, it is clear from Fig 6.3 that 
both these complexes are dependent on IHF, they are not observed when 
SB10 extracts are assayed. Furthermore, they are formed when partially 
purified IHF is assayed. Thus, it seems likely that both complexes are 
caused by IHF binding, an alternative explanation would require that one 
complex is due to IHF, the other being created by binding of a factor that is 
dependent on IHF for its expression and which also co-purifies with IHF. 
This seems unlikely. However, as discussed below, problems exist with the 
first interpretation, that both complexes are caused by IHF binding.
Two potential explanations exist to explain the formation of the two 
complexes.
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1) The complexes correspond to IHF bound to different sites in the 
molecule, thus inducing distinct bend centres. Molecules with differently 
located bends would migrate differently on electrophoresis.
2) The lower and upper complexes could correspond to 1 and 2 IHF 
molecules bound to the DNA.
The first hypothesis is unlikely because studies on the mobility of 
fragments carrying multiple IHF sites have shown that IHF binding is a 
dynamic process. IHF appears able to transfer from site to site on a given 
fragment. The overall effect is to cause a singly bound multi-site molecule 
to migrate at a single, averaged mobility (Prentki, Chandler et al. 1987 ). 
Further data against the first hypothesis lies in the observation that even 
at high IHF concentrations, where no unbound DNA remains, no third, 
upper complex corresponding to a molecule with both presumptive sites 
occupied is detected.
The second hypothesis initially also seems unlikely. A naive expectation 
would be that the shift in mobility from unbound to singly bound would 
be similar to the shift from singly to doubly bound. However, this 
interpretation does not take the bending induced by IHF into account. 
Work by Snyder et al has shown that the mobility shift from singly to 
doubly bound molecules is dependant on the helical phasing between the 
IHF sites. Sites which are in phase result in an augmented bend and thus 
a large mobility shift. Out of phase sites effectively cancel out the 
respective bends and can even cause an increase in mobility of doubly 
bound DNA relative to singly bound (Snyder, Thompson et al. 1989 ).
6.3 Interactions between IHF and TnsD
The proposed IHF site IHFj lies immediately adjacent to the sequences 
implicated in TnsD binding. It might, therefore, be predicted that IHF may 
influence TnsD binding to the site. In the case of the lambda integration 
and excision reactions it has been demonstrated that there is co-operative 
binding of IHF and Int at attP and IHF, Int and Xis at attR. Studies of IHF 
binding to the termini of y5 have also shown co-operative interactions 
between the y8  transposase and IHF (Wiater and Grindley 1990 ). In order 
to test if similar co-operative interactions occur at attTn7  a series of
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1 2 3 4 5 6 7
Fig 6.5: Autoradiograph of gel used to examine 
co-operativity in TnsD and IHF binding.
All reactions performed in standard TnsD conditions.
All reactions have 10(ig of a SB10 pMR64 extract and varying 
amounts of IHF.
Lane 1: 20ng IHF 
Lane 2: lOng IHF 
Lane 3: 5ng IHF 
Lane 4: 2.5ng IHF 
Lane 5: 1.3ng IHF 
Lane 6: 0.6 ng IHF 
Lane 7: no IHF
a) 0.8
b)
c)
Complex I total
s
I
C
Complex Di/total
Unbound/total 
■+■ Complex D /tot
0 2■1 1
log IHF
0 .2 -
l o 21
Complex I/total
(Complex D+ComplexDI)/total
log IHF
-a- Ratio of Complex!runbound
1 0 -
Ratio of Complex DI: Complex D
0 2•1 1
log IHF
F ig . 6 .6  P lo t  o f  r e l a t i v e  i n te n s i t i e s  o f  T n s D  a n d  IH F  c o m p le x e s  f r o m  F ig . 6 .5
a )  T h e  in t e n s i t y  o f  i n d i v i d u a l  c o m p le x e s  s t a n d a r d i s e d  a g a i n s t  th e  s u m  o f  i n t e n s i t i e s  a t  v a r y i n g  IH F  
c o n c e n t r a t io i n s
b )  T h e  in t e n s i t y  o f  th e  I H F  c o m p le x e s  a n d  th e  s u m  o f  th e  in te n s i t ie s  o f  c o m p le x  D  a n d  D I a g a i n s t  IH F  
c o n c e n t r a t i o n
c ) T h e  r a t i o s  o f  i n t e n s i t y  o f  c o m p le x  I / u n b o u n d  a n d  c o m p le x  D I / D  a t  v a r y in g  I H F  c o n c e n t r a t io n .  
B e c a u s e  th e  a b s o l u t e  c o n c e n t r a t i o n  o f  I H F  is  n o t  k n o w n  th e  x -a x is  is  in  a r b i t a r y  v a lu e s
retardations were performed using end labelled EcoRI/Hindlll digested 
pMR80.
This DNA substrate was incubated with a sub-saturating amount of SB10 
pMR64 extract such that approximately one third of the attTn7 containing 
fragment was bound by TnsD. Aliquots of this binding reaction were added 
to two fold serial dilutions of partially purified IHF. Binding was 
continued for ten minutes and then the reactions were loaded onto a 6 % 
poly-acrylamide gel and electrophoresed. An autoradiograph of the gel is 
shown in Fig. 6.5. The film was pre-flashed prior to exposure to the dried 
gel. This was done to increase the film's sensitivity and also to attempt to 
obtain a linear response to signal intensity. The following discussion of 
the result of this experiment assumes that the film has responded in such 
a linear fashion.
It is apparent from the autoradiograph that IHF binds to attT n7  
independently of TnsD. If this was the case it would be predicted that the 
ratio of complex I to unbound DNA would be the same as the ratio of 
complex DI to complex D. If IHF and TnsD interact positvely then the 
ratio of DI to D would be greater than Complex I to unbound. If they 
interact negatively then DI:D would be less than I:unbound.
The autoradiograph was scanned into a digital image in a Macintosh 
computer using a Apple "OneScanner". The resultant image was analysed 
using the Image 1.41 package. The apparent intensities of the various 
bands of the gel were quantified and the resultant values of intensity 
plotted against log(IHF). In addition the ratios of complex I to unbound 
and complex DI to complex D intensities were calculated and plotted (Fig. 
6 .6 ). This more quantitative analysis suggests that IHF binding to the 
attTn7 sequences does not facilitate TnsD binding and may actually be 
slightly inhibitory.
6.4 Localisation of IHF binding Site
An initial search using the core IHF binding consensus as "probe" 
identified the putative sites IHFj IHF2  and IHF 3 . These potential sites 
differ by at least one base from the consensus. In the case of IHFj the A-C 
deviation from the consensus is likely to have a highly deleterious effect 
on IHF binding. The relative contributions of bases within the consensus
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site was examined by mutational analysis of the lambda H* site. Mutant 
IHF sites with decreased ability to bind IHF were identified by a phage 
challenge assay. A mutant site with an A-C change at this position caused 
a several thousand fold drop in lysogenisation frequency relative to wild 
type (Lee, 1991). It appears unlikely therefore that the putative IHFj site is
a functional IHF binding site.
A feature of IHF binding sites is that a large ( approximately 48nt) region is 
protected from nuclease digestion on IHF binding. Recent work has 
compiled data from 27 known IHF binding sites and proposed an 
expanded binding site consensus (Goodrich, Schwartz et al. 1990 ).
These workers complied the base scores for each position of a 48 base pair 
region surrounding and including each of the 27 IHF consensus sites. A 
similarity score can be calculated by the equation shown below
SS= 100x(Sum of base scores for candidate site-baseline score)/(maximum 
score-baseline score)
The similarity scores calculated for the 27 bona fide IHF sites ranged in 
value from 46.2 to 76.6. When the similarity score for IHFj was calculated
it was found to be 14.2, thus this region of the attTn7 locus is unlikely to be 
the binding site for IHF.
When the similarity score for IHF3  was determined it was found that the 
eight base-pairs at the 5' end of the 48bp sequence belonged to pUC8  
polylinker. Similarity scores were therefore calculated for both the cloned 
site and the native chromosomal site. These values were 47.6 and 52.4 
respectively. On the basis of this analysis it appears that IHF3  may be the
binding site for IHF detected in the above retardation assays.
The similarity score was also calculated for the cloned IHF2  site as 40.7,
lower than the lowest score for a genuine site (46.2).
In order to determine which sequence elements within the 280 nt attTn7 
sequence are recognised by the various proteins various end-labelled 
restriction fragments were generated. pMR80 was digested with either 
EcoRI or Hindlll and end-labelled. The resultant DNA's were purified and 
then digested with MboII and Msel to create the fragments shown in Fig
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Fig.6.8 Localisation of IHF binding.
The restriction fragments in described in Fig. 6.7 were used in retardation assays
under standard TnsD conditions with either 20ng IHF or lOpg DS941 pMR64 
extract.
The reactions loaded in each lane are as below:
Lanes 1-3: EcoRI-Msel fragments 
Lanes 4-6: EcoRI-MboII fragments 
Lanes 7-9: Hindlll-M sel fragments 
Lanes 10-12: Hindlll-MboII fragments
Lanes 1,4,7,10 IHF
Lanes 2,5,8,11 DS941 pMR64 extract
Lanes 3,6,9,12 Unbound
6.7. Because of the scarcity of unique restriction sites in the attTn7  
sequence it was not possible to probe for binding directed to the central 
portion of the pMR80 insert.
Gel retardation assays were performed using purified IHF and DS941 
pMR64 (IHF+, TnsD+) extract with each of the various substrate DNA's. 
The autoradiograph is shown in Fig. 6 .8 .
This result shows that, as previously demonstrated, TnsD binds to the left 
end of the pMR64 insert. In addition it reveals that IHF binds to the left 
end, presumably to the putative IHF3 motif. No IHF binding is detected to 
the IHFi motif adjacent to the TnsD site.
6.5 DNA Bending at attTn7
A prediction resulting from the observation of IHF binding to attTn7 
sequences would be that a bend should be induced in the bound DNA. A 
plasmid vector, pBend-2, has been constructed for use as a tool in detecting 
such bent molecules (Kim, Zweib et al. 1989 ). The theoretical basis for 
bend detection is that a molecule with a central bend will migrate more 
slowly on an electrophoretic gel than an identically sized molecule with a 
bend nearer its end (Wu and Crothers 1984 ). pBend-2 exploits this 
observation by having a long, directly repeated polylinker with two 
unique cloning sites between the direct repeats. The sequence of interest is 
cloned into pBend-2 using these unique sites. Restriction of the 
recombinant plasmid by enzymes which cleave within the direct repeats 
generates a series of identical sized fragments with the insert DNA a 
varying distance from the ends of the fragments . Electrophoresis of these 
fragments will then allow detection of differences in mobility indicative of 
bending.
The 250 nt HincII fragment of pMR80 was gel isolated and ligated to blunt 
ended Klenow treated Sail digested pBend-2. The orientation of the insert 
in a recombinant clone, pSB500, was confirmed by digestion with BamHI.
lp g  aliquots of pSB500 were digested with Mlul, Styl and PvuII. The 
resultant fragments were end-labelled using Klenow, dATP, dTTP, dGTP,
a .32pcjCTP. It should be noted that the PvuII digest was incubated with 
Klenow for 15 minutes prior to addition of dNTPs. This was to enable the 
3' to 5' exonuclease activity of the enzyme to generate suitable ends for 
filling in. A consequence of this action was that the PvuII fragment was
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Fig. 6.9 DNA Bending at attTn7
Lanes 1,2 & 3: N o extract 
Lanes 4,5 & 6: 20ng IHF
Lanes 7,8 & 9: 10pg DS941 pMR64 extract
Lanes 1,4 & 7: Mlul digested pSB500 
Lanes 2,5 & 8: Styl digested pSB500 
lanes 3,6,& 9: PvuII digested pSB500
Fig. 6.9b Gel retardation of pSB500 fragments with IHF or TnsD exreacts 
The vertical axis on the plot below  is of mobility of com plex/ mobility oi 
DNA.
T n s D  c o m p l e x
■9-------  E H F + T n s D  c o m p l e x
I H F  c o m p l e x
0.5
M l u l S t y l P v u I I
Restriction fragment of pSB500
attTn7 +9 attTn7 +55
5 . I . | 3 ’
CTAGGGCATCCATTTATTACTCAACCGTAACCGATTTTGCCAGGTTACG
3 . CCGTAGGTAAATAATGAGTTGGCATTGGCTAAAACGGTCCAATGCAGCT5'
Xbal Sail
Fig. 6.10
attTn7 oligonucleotides used to make pSB400
♦
2nt shorter than the other att-site containing molecules. This difference 
does not affect interpretation of the results of this experiment.
The endlabelled fragments were used in gel retardation assays with 
partially purified IHF and a DS941 pMR64 extract, (IHF+, TnsD+). 
Following binding, the complexes were electrophoresed on a 4% 
polyacrylamide gel which was dried and autoradiographed. The result is 
shown in Fig. 6.9.
It is clear that the mobility of the IHF complex varies depending on the 
location of the att-site relative to the end of the molecule. This indicates 
that, as predicted, IHF induces a bend upon binding. An examination of 
the data suggests that the induced bend centre is near the left end of the 
att-site sequence, some distance from, and on the opposite side of the Tn7 
insertion site to, the TnsD binding site. This is in good agreement with the 
findings of the experiment to localise the IHF binding described above.
The data also suggest that TnsD binding itself also induces a bend upon 
binding, however this bend is considerably less than that induced by IHF. 
There also apears to be an intrinsic bend within the attTn7 sequences, the 
centre of this bend is situated towards the right end of the molecule.
6 .6  Binding to attTn7 +9 to +55
The results of the localisation experiments above show only TnsD 
binding to the EcoRI Msel fragment. However, Waddell and Craig show a 
host factor binding activity directed to this region. They further purport to 
have localised this activity to be directed to attTn7 +10 to +27 
In order to address this matter I synthesised two oligonucleotides 
corresponding to both strands of attTn7 sequences +9 to +55, those 
regions shown by Waddell and Craig to bind both TnsD and the host 
factor. The insertion site proximal, left, and insertion site distal, right, 
ends of the annealed oligonucleotides had 5' extensions compatible with 
Xbal and Sail restricted DNA respectively (See Fig. 6.10). The 
oligonucleotides were deprotected and gel purified as detailed in 
Materials and Methods. They were then annealed and ligated into 
Xbal/Sall digested pUC18 to generate pSB400. The insert in this plasmid 
was confirmed by DNA sequencing.
The DNA substrate used for the initial retardations in this section was an 
end-labelled EcoRI/Hindlll digest of pSB400. The attTn7 containing
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1 2 3 4 5 6 7 8 9  10 11 12
pSB400 DNA
(+9—1-55 in pUC) pMR80 DNA
Fig. 6.11: Binding to cloned +9-+55 oligonucleotide 
Reactions were in standard TnsD conditions.
Lanes 1&7:10 fig SB10 pMR64 extract 
Lanes 2& 8:10 pg DS941 pMR64 extract 
Lanes 3& 9:10 pg SB10 extract 
Lanes 4& 10:10 pg DS941 extract 
Lanees5& ll: 20ng IHF
Oligo +9-+55 Cloned oligo pMR80
Fig. 6.12 Binding to various substrates by TnsD and IHF.
Reaction conditions standard TnsD
Lanes 1-4 Labelled substrate is annealed oligonucleotide +9- +55 
Lanes 5-8 The substrate is a labelled EcoRI/Hindllldigest of pSB400 
Lanes 9-11 The substrate is labelled EcoRI/HindlHdigest of pMR80
Lanes 1,5&9: No extract
Lanes 2&6:10 pg DS941 extract
Lanes 3,7&11:10 pg SB10 extract 
Lanes 4,8&12: 20ng IHF
fragment therefore comprised the cloned oligonucleotide flanked by 
pUC18 polylinker sequences. DNA binding assays were carried out using 
equal quantities, 20 |ig, of DS941, SB10 QiimA’), DS941 pMR64 and SB10 
pMR64 extracts, assays were also performed using 20ng of partially 
purified IHF. The results are shown in figure 6.11. A single retarded 
species was seen with both TnsD containing extracts, surprisingly no 
retarded species are observed with DS941 extract or IHF. Binding reactions 
with the 280nt fragment of pMR80 were also done as controls for binding 
activities in the extracts.
This result initially appears at variance with that of Waddell and Craig, 
that attTn7 +10 to +27 confers a host binding activity. In their experiment 
an annealed and endlabelled oligonucleotide of +10 to +64 is shown to 
bind a host activity. Thus their DNA substrate differs from the one I used 
in three ways:-
1) It possesses attTn7 +55 to +64.
2 ) It is not flanked by pUC18 polylinker sequences.
3) It is synthetic DNA, it will neither be methylated nor 5' 
phosphorylated.
The latter difference is dependent on the DNA possessing a methylation 
signal. There is a dcm methylation site centred at attTn7 +48.
The experiment was repeated, this time including the use of end-labelled 
annealed oligonucleotide attTn7 +9 to +55 as substrate (Fig. 6.12). This 
molecule was observed to bind an activity present in both DS941 and 
SB10 but not to bind partially purified IHF. Thus it would appear that 
either some unknown feature imposed by the pUC polylinker, or 
methylation differences prevents binding by this host factor to digested 
pSB400. However, this is clearly an IHF independent phenomenon, 
unlike the binding activities described above.
A close examination of the data presented by Waddell and Craig allows 
re-interpretation of their results. They see a host binding activity directed 
to the synthetic +10 to +64 and also to cloned attTn7 -25 to +64. Their 
assumption is that these activities are the same. However, the synthetic 
fragment, whilst able to compete effectively for TnsD binding, does not
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Fig. 6.13 Confirmation o id c m  phenotype. 
Agarose gel of pSB400 D N A  prepared from 
DS941 and ET12567 electrophoresed uncut or 
restricted with EcoRII prior to loading.
Lane 1 BRL1 kb ladder
Lane 2 Un-cut pSB400 (ex ET12567)
Lane 3 EcoRII digested pSB400 (ex ET12567) 
Lane 4 Un-cut pSB400 (ex DS941)
Lane 5 EcoRII digested pSB400 (ex DS941)
1 2 3 4 5 6 7 8 9 1 0 1 1  1 2 1 3 1 4 1 5 1 6 1 7 1 8
Oligo +9 - +55 Cloned oligo dcm Cloned oligo dcm
Fig. 6.14: Effect of dcm methylation on binding to cloned attTn7  +9- +55.
Lanes 1-6: D N A  substrate is annealed oligonucleotide attTn7  +9- +55 
Lanes 7-12: D N A  substrate is labelled EcoR I/H indlll digest of pSB400, 
prepared from DS941
Lanes 13-18:DNA substrate is labelled EcoR I/H indlll digest of pSB400, 
prepared from ET12567 i.e no dcm methylation
Extracts
Lanes 1,7,13:10|ig DS941 extract
Lanes 2,8,14:10pg SB10 extract
Lanes 3,9,15:10(ig DS941 pMR64 extract
Lanes 4,10,16: 10|ig SB10 pMR64 extract
Lanes 5,11,17: lOpg ET12567 extract 
Lanes 6,12,18: no protein extract
compete for host factor binding to attTn7 -25 to +64.(Waddell and Craig 
(1989) Fig.2 Lanes 8  and 9) This argues that two separate activities are 
being observed.
6.7 Methylation at dcm site
In order to determine whether the binding activity directed to the 
oligonucleotide is due to the lack of methylation a dcm" strain was 
obtained, a kind gift of Dr. Iain Hunter. This strain was transformed with 
pSB400. L-broth was inoculated with this strain and allowed to grow for 
approximately 40 generations, thereby reducing the initial methylated 
DNA to an insignificant level in the population. Plasmid DNA was 
prepared by large scale alkaline lysis method as described in Materials and 
Methods. The non-methylated status of this DNA was confirmed by 
restriction digestion with EcoRII, this enzyme cuts DNA only at non- 
methylated dcm sites (Fig. 6.13). Having confirmed the absence of 
methylation l|ig  of pSB400 (dcmr) was digested with EcoRI and Hindlll 
and end-labelled. This DNA was then used in the retardation assays 
shown in Fig. 6.14.
This figure indicates that the methylation status of the pSB500 insert does 
not influence binding by a host factor.
6 .8  Consequences of IHF binding in vivo
6.8.1 Effect of IHF on Tn7 transposition in vivo
Previous work in this laboratory had suggested that there was a ~ 6  fold 
decrease in apparent hot-site transposition frequencies in IHF' cells 
relative to IHF+ cells (N. Ekaterinaki, unpublished results). These data 
were derived from 3 sets of mate out assays using non-isogenic IHF+ and 
IH F' cells as donor. Two IHF mutants were used,/nmA:;7>z20 and hip 
::Cm, in which a chloramphenicol resistance cassette is inserted in the hip 
gene.
In order to determine the effect of lack of IHF in otherwise iso-genic 
strains, Tn7-1 was introduced into SB10 by PI transduction. The PI lysate 
as made from DS941::Tn7-l. Mate out assays were carried out as detailed 
in Materials and Methods, using DS941::Tn7.1 pSB84 pEN300 and 
SB10::Tn7.1 pSB84 pEN300 as donor and DS916 as recipient. The assays
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Donor strain DS941 SB10
8.0 1.6
2.3 1.1
Apparent 6.6 0.4
Transposition 9.6 0.76
Frequencies 3.9 0.81
(% of 5.6 0.62
exconjugants 5.7 0.46
that are Cm 2.1 1.0
resistant) 2.2 0.86
4.0 4.3
Average 5.0 1.2
Fig. 6.15 Table of apparent transposition frequencies 
of IHF+ and IHF- cells. Mate-out assays were 
performed as detailed in the text.
Apparent Transposition Frequencies in DS941 (IHF+/-)
IHF+
IHF-
-2.5 -2 -1.5
lo g  (T ra n s p o s i t io n  F re q u e n c y )
Anomalous 4.3% value
Fig. 6.16
Box plot of values of log(apparent transposition frequency) for IHF+ and IHF- 
donor cells
Boxes represent the range of values with the mean indicated as a vertical line. 
Error bars of 2x Standard Error from mean are also shown.
were performed on three separate occasions each time using freshly 
prepared donor strains. In total 10 colonies of both donor strains were 
assayed. The results obtained are shown in Figs 6.15 and 6.16. These 
results suggest a lower level of apparent transposition in the IHF” donor 
strain. One data point, 4.3%, in the IHF” set appears anomalous.
A f-Test was employed to test the statistical significance of the two result 
sets. If the 4.3% value of the IHF” data set was included the test gave a 
value of f=5.43, p<0.001, indicating a statistically significant difference 
between sets. The means of the two sets differ by a factor of 2.5. If the 4.3% 
value is discounted then the difference between means rises to 6  fold.
The results suggest a small (2.5-6 fold) but significant difference between 
the transposition levels assayed in the IHF+ and IHF” cells. The donor 
strain used in the above assays were isogenic apart from the himAr.TnlO 
allele. Thus the reduction in apparent transposition may caused by some 
unknown form of interference between Tn7 and TnlO. However, when 
these data are added to those of N. Etkaterinaki, who used a two different 
IHF mutations, it appears likely that the lack of IHF is mediating this 
reduction. With such an insensitive assay it is not possible to determine 
at which stage in the transposition process this effect is exerted. However, 
the IHF dependent attTn7 binding activity suggests it may be a direct 
effect. The finding by the Craig group that a boiled and spun host extract 
stimulates the in vitro Tn7 transposition assay adds further 
circumstantial evidence to this proposal (Bainton, Gamas et al. 1991, R. 
Bainton per s. comm.).
The levels of conjugation were essentially identical in each set of assays, 
thus there is no obvious loss of ability to transfer pEN300 in the IHF 
mutant. Thus, unlike the case of the F-factor and R100-1, R388 
conjugative transfer is unaltered in the himA strain (Dempsey 1987 ).
The location of the insertion event was determined by EcoRI digestion of 
plasmid DNA prepared from ex-conjugants. The restricted DNA was then 
electrophoresed on a 0.8% agarose gel (Fig. 6.17). The insertion sites 
appear to be the same in both assay sets. A further 10 exconjugants were 
tested, one had an insertion at a novel location in the lkb attT n7  
containing EcoRI fragment of pEN300, data not shown. This is not
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Fig. 6.17 Agarose gel of digested pEN300::Tn7-l.
The markers are BRL 1 kb ladder, lanes contain EcoRI digested  
mini-preps of plasm id D N A  from exconjugants, as described in 
the text. The bands migrating at 1.7 and 2.1 kb are indicative of 
Tn7-1 insertion at attTn7  position 0.
significant as approximately 10% of all Tn7-1 insertions in pEN300 occur 
at such sites in wild type strains. (M. Rogers, Ph.D Thesis, Glasgow)
Thus, if the lack of IHF is altering choice of the site of insertion, it is doing 
so at a level below the sensitivity of detection of this assay.
6.8.2 IHF and FhoS Transcription
The data presented above show IHF binding to a site on the opposite side 
of the Tn7 insertion point from the TnsD binding region. The site, IHF3  in
figure 6 .1 , lies a short distance upstream of the promoter regions of the 
PhoS gene. This gene, also known as PstS, encodes a 35 kD periplasmic 
phosphate binding protein ( Magota, K. et al., 1984; Surin, B. et al. 1984)). 
The PhoS protein plays an important role in the Pst system for the uptake 
of inorganic phosphate from the growth medium. Induction of the Pst 
system occurs on depriving E. coli of phosphate. The Pst system also exerts 
negative control over the synthesis of alkaline phosphatase. Thus, a 
phenotype conferred by PhoS mutants is constitutive expression of 
alkaline phosphatase.
Both in vivo and in vitro studies have mapped the transcription 
initiation site of the PhoS mRNA and promoter elements have been 
characterised ( Makino, K et al., 1988). The transcription initiation site lies 
approximately 100 nts downstream of the IHF3  site. It should be stressed 
that none of the promoter elements lie in the attTn7 containing insert in 
pMR80.
As discussed in the introduction, IHF is implicated in the expression of a 
number of genes in E. coli (Freundlich, Ramani et al. 1992 ).
Expression of the ilvGMEDA, ilvBN, aceBl, pfl and psp operons have 
shown to be reduced in strains lacking IHF. However expression of several 
other operons e.g. ompC, ompF and pyrB is increased in IHF mutants. 
Thus, IHF can both activate or repress transcription. A recent review has 
also demonstrated the presence of IHF binding sites in the proximity of the 
promoters of a number of genes . However, a role for IHF in the 
expression of these genes has not yet been demonstrated.
The location of the IHF binding site relative to the start of transcription of 
these various genes varies from -179 to +131. There is no apparent 
correlation between location of binding site and either stimulatory or 
inhibitory effect of IHF.
92
II
r~°ra
A lk a lin e
P h o s p h a ta s e
H
XP
White
Blue
Fig. 6.18
Chemical basis of blue/w hite Alkaline Phosphatase Test
DS941 SB10
Repressing
-5.8.3x10 M PO,
De-repressing 
8.3x10^1 P 0 4
Fig. 6.19 Photograph of DS941 and SB 10 grown on Medium 121 plates 
in repressing or de-repressing conditions in the presence of XP.
By analogy with the above examples it is possible that IHF binding to the 
IHF3  site adjacent to PhoS may influence expression of the PhoS gene.
As stated above, a loss of PhoS expression leads to constitutive synthesis of 
alkaline phosphatase; the inverse has also been demonstrated, increased 
PhoS expression leads to decreased alkaline phosphatase activity, even 
under de-repressing conditions (Amemura, 1982).
A blue/white plate based assay analogous to the B-galactosidase/X-Gal test 
exists for alkaline phosphatase activity.The indicator dye, 5-bromo-4- 
chloro-3-indolylphosphate-p-toluidine (XP) is added to minimal medium 
1 2 1  plates containing either de-repressing or repressing concentrations of 
phosphate.(Berg P.E., 1981) Colonies producing alkaline phosphatase stain 
blue, those not producing stain white( Fig. 6.18).
DS941 and SB10 were plated on Medium 121 containing 40 |ig/m l XP and 
either 8.3xlO"^M K2 HPO 4  (excess phosphate) or 8.3x10T"5m K2 HPO 4
(limiting phosphate). After overnight growth at 37°C the colour of the 
resultant colonies was observed.
As can be seen from Fig. 6.19 SB10 and DS941 produced equally intense 
blue colonies on the low phosphate plates and white colonies on the high 
phosphate plates. Thus as measured by this assay there is no detectable 
difference in levels of alkaline phosphatase in the presence or absence of 
IHF. However, the sensitivity of this assay is such that it will only detect 
gross alterations in the level of alkaline phosphatase in the cells. An 
important caveat to the interpretation of the results of this indirect assay is 
that IHF may influence transcription of the alkaline phosphatase gene 
itself, thus masking any effects of PhoS expression levels.
It remains possible that IHF may modulate the expression of PhoS to a 
limited extent, below the level of detection of this indirect assay. A more 
accurate determination of alkaline phosphatase activity, or preferably, 
direct quantitation of the PhoS gene product or use of a promoter probe 
construct to detect promoter activity in the IHF+ and IHF" strains will be 
necessary to detect any more subtle effects of IHF on transcription of the 
PhoS gene.
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6.9 Discussion
The data presented in this chapter suggest a complex arrangement of 
protein binding sites within the attTn7 locus. The retardation assays using 
the 280nt pMR80 fragment show, in addition to the TnsD specific 
complexes, two closely migrating host-factor complexes. On following 
criteria both these complexes appear to be caused by IHF binding to two 
sites in this molecule.
1) The activity is absent in himA~ cell
2 ) The complexes are formed even when the protein extract has been 
submitted to 10 minutes at 100°C
3) Binding is strongly enhanced when a partially purified IHF extract is 
assayed.
4) One strong match to the IHF binding consensus site is found in the 
pMR80 insert, at the position designated IHF3  in Fig. 6.4. Two further 
poorer matches to the consensus are also detected.
5) Binding of the host factor induces a sharp bend in the DNA.
Whilst individually none of the above observations prove that the host 
activity is IHF, the combination of observations strongly support this 
theory.
With the exception of IHF3  the matches to the IHF consensus are not 
particularly strong. Because of the large region of protection caused by IHF 
binding to other substrates it appears that sequences beyond the 
WATCAANNNNTTR consensus are important for IHF binding. Indeed, 
some potential IHF sites with strong matches to the core consensus bind 
IHF very poorly. Therefore, one of the complexes is probably due to 
binding to IHF3 , this is supported by the localisation of binding to the 
Hindlll-Msel and Hindlll-MboII restriction fragments of pMR80, and by 
the apparent centre of the bend induced by IHF binding. As noted above 
the second IHF dependent band is not always present, this may reflect a 
weak interaction with one of the poorer IHF sites. It has been 
demonstrated that IHF will bind tightly but non-sequence specifically to 
DNA containing an intrinsic bend. Thus, in addition to the requirement 
for the consensus sequence, local structure probably strongly influences 
the binding of the protein (Bonnefoy and Rouviere-Yaniv 1991 ).
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It has been observed that binding of HU to DNA can influence the affinity 
of binding of IHF to the same molecule (Bonnefoy and Rouviere-Yaniv 
1992 ). Thus it is possible that sites with weak affinites for IHF in vitro may 
become better binding sites in vivo . Although HU may be present in the 
crude extracts used in binding reactions, the presence of excess Salmon 
Sperm DNA will prevent its binding to the pMR80 DNA.
Further evidence for a role for IHF in Tn7 transposition comes from the 
observation that the apparent transposition of Tn7-1 is reduced in a himA~ 
strain. Obviously this slight effect could be caused at any stage in the 
transposition process. However, it is important to note that it has been 
demonstrated, in this laboratory, that IHF does not bind to the 
transposon's termini (Morrell 1990 ). In light of the above binding data, it 
is tempting to suggest that IHF may favourably influence the 
conformation of the att-site, either for transposon excision from the 
chromosomal attTn7::Tn7-l donor site or incision of the Tn7-1 element in 
the recipient pEN300, or both processes. Work by Mark Rogers, presented 
in his PhD Thesis, has shown that the transposition rate of Tn7 is 
apparently not influenced by the flanking donor host sequences. Thus if 
IHF binding to the att-site is influencing transposition it is more likely to 
be at the level of insertion.
The work of Waddell and Craig agrees in part with the observations 
described above. In addition to the TnsD specific complex they also 
detected a complex caused by a heat stable host factor. Only one host 
complex was observed, presumably reflecting their use of shorter DNA 
substrates in the binding reactions. They claim to have localised important 
sequence determinants for this binding to attTn7 +10 to +27. As I discussed 
earlier, I feel that their data was incorrectly interpreted, since +10 to +27 
does not compete for binding of a protein to -25 to +64. This suggests that 
different binding activities are being detected on these over-lapping 
fragments. The cause of the weak binding to the +9 to +55 oligonucleotide 
observed in my work may be the same factor that binds to the +10 to +27 
in the published work . This binding is possibly due to recognition of some 
feature of the synthetic DNA. It is clearly not due to the absence of 
methylation at the dcm site at +48.
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Although the data presented in this chapter identifies an IHF site in the 
attTn7 locus, it has not allowed identification of the host factor responsible 
for the binding detected by Waddell and Craig. It is clear that in the absence 
of IHF no host binding is observed using the full length pMR80 insert. It is 
possible that the binding observed by Waddell and Craig corresponds to 
the weak, and sometimes irreproducible, second band produced by IHF 
binding to the pMR80 insert.
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Chapter 7 
Concluding Remarks
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This project addressed various aspects of the transposon Tn7. The initial 
work, presented in Chapter 3 completes the known DNA sequence of the 
element. A entire DNA sequence is compiled and presented in this 
chapter. An intriguing finding is that a considerable proportion of the 
element appears to be non-coding; in addition two potential genes have 
little or no function in vivo, a lambda integrase in the left end of the Tn7 
is interupted by a stop codon, furthermore the sat gene is only expressed at 
very low levels , conferring resistance to only very low levels of 
streptothricin. The low level of expression of this gene is proposed to be 
due to insertion of the upstream dhfr gene cassette in the ribosome 
binding site of the sat gene.
It is suprising that an element such as Tn7 , which could be viewed as 
parasitic DNA should have so much non-coding DNA. It is possible that, 
by analogy with the IAS of phage Mu, some of these regions have a 
structural role in Tn7 transpostion process. The potential role of a series of 
repeated motifs in the centre of the transposon was also addressed in this 
chapter. It is clear from previous studies of Tn7 transposition that the only 
cis acting sequences required for Tn7 transposition are those at the termini 
of the element. However with the relative insensitivity of the in vivo 
transposition assay it remains a possibility that internal elements may play 
a role in transposition. Future workers could address this question by 
using short restriction fragments of the inner regions of Tn7 in gel 
retardation assays with extracts prepared from cells overexpressing the Tns 
proteins in the hope of detecting specific binding to these regions.
Perhaps the nature of the Tn7 transposition pathways has permitted the 
accumulation of large regions of apparently non-functional DNA with 
little detriment to the transposon. Studies indicate that Tn7 is generally 
found at a single site in the chromosome of several species of Gram 
negative bacteria. In E coli it has been demonstrated that apart from the 
acquisition of drug resistance this insertion is phenotypically silent, i.e. 
insertion does not disrupt any cellular gene expression. By spending most 
of its time in the chromosome and only occasionally transposing to broad 
host range plasmids perhaps there is little selective pressure for loss of 
these non-coding regions of Tn7.
Chapter 4 presented data on the construction of plasmids to coordinately 
over express TsnABCD, one construct was observed to have bizarre effects
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on the detection of transposition products in vivo. A model was proposed 
for this effect and attempts were made to detect double strand breaks, none 
were observed but this may reflect a limitation of the detection method. 
For future workers it would be useful to repeat this analysis using the 
pSB84 construct, which supported high levels of in vivo transposition. 
This chapter also described attempts to generate a Tn7 in vitro system, 
again, this was unsuccessful, potential transposition products were 
detected, but never reproducibly. Chapter 5 presented data that suggests 
that in pSB84 extracts TnsD is prevented from recognising the attTn7 site 
by an interaction with one or more of TnsABC. The presence of ATP and 
low levels of Mg ions enabled detection TnsD binding. These data may 
explain why the attempts to develop an in vitro system were largely 
unsuccessful. Any future work to develop a Tn7 in vitro system must 
take these observations into account. Presumably in the Craig group in 
vitro system condition this effect is overcome by the relative ratios of the 
Tns proteins. In light of the data presented in Chapter 4 on the 
interference of Mg++ with TnsD binding, it may be possible to alter the 
conditions of the in vitro reaction to have low Mg++ and ATP present 
throughout the entire time course of the reaction.
Finally, work presented in Chapter 6  identified an IHF binding site in the 
attTn7 locus. Only a prelimnary characterisation of the site is presented, 
further work should examine the protection from cleavage by DNasel 
conferred by binding to this site and use other DNA footprinting 
techniques. A potential role for IHF in the transcription of the phoS (pstS) 
gene is also suggested, to examine this question transcriptional fusions of a 
reporter gene to this locus should be constructed and levels of 
transcription assayed in isogenic IHF+ and IHF" cells.
In conclusion, it is clear that there are many aspects of the Tn7 
transposition reaction that are poorly understood, with the development 
of an in vitro reaction by the Craig group, and hopefully here in Glasgow, 
more understanding will be gained on the complex interactions between 
the Tns proteins and DNA sites involved in Tn7 transposition.
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